<!doctype html>
<html lang="en">
<head>
  <link rel="icon" href="https://wtd-1.github.io/web/pc.png?v=1" type="image/png">

  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>WTD Neuro</title>

  <style>
    :root {
      --mono: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas,
              "Liberation Mono", "Courier New", monospace;
    }

    html { font-size: 14px; }              /* was 14x → 14px */

    body {
      font-family: var(--mono);
      line-height: 1.6;
      margin: 0 auto;
      max-width: 70ch;
      padding: 2rem 1rem;
      text-align: none;                 /* justify all text */
      text-justify: inter-word;            /* hint for some engines */
    }

    h1, h2, h3, h4, h5, h6 { 
      font-weight: 900;                    /* 1000 → clamp to 900 */
      margin: 1.5rem 0 .5rem; 
      /* headings will justify if they wrap */
    }

    p {
      margin: .75rem 0;
      font-size: 0.85rem;
      line-height: 1.6;
      hyphens: auto;                       /* better word breaks */
      overflow-wrap: anywhere;             /* prevents overflow */
    }

    /* Keep code/pre in the same font (explicitly) */
    code, pre, kbd, samp { font-family: inherit; }

    hr { border: none; border-top: 1px solid #ccc; margin: 2rem 0; }

    @media (prefers-color-scheme: dark) {
      body { background: #0b0b0c; color: #eaeaea; }
      a { color: #9ccaff; }
      hr { border-top-color: #333; }
    }

    /* Basic table look */
    .pub-table {
    width: 100%;
    border-collapse: collapse;
    table-layout: fixed;
    }
    .pub-table th, .pub-table td {
    padding: .5rem .6rem;
    border-bottom: 1px solid #ccc;
    vertical-align: top;
    }
    .pub-table thead th { text-align: left; }

/* Optional: make the year column subtle on narrow screens */
@media (max-width: 640px) {
  .pub-table .year { opacity: .7; width: 5ch; }
}

  </style>

  <!-- MathJax v3 (TeX input, SVG output) -->
  <script>
    window.MathJax = {
      tex: {
        inlineMath: [['$', '$'], ['\\(', '\\)']],
        displayMath: [['$$', '$$'], ['\\[', '\\]']]
      },
      svg: { fontCache: 'global' }
    };
  </script>
  <script id="MathJax-script" async
    src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-svg.js"></script>
</head>
<body>

<h1>Introduction to Neuroscience</h1>
<center><p>[ <a href="teach.html"><b>BACK TO TEACHING PAGE</b></a> ]</p>
</center><br>

<p>
          The brain has always been understood to be vital to life. Neuroscience draws its origins to
          prehistoric life, when our ancestors recognized the brain’s importance and even performed skull
          surgeries such as trepanation. Evidence shows that many of these early patients survived, as their
          skulls reveal signs of healing. Later, in ancient Egypt, people believed the heart was the seat of
          the soul and memory rather than the brain. During mummification, the lungs, stomach, liver, and
          intestines were preserved, while the brain was removed and discarded. However, the Egyptians still
          noted the brain’s role in health, as seen in the Edwin Smith Papyrus, the oldest known surgical
          document, which describes the treatment of traumatic brain injuries and their consequences.
        </p>
      </section>

      <section id="chapter2"><h2>Neuroanatomy</h2>
        <p>The nervous system can be divided in two: the peripheral nervous system (nerves and
          ganglia) and the central nervous system (tracts and nuclei). These divisions can be further subdivided:
          the former into the somatic (voluntary) nervous system and the latter into the autonomic nervous system 
          (which itself is further split into the sympathetic, fight or flight, and the parasympathetic, 
          rest and digest, nervous systems).
        </p>
        <p>The nervous system is the body's information system—it gathers input, processes, and produces output.
          The spinal and cranial nerves take in sensory information and mediate output in the periphery—that is, not 
          in the central nervous system. Incidentally, the spinal cord and brain stem are what relay information between
          the periphery to the brain; they also have some processing and output capacity. The brain is the hub of such 
          information; it is a major site of processing and (initiating) output.
        </p>
        <p><strong>Recall.</strong> The peripheral nervous system (PNS) is divided in two: the somatic and 
        autonomic nervous systems. </p>
        <h3>The Somatic Nervous System</h3>
        <p>
          The processes of the somatic nervous system are more strongly associated with conscious awareness and control 
          whereas the autonomic nervous system (ANS) is not (e.g., blood pressure, pupil dilation/contriction).
        </p>
        <p>There are anatomical anchor points to determine where you are in the nervous system. These are: 
          <ul>
            <li>the ganglia, groups of neurons in the periphery</li>
            <li>dorsal root ganglia, those groups of neurons which are closer to the back and relate sensory 
              information to the spine
            </li>
            <li>ventral roots, which lie close to the stomach and sent motor commands to the muscles. </li>
          </ul>
        </p>
        <p><strong>Remark.</strong> Dorsal root ganglia contain the sensory neuron cell bodies that send 
          signals from the body to the spinal cord, while ventral roots carry motor commands from the 
          spinal cord to the skeletal muscles, forming the core of the somatic nervous system for voluntary 
          movement and sensation. The somatic nervous system, via these roots, connects the central nervous 
          system to sensory receptors and muscles, allowing conscious control and perception.  </p>
        <p>The sympathetic chain contains the nerves of the autonomic system that innervates organs.</p>
        <h3>Cranial Nerves</h3>
          <p>Cranial Nerves are those which emerge directly from the brain. They are for the body parts which 
            are above and include the neck. The cranial nerves are numbered <tt>1</tt> through <tt>12</tt>; three
            are for sensory only, five are motor only, and four contain both sensory and motor neurons. 
          </p>
          <p>The rule stated above about how cranial nerves are for those body parts which lie above and include
            the neck has an exception: the vagus nerve, which is a cranial nerve that sends information to and
            from the organs of the body.
          </p>
          <h3>The Autonomic Nervous System</h3>
          <p>There are two divisions of the ANS, a latter third arises if one squints: 
            <ul>
              <li>The sympathetic nervous system </li>
              <li>The autonomic nervous system </li>
              <li>The enteric nervous system (guts/digestive)</li>
            </ul>
          </p>
          <p>The sympathetic nervous system is known for the fight, flight or freeze response. Think: "emergency! 
            I must live!" 
            The sympathetic chain is innervated by preganglionic neurons in the spinal cord and runs along each side
            of the spinal column. 
          </p>
          <p>On the other hand, the parasympathetic nervous system is the system of rest and digest and is often 
            in opposition to sympathetic activity. It is concerned with long term survival. Consider: a sympathetic nervous response elevates 
            the heart's rate; it will slow by parasympathetic activity. 
          </p>
          <p>The enteric nervous system consists of a local network of neurons that governs the function of the
            gut; it is innervated by both the sympathetic and parasympathetic divisions of the nervous system.
          </p>
          <h3>The Central Nervous System (CNS)</h3>
          <p>The brain and spinal cord live in a controlled, privileged environment encased in bone and 
          a protective covering called meninges. The central nervous system has certain privileges of note:
            <ul>
              <li>Metabolic, first dibs on oxygen and glucose</li>
              <li>Immune, isolated from the ebbs and errs of the immune response in the periphery (i.e., anything not 
                in the CNS).
              </li>
            </ul>
          </p>
          <p><strong><u>Definition</u>.</strong> Meninges are the three protective soft tissue layers surrounding
          the entire central nervous system, both the brain and spinal cord. </p>
          <p>There are three layers to the meninges (IN TOP-DOWN, bone to brain, ORDER): 
            <ul>
              <li>the tough outside, the Dura Mater</li>
              <li>the blood-brain barrier, the arachnoid (think: spidery, webby)</li>
              <li>the brain surface, the Pia Mater</li>
            </ul>
          </p>
          <p><strong><u>Definition</u>.</strong> The blood-brain barrier (BBB) is a system of protection
          involving capillary endothelial cells and astrocytes that form a highly selective semipermeable
          border between the circulatory and central nervous systems (i.e., from bloodstream to brain). It
          regulates the transfer of solutes and chemicals.  </p>    
          
          <h3>On the Brain</h3>
          <p>The brain is dominated by two cerebral hemispheres, a left side and a right side, separated 
            by the median longitudinal fissure (the gap betwixt the two) and connected
            by the corpus callosum. These hemispheres are lateralised, meaning they have specialised functions. 
          In particular, the left is generally dominatnt for language and logical tasks and the right for processing 
        spacial information, emotions and creativity. </p>
        <p>There is an outermost layer of the cerebral hemispheres, the cerebral cortex. Cortex (n.) is derived from 
          Latin <i>cortex</i>, meaning "bark, rind, outer shell."</p>
          <h3>Memories and Sensation</h3>
          <p>The idea of memories, sensation and the brain find their origins in the propositions of 
            Galen in the second century CE. Galen believed the brain had different parts suited to different
            tasks. The cerebrum, being relatively soft, seemed designed to receive impressions from the sensations
            and the cerebellu, being firmer, seemed better suited to movement command. It was also thought
            by Galen that there were special fluids, "animal spirits," contained in the ventricles that flowed through
            hollow nerves to communicate movement and sensation throughout the body. Taken together, Galen
            advanced an early understanding of localisation of function, that is: sensation in the cerebrum, 
            motor control in the cerebellum, and fluid-mediated communication via the ventricles. 
          </p>
          <p>In Galen's framework, the ventricles were not only empty spaces; rather they were the engine room. 
            He imagined the fluids inside them carried signals. This "ventricular theory" was later expanded by
            medieval scholars, assigning mental faculties to specific chambers: 
            <ul>
              <li>the anterior ventricle being for immagination and common sense</li>
              <li>the middle ventricle for reasoning</li>
              <li>the posterior ventricle for memory</li>
            </ul>
          </p>

          <p>In this age of modernity, we understand the ventricles differently, as four connected, fluid-filled
            spaces that circulate cerebrospinal fluid which cushions the brain, helps maintain chemical stability, 
            and supports waste clearance. Fluid theory is replaced with neural circuits, locating sensation in the 
            cortical sensory areas and memory in the hippocampus (formation) and distributed cortex (storage).
          </p>
          <h3>Some Anatomical Vocabulary</h3>
          <p>We have the frontal lobe, which is the most anterior region; the parietal lobe, which lies
            between the fontal and occipital lobes; the occipital, posterior, lobe; and the temporal, lateral, 
            lobe.
            <ul>
            <li>The frontal lobe is for planning, decision-making and voluntary movement</li>  
            <li>The parietal lobe is for sensory processing—touch and spatial orientation</li>
            <li>The temporal lobe is for auditory processiong, memory and language comprehension</li>
            <li>The occipital lobe is for visual processing</li>
            </ul>
            
          </p>
          <p>In addition to knowing the four lobes of the cerebrum, we also must know more about how 
            the brain can be further described. With regard to the surface of the brain, the <strong>gyrus</strong>
             is a ridged or raised portion of the convoluted brain surface and the <strong>sulcus</strong>
             is a furrow of such surface. 
          </p>
          <p>Sulci and gyri can be used to describe the brain, this we know, which means there are certain 
            landmarks which are of note: 
            <ul>
              <li>the lateral sulcus, the Sylvian Fissure, formes the boundary of the temporal lobe</li>
              <li>the central sulcus divides the frontal from the pariental lobe</li>
              <li>the postcentral sulcus is a strip of sulcus behind the central cortex that is 
                critical for touch
              </li>
              <li>the precentral gyrus, which is in the frontal lobe and is important for motor control</li>
            </ul>
          </p>
          <h3>Localisation: the 19th-century Debate and Now
          </h3>
          <p>In the 1800s, scientists argued about whether the mind was spread uniformly across the brain
            or whether specific mental faculties were located in different areas. Franz Joseph Gall's 
            phrenology pushed a strong, perhaps even too strong, perspective of localisation. To him, the brain 
            is an organ of the mind that is itself constituted by multiple "organs" for distinct mental abilities. 
            The argument was that such organs were topogrpahically localised and that, all other things being equal, 
            the size of an organ determines it's strength. Furthermore, Gall argued phrenology, the idea that the 
            external contours of the skull, which can be felt, revealed much about a person's mental traints. 
          </p>
          <p>Indeed, Gall's phrenological thesis is flawed—there is no correlation between a skull's shape
            and the brains topology. However, the idea of localisation was popularised on Gall's account, which 
            propelled neuroscience further into investigating structure-function relationships in the brain. 
          </p>
          <p>And Gall's making of the brain to be localised was not wrong either—just taken too far. Phineas Gage
            survived an explosion in which a tamping iron impaled his left frontal lobe: rendering him more 
            impulsive, unreliable, and socially inappropriate. This gives strong evidence of the frontal lobes 
            being linked to executive control, decision making and social behaviour. 
          </p>
          <p>Another example of localisation is in the discovery of Broca's Area. A patient "Tan" could understand
            language but could only speak one syllable: "Tan." Following Tan's death, it was later found that
            a lesion in the left inferior frontal gyrus, now Broca's Area, the area responsible for expressive 
            (motor) communication. 
          </p>
          <h3>The Functions of Each Lobe (in depth)</h3>
          <p>
            The frontal lobe is the motor cortex on the precentral gyrus and controls voluntary movement. 
            It houses Broca's Area, where speech production occurs, as well as the prefontal cortex, where 
            planning, impulse control, and decision-making occurs. 
          </p>
          <p>The parietal lobe is important for body sensations, attention, perception, and spatial
            localisation. It is the primary somatosensory cortex on the postcentral gyrus and 
            processes skin senses, body position and movement. Parietal association areas integrate information 
            from different sensory modalities. 
          </p>
          <p>The temporal lobe is delinated by the sylvian fissure and contains the primary auditory cortex. 
            It also contains Wernicke's Area, where language comprehension and production is found. The 
            temporal lobe also has inferior temporal cortex visual indentification. 
          </p>
          <p>The occipital lobe is primarily a visual cortex that contains a map of visual space. It 
            also contains secondary visual areas that process individual components of a scene. 
          </p>
          <h3>Orientations of the Brain</h3>
          <p>To discuss the orientation of the brain, we must examine its planes. 
            <ul>
              <li>The sagittal plane bisects the brain into left and right regions</li>
              <li>The coronal plane divides the brain into front (anterior) and back (posterior) regions</li>
              <li>The horizontal plane divides the brain into an upper and lower part</li>
            </ul>
          </p>
          <p>There are some more vocabulary words to know. Namely, 
            we use <strong>medial</strong> to mean “toward the middle,” while <strong>lateral</strong> means “toward the side.” 
            If something is on the <strong>ipsilateral</strong> side, it is on the same side of the body, whereas <strong>contralateral</strong> means it is on the opposite side. 
            We say <strong>anterior</strong> (or <strong>rostral</strong>) when referring to the head end, and <strong>posterior</strong> (or <strong>caudal</strong>) for the tail end. 
            When a structure is <strong>proximal</strong>, it is closer to the center, and when it is <strong>distal</strong>, it is farther out toward the periphery. 
            Finally, <strong>dorsal</strong> means “toward the back,” while <strong>ventral</strong> means “toward the belly or front.”
          </p>
          <h3>About the Brain</h3>
          <p>White matter consists mostly of axons with white myelin sheaths; hence the "white" in the name. 
            On the other hand, gray matter contains more cell bodies and dendrites, both of which lack myelin. 
          </p>
          <p><strong>Recall.</strong> The corpus callosum connects the left and right hemispheres of the brain. It is 
          a fat body; a tract of axons.</p>
          <p>The thalamus is responsible for sensory processing and arousal. The Hypothalamus is the master
            hormone regulator and is responsible for emotions and motivations. The Midbrain plays secondary roles
            in vision, audition and movement. The Hindbrain is subdivided into parts:
            <ul>
              <li>The Medulla and Pons, which regulates vital and unconscious processes including breathing, 
                swallowing, and etc. 
              </li>
              <li>
                The cerebellum, which is involved in motor coordination. 
              </li>
            </ul>
          </p>
          <p>There are certain brain structures which are unseen from the outside or midsaggital views.
            The are: 
            <ul>
              <li>The Basal Ganglia, which plays a secondary role in motor coordination and motor learning</li>
              <li>The Limbic System, which is the emotional system of the brain that mediates emotional 
                responses and is important for emotional learning. 
              </li>
            </ul>
          </p>
        </section>

      <section id="chapter3"><h2>Neurons & Membrane Potentials</h2>
        <p>To understand how the nervous system works, it helps to start with the basic building blocks. We will first look at the parts of a neuron and its overall morphology, which shape how it functions. Next, we will trace the flow of information both within a single neuron and between neurons through their connections. Finally, we will consider the non-neuronal cells of the nervous system, which provide essential support, protection, and regulation for neural activity.</p>
        <h3>The Eukaryotic Cell</h3>
        <p>Recall that eukaryotic cells carry a nucleus. It is critical for us to furthermore 
          recollect the organelles that are not only important for cellular life but also for 
        neuroscience.  </p>
        <p>The plasma membrane is the most critical structure for membrane potentials. It contains
          the ion channels, pumps, and receptors that regulate the flow of sodium(Na<sup>+</sup>), 
          potassium (K<sup>+</sup>), cloride (Cl<sup>-</sup>) and calcium (Ca<sup>2+</sup>). 
          The Na<sup>+</sup>/K<sup>+</sup> ATPase pump, or more simply the sodium-potassium pump, is embedded
          in this membrane and maintains the resting potential by transporting sodium out and potassium in.
        </p>
        <p><strong><u>Remark.</u></strong> At rest, neuronal membranes are more permeable to K<sup>+</sup>
        than to Na<sup>+</sup>. That is why the resting membrane potential is around -65 to -70 mV, which happens
      to be close to the Nernst equilibrium potential for K<sup>+</sup> (around -90 mV). 
    Put differently, potassium "dominates" the resting potential since it leaks through K<sup>+</sup>
  leak channels. This efflux sets up a negative relative to the outside. But even at rest, a small
amount of Na<sup>+</sup> leaks in, since sodium's equilibrium potential is around +60 mV and the 
plasma membrane, hereafter "the membrane," is not perfectly impermeable. Without correction, sodium will 
gradually depolarise the cell (i.e., make it less negative) and disrupt the potassium gradient.
<br><br>
<strong><u>Note:</u></strong> The inside of a neuronal cell is low in Na<sup>+</sup> and high in K<sup>+</sup> and vice versa for 
the outside. The higher concentration of an ion is called as the "gradient." The reason why sodium 
keeps wanting to enter the membrane is simple: it is positive (and the inside is more negative at an
approximate -65 mV resting potential) and there are less sodiums inside and a surplus of them outside. 
<br><br>
<strong><u>Remark (cont'd).</u></strong> This is bad, because as sodium accumulates inside, the 
concentration gradient that favours potassium leaving—which incidentally is what keeps the
resting potential stable—is diminished. Without the corrective actions of the sodium-potassium pump, which 
contantly pushes sodium out and sucks potassium in, then the cell can maintain its resting potential no longer. 
So, while the sodium-potassium pump does not actually set the -65 mV resting potntial directly, it preserves
the conditions requisite of allowing the K<sup>+</sup> leak channels to do that work. 
<br><br>
<strong><u>Note:</u></strong> The sodium-potassium pump maintains the gradients by pumping out three 
sodiums and sucking two potassiums. It does that by being activated by adenosine triphosphate (ATP). Remember:
the membrane is passively K<sup>+</sup> permeable.</p>
<p>The mitochondria is the "powerhouse of the cell." It produces the ATP that powers ion pumps, like those
  Na<sup>+</sup>/K<sup>+</sup> ATPase pumps and Ca<sup>2+</sup> transporters. The crux of the matter here 
  is that without mitochondria, there will not be any ATP production, which means cells cannot 
  maintain their electrical gradients; that is bad because it can lead to cell disfunction or death. 
</p>
<p>The endoplasmic reticulum (ER) has two variants:
  <ul>
    <li>the rough variant studded with ribosoes synthesises proteins—especially receptors and ion channels that
      are inserted into the neuronal membrane
    </li>
    <li>
      the smooth ER, which helps regulate intracellular calcium storage and release; critical for 
      neurotransmitter release at the synapses.
    </li>
  </ul>
</p>
    <p>
      The Golgi apparatus packages and modifies the proteins made in the ER (specifically the rough one!). 
      In neurons, the Golgi apparatus is essential for sorting ion channels, neurotransmitter receptors, and
      transport proteins to their correct destinations (e.g., to axon vs. to dendrite).
    </p>
    <p>The cytoskeleton provides the cell its structure and support but, in neurons, also guides the 
      transport of vesicles, receptors, and transport proteins to their correct destinations (e.g., to axon vs. to dendrite). 
    </p>
    <p>The nucleus controls gene expression, including the production of proteins needed for ion channels
      and synaptic function. The nucleolus produces ribosomes, which are vital for protein synthesis (which
      requires ATP).<br><br>
      <strong><u>Note:</u></strong> Gene expression changes underlie long-term plasticity in neurons.
    </p>
    <h3>So, What Makes a Neuron Different than a Eukaryotic Cell?</h3>
    <p>Neurons share the same basic organelles as a typical eukaryotic cell: a nucleus, nucleolus, 
      rough and smooth ER, Golgi apparatus, mitochondria, ribosomes, cytoskeleton, and plasma membrane. 
    </p>
    <p>But, neurons are not just the life support machinery eukaryotic cells are—they are highly 
      specialised communication machines optimised for rapid, long-distance electrical and chemical 
      signaling. In particular, some special features of neurons include: 
      <ol>
        <li>
          <strong>Extreme polarisation</strong>. Neurons have distinct domains:
          <ul>
            <li>the soma (cell body) which serves as the metabolic center that houses the nucleus</li>
            <li>dendrites, which are the input structures that receive synaptic signals</li>
            <li>axons, the output structures that can be extremely long, carrying action potentials (APs)
              to target destinations
            </li>
          </ul>
          with a clear division of labour unlike most eukaryotic cells.
        </li><br>
        <li><strong>Information Flow.</strong> Signals flow in a directional pathway key to neural networks: <br>
        <center>dendrite $\rightarrow$ soma $\rightarrow$ axon $\rightarrow$ synaptic terminals.</center>
        </li><br>
        <li><strong>A Specialised Plama Membrane</strong>. The neuronal variant of
          plasma membranes come packed with ion channels, pumps, and receptors that generate 
        and propagate electrical signals called membrane potentials. Furthermore, these have a 
          unique ability to fire APs and communicate rapidly across long distances.</li><br>
          <li><strong>Synaptic Specialisations.</strong> Neurons form synapses, specialised contact points 
          with other neurons or muscles. They contain synaptic vesicles, neurotransmiter release machinery, 
        and postsynaptic receptor clustering.</li><br>
          <li><strong>Cytoskeletal Adaptations.</strong> Neurons rely on a dynamic cytoskeleton to transport 
        proteins, mitochondries and vesicles across vast distances along dendrites and axons. This sort 
      sort of long distnace trafficking is rate in most other cells. </li><br>
          <li><strong>High Energy Demand. </strong>Mitochondria are especially abundant in axon terminals
          and dendrites to meet enormous energy requirements for maintiang ion gradients and neurotransmission
        (a lot of ATP is produced).</li>
      </ol>
    </p>
    <br>

     <p>Cajal used Golgi's staining method to visualise neurons and revealed them as distinct cells, 
      the "neuron doctrine," as opposed to a previous framework. The drawing shows many different 
      neuronal morphologies: 
      <ul>
        <li>pyramidal cells with long apical dendrites</li>
        <li>purkinje cells with elaborate, tree-like dendritic arbours</li>
        <li>granule cells that are tiny and densely packed</li>
        <li>stellate and basket cells with wide-spreading dendrite</li>
      </ul> 
     </p>
     <p>Each morphology is adapted for a specific computational role within the brain. Speaking of 
      form, form supports function. Large, branching dendritic trees (e.g., purkinje cells) integrate 
      thousands of inputs for complex processing; long axons enable communication spanning distant 
      brain regions; small, compact neurons for fast, local processing. All of these give rise to the 
      concept of functional specialisation of different brain circuits. 
     </p>
     <h3>(Nervous System) Cells at Work!</h3>
     <p>Neurons are electrically active cells that store and transmit information. They are supported
      by glial cells provide support for such neurons; they are:
      <ul>
        <li>astrocytes</li>
        <li>microglia</li>
        <li>oligodendrocytes and Schwann cells</li>
      </ul>
     </p>
     <h3>Neurons</h3>
     <p>Notice the form of the neuron: it illustrates the direction of information flow. Dendrites
      receive information; the cell body/soma integrates; axons and axon terminals conduct and output 
      information
     </p>
     <p>
      Information generally flows in a single direction. Pre-synaptic flow concerns the axon sending 
      information. The axon generates an AP which arrives at the pre-synaptic terminal, which introduces
      an influx of calcium ions through voltage-gated calcium channels that cause neurotransmitter release. 
     </p>
     <p>Post-synaptic concerns the dendrites mostly, receiving information. The neurotransmitter activates
      the postsynaptic terminal on dendrites, which transmit a signal to the cell body. 
     </p>
     <h3>Classifying Neurons</h3>
     <p><u><strong>Definition.</strong></u> A process is said to be primary, or called as a neurite, if it 
      originates directly from the cell body.</p>
      <ul><strong>Corollary. </strong> All neurons have one and only one primary axon.</ul>
      <p>Neurons may be classified by the number of primary dendrites.</p>
      <p>Consider the following: <ol>
        <li>Multipolar, where there are more than one primary dendrite. Many dendrites extend 
          from the cell body; only one axon is present. Very common in the central and peripheral 
          nervous system.
        </li>
        <li>Bipolar, where there is only one primary dendrite. The single dendrite extends from the cell
          body and there is a single axon. Very common in the central and peripheral 
          nervous system.
        </li>
        <li>Unipolar, where there is one process consistin of a fused dendrite and axon. This 
          single branch that extends in two directions from the cell body. Its unipolarity comes from the fact 
          that the single branch serves as both a dendrite and an axon. These are often 
          sensory neurons.
        </li>
      </ol></p>
      <p>All neurons have the same four functional zones—
        <ol>
          <li>input</li>
          <li>integration</li>
          <li>conduction</li>
          <li>output</li>
        </ol>
      </p>
      <p>—although they are organised in different ways. </p>
      <h3>Synapses</h3>
      <p>Synapses are where two neurons exchange information,. They require closely apposed 
        membranes: 
        <ul>
          <li>presynaptic membrane, which is on the axon terminal of the presynaptic neuron.</li>
          <li>postsynaptic membrane, which is on the dendrite or cell body of the postsynaptic neuron.</li>
          <li>the synaptic cleft, a gap which separates the membranes</li>
        </ul>
      </p>
      <p>Like all structures, synapses have certain key features. <i>Synaptic vesicles</i> contain 
          neurotransmitters, which are released in response to electrical activity in the axon. 
        <i>Receptors</i> in the postsynaptic membrane are specialised proteins that react to a neurotransmitter.</p>
     <h3>Axons; Dendrites</h3>
     <p>Axons are different from dendrites! The former transmits the information that the latter receives. 
      They have distinct morphology/subcellular structures. 
     </p>
     <p>Dendritic spines are specialised protrusions on dendrites that contain postsynaptic density 
      for receiving signals. It increases surface area for synapses. They are said to be <i>plastic</i>, that is, 
      they can change in size or shape and in number; such changes occur in response to neural activity
      or experience.
     </p>
     <p>We have already discussed some features of the axon—see the aforementioned discussions on dendrites, 
      synapses, cell body, and polarity—but there are some that deserve to be further clarified. The <i>axon hillock</i>
       is a cone-shaped area of the cell body that gives rise to the axon. The <i>axon collateral</i> is a branch of an aon that also
       ends in terminals and innervates other cells. 
     </p>
     <p>
<center>
<table class="neuro-table">
  <caption>
<u>    Axon vs. Dendrite
</u>  </caption>
  <thead>
    <tr>
      <th><center><u>Property</u></center></th>
      <th><center><u>Axons</u></center></th>
      <th><center><u>Dendrites</u></center></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><center>Number</center></td>
      <td>Usually one per neuron, with many terminal branches</td>
      <td>Usually many per neuron</td>
    </tr>
    <tr>
      <td><center>Diameter</center></td>
      <td>Uniform until the start of terminal branching</td>
      <td>Tapers progressively towards ending</td>
    </tr>
    <tr>
      <td><center>Axon Hillock</center></td>
      <td>Present</td>
      <td>None</td>
    </tr>
    <tr>
      <td><center>Sheathing</center></td>
      <td>Has myelin sheathing</td>
      <td>None</td>
    </tr>
    <tr>
      <td><center>Length</center></td>
      <td>Can be practically nonexistent to several metres long</td>
      <td>Oftentimes much shorter than axons</td>
    </tr>
  </tbody>
</table>
</center>
     </p>
     <h3>Myelination of Axons</h3>
     <p>Recall the two classifications of nervous system cells: neurons and glia—the latter of which can be further 
      subdivided into astrocytes (for metabolic and other support), microglia (the immune cells), and oligodencrocytes/
      Schwann cells (responsible for the myelination of axons).
    That lattermost part, the Schwann cells/oligodendrocytes, is the focus of this section. This is the part where information 
      get's transmitted over great distances, the conduction zone, starting from the axon hillock (the integration zone, where the 
      decision to produce a neural signal is made) all the way to the head of the axon terminals, the output zone.
     </p>
     <p>Oligodendrocytes are a part of the CNS and Schwann cells the PNS; they insulate axons so the electric signals can propogate. 
      Along the myelination, the fatty insulation, there are certain gaps called the <i>Nodes of Ranvier</i> where the axolemma is 
      exposed to the extracellular space. These domains are high in sodium and potassium ion channels that are complexed with cell adhesion
      molecules. This results in an exchange of ions that regenerates the action potential (AP). 
     </p>
     <p><strong><u>Note:</u></strong> myelination is not universal among vertebrate, with primitive groups lacking it. The reason
    for that is there are two ways one can preserve the action potention as it travels across the axon: <ol>
      <li>have an axon of huge diameter which reduces resistance and allows the AP to travel faster</li>
      <li>mylinate the axon and take advantage of <i>saltatory conduction</i>, where the APs "jump" between nodes of Ranvier</li>
    </ol></p>
     <h3>On Astrocytes</h3>
     <p>Astrocytes provide structural, metabolic and trophic (nutritional) support for neurons. They help form the blood-brain barrier
      (BBB) and play important roles in plasticity and in modifying/supporting synaptic activity. They are star-shaped and detect
      neural activity; they also regulate adjacent capillaries for blood flow, supplying neurons with more energy when they 
      are active. 
     </p>
     <p>Astrocytes can also aid in neurotransmitter removal from the extracellular space. Consider a case in which which a 
      neurotransmitter is released into the synaptic cleft. It will bind to receptors in the postsynaptic neuron and trigger a response.
      However, the neurotransmitter must be cleared away swiftly, lest it overstimulates the neuron. And so, we remove the 
      neurotransmitter by:
      <ol>
        <li>reuptake into presynaptic neurons via specific transporters</li>
        <li>uptake by glial cells, where astrocytes takes up the excess using Excitatory Amino Acid Transporters (EAATs) or GABA
          Transporters (GATs)
        </li>
        <li>ezymatic brackdown, where something such as acetylcholine is broken down into choline and 
          acetate by acetylcholinesterase (AChE) and the choline is transported back into the presynaptic terminal and 
          reused to make new ACh. 
        </li>
      </ol>
     </p>
     <h3>On Microglia</h3>
     <p>Microglia are the immune cells of the central nervous system; they can be thought of as special immune cells, since
      the regular ones cannot enter the brain. They are macrophage-like, in that they scavenge the brain for debris. 
     </p>
      <h3>Electric Potentials in Neurons</h3>
      <p>
        A critical question of this section is as follows:</p>
        <center><p>        <i>How are neurons electrically active?</i></p></center>
      <p>        At rest (i.e., equilibrium), there is an electric potential across a neuron's plasma membrane. The basis
        for electrical potential across the neuron's membrane lies inside the neuron proper, where we know its interior 
        is negative with respect to the extracellular space outside (and this can be 
        shown by inserting a microelectrode). Neurons actively establish a differential distribution of
        ions across the plasma membrane. Changes in the membrane potential $V_m$ are the electrical signals neurons produce.
      The resting membrane potential is $-50$ to $-80$ mV with respect to the extracellular solution. The convention 
    of this class, and perhaps of the industry, is to assume $V_m = -65$ mV.</p>
        <p>
          That said,
        </p>
                <center><p>        <i>How does the neuron establish the resting membrane potential?</i></p></center>
        <p>To answer this question, let us consider how solutes (i.e., ions) behave in a solution. We do this by
          beginning to recall the behaviour of solutes: that they will "run down" their chemical gradient. This is a formal way to 
          say, "solutes will diffuse from areas of high concentration to areas of low concentration to achieve equilibrium."
        </p> 
        <p>To cross a membrane, one of two things must be true: 
          <ol>
            <li>the solute must be small and hydrophobic</li>
            <li>there is a channel, a door, specific to the solute (remember the talk of channels earlier?)</li>
          </ol>
        </p><p>This is because of the biological property that membranes are semipermeable.</p>
        <p><strong><u>Note:</u></strong> electrostatic forces also play a role in the distribution of ions. Recall the principle
        of opposites attract. This means ions will run down their electrical gradient to equalise charge. So, what we are doing
      is speaking to the fact ions run down their <strong>electrochemical gradient</strong>, the distribution of both concenctration AND charge. </p>
          
      <h3>The Membrane Potential of Neurons</h3>
     <p>Having said all these facts, we can now explain how neurons are electrically active. They are so because a
constant voltage difference across their membrane (the membrane potential, V<sub>m</sub>) is maintained and can be rapidly
changed in response to stimuli. This potential is created by the unequal distribution of ions—mainly
Na<sup>+</sup>, K<sup>+</sup>, and Cl<sup>–</sup>—across the plasma membrane, the selective permeability of ion
channels, and the continuous action of the sodium–potassium pump.</p>

<p>The sodium–potassium pump is fundamental: it uses ATP to move 3 Na<sup>+</sup> ions out of the neuron and 2 K<sup>+</sup> ions
into the neuron with each cycle. This action not only maintains the steep concentration gradients for sodium and potassium
but also directly contributes to the inside of the cell being more negative, since more positive charge leaves than enters.</p>

<p>At rest, the inside of the neuron is negative relative to the extracellular space. However, the resting membrane is not
equally permeable to all ions. Instead, it is much more permeable to K<sup>+</sup>, because of the abundance of open
K<sup>+</sup> “leak” channels. As a result, the resting membrane potential lies much closer to the equilibrium potential for K<sup>+</sup>
(≈ −90 mV) than to that of Na<sup>+</sup> (+60 mV). The sodium–potassium pump and the small sodium influx through resting channels
stabilize this potential near −65 mV.</p>

<p>When ion channels open, ions move according to their <em>electrochemical</em> gradients (the combination of concentration and electrical
forces). Potassium, being more concentrated inside the neuron, tends to leave the cell through K<sup>+</sup> channels; this efflux is
opposed by the negative interior, so net K<sup>+</sup> movement is outward but moderated by electrical pull. Sodium, which is more
concentrated outside, rushes into the cell through Na<sup>+</sup> channels because both its concentration gradient and the negative
interior drive it inward. For Cl<sup>–</sup>, the concentration gradient often favors inward movement while the electrical gradient
(negative inside) favors outward movement; its equilibrium potential (E<sub>Cl</sub>) usually lies near the resting potential, so opening
Cl<sup>–</sup> channels tends to stabilize or slightly hyperpolarize the membrane.</p>

<p>Each ion has its own equilibrium potential (E<sub>ion</sub>), the voltage at which the outward and inward forces on that ion are balanced.
For K<sup>+</sup>, this is around −90 mV; for Na<sup>+</sup>, about +60 mV; and for Cl<sup>–</sup>, near −65 mV in many neurons. The actual resting
membrane potential represents a weighted average of these equilibrium potentials, determined by the relative permeability of the
membrane to each ion, as described by the Goldman–Hodgkin–Katz equation.</p>

<p>Importantly, because the resting potential lies much closer to E<sub>K</sub> than to E<sub>Na</sub>, there is a large “stored” driving force for Na<sup>+</sup>
entry. When voltage-gated Na<sup>+</sup> channels open, Na<sup>+</sup> rushes inward, causing the rapid depolarization that defines an
<strong>action potential</strong>. Action potentials propagate along axons and enable neurons to communicate with one another and with target
tissues (e.g., muscles). Thus, the interplay of ion pumps, leak channels, selective permeability, and voltage-gated ion channels
explains how neurons are electrically active and why dynamic control of the membrane potential underlies excitability and the
brain’s ability to process and transmit information.</p>

      <p><em>Equation cue:</em> Ions drive the membrane toward their own equilibrium potentials.</p>

              $$
              I_{\text{ion}} \;=\; g_{\text{ion}}\bigl(V_m - E_{\text{ion}}\bigr)
              $$

              <p>
              where \(g_{\text{ion}}\) is the ion’s conductance (proportional to the number of open channels),
              \(V_m\) is the membrane potential, and \(E_{\text{ion}}\) is the Nernst (equilibrium) potential for that ion.
              </p>

              <p style="font-size:0.9em;color:#555;">
              Convention note: some texts write \(I_{\text{ion}} = g_{\text{ion}}(E_{\text{ion}} - V_m)\).
              Both are equivalent as long as you keep a consistent sign convention for inward/outward current.
              </p> <br>


      <table style="width:100%; border-collapse:collapse; font-size:0.95rem;">
  <thead>
    <tr>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Ion</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Typical Distribution</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Net Electrochemical Drive (at ~–65 mV)</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">E<sub>ion</sub> (≈, mV)</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Effect when Channel Opens</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="padding:6px;"><strong>Na<sup>+</sup></strong></td>
      <td style="padding:6px;">High outside &rarr; low inside</td>
      <td style="padding:6px;">Strongly <em>inward</em> (both chemical and electrical)</td>
      <td style="padding:6px;">≈ +60</td>
      <td style="padding:6px;">Depolarizes (V<sub>m</sub> moves toward +60 mV)</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>K<sup>+</sup></strong></td>
      <td style="padding:6px;">High inside &rarr; low outside</td>
      <td style="padding:6px;"><em>Outward</em> (chemical out, electrical in; chemical dominates at rest)</td>
      <td style="padding:6px;">≈ −90</td>
      <td style="padding:6px;">Hyperpolarizes/stabilizes (V<sub>m</sub> moves toward −90 mV)</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Cl<sup>−</sup></strong></td>
      <td style="padding:6px;">Higher outside than inside (mature neurons)</td>
      <td style="padding:6px;">Chemical <em>inward</em>, electrical <em>outward</em> (often balance near rest)</td>
      <td style="padding:6px;">≈ −65 (varies by cell/type)</td>
      <td style="padding:6px;">Stabilizes or slight hyperpolarization (tracks V<sub>m</sub>)</td>
    </tr>
  </tbody>
</table>
<p style="font-size:0.9rem; color:#555; margin-top:6px;">
Notes: Values are typical for mammalian neurons at ~37&nbsp;°C; exact numbers vary with 
ionic concentrations and temperature. E<sub>ion</sub> is from the Nernst equation; 
V<sub>m</sub> is set by the weighted contributions of permeant ions (Goldman–Hodgkin–Hatz).
</p>
        
    </section>

      <section id="chapter4"><h2>Synaptic Transmission</h2>
        <p>Here's a question:</p>
                <center><p>        <i>What are ways a neuron could
change its membrane potential?</i></p></center>
<p>Well, we talked about that in the previous section! A neuron's membrane potential changes whenever the movement of ions across the 
  membrane is altered. This can happen in several ways:
  <ol>
    <li>Open/close ion channels</li>
    <ul>
      <li>Opening <strong>$Na^+$ channels</strong> lets sodium rush into the cell from 
        the outside. This <i>depolarises</i> as $V_m$ becomes less negative (as
      cations flood the inside of the neuron), which means the inside of the neuron becomes more positive.  </li>
      <li>Open <strong>$K^+$ channels</strong> to let potassium leave the inside of the cell. This leads to <i>
        hyperpolarisation
      </i>, where $V_m$ becomes more negative as the outside has less positive potassium than the inside, so $K^+$ moves along the 
    electric concentration gradient. </li>
    <li>Open <strong>$Cl^-$ channels</strong> to induce inhibition or stabilisation.</li>
    <li>Open <strong>$Ca^{2+}$ channels</strong> to let positive calcium into the cell (as there is a deficit of calcium 
    inside and a surplus of it outside) to depolarise.</li>
    </ul>
    <li>Changing channel properties
      <ul>
        <li>Voltage-gated channels open in response to changes in $V_m$, which is important for action potentials</li>
        <li>Ligand-gated channels open when neurotransmitters bind, which is important for synaptic inputs</li>
        <li>Mechanically-gated channels open in response to stretch or pressure, which is important in sensory neurons</li>
      </ul>
    </li>
    <li>Modulating the activity of the sodium-potassium pump
      <ul>
        <li>The activities of the sodium-potassium pump can adjust long-term ioninc gradients (e.g., 
          stronger $Na^+/K^+$ ATPase activity makes the cell slightly more negative). 
        </li>
      </ul>
    </li>
    <li>Change the extracellular or intracellular ion concentrations inside or outside the cell
      <ul>
        <li>Shifts in $K^+$ outside the neuron strongly influence $V_m$. For instance, high extracellular $K^+$ reduces the $K^+$ 
          gradient, depolarising the cell. 
        </li>
      </ul>
    </li>
  </ol>
</p>
<h3>The Action Potential</h3>
  <p><strong><u>Definition. </u></strong>An action potential (AP) is a highly stereotyped wave of depolarisation that travels down the axon. 
  It is the electrical signal that propagates down the axon and triggers communication across a synapse.</p>
<p>APs are regenerated along the axon—each adjacent section is depolarised and a new AP occurs. The direction of the AP's travel 
  is unidirectional as the refractory state of the membrane after a depolarisation event. It starts at the axon hillock, when it 
  it depolarised to threshold. 
</p>
  <p><strong><u>Definition. </u></strong>The refractory state of an action potential refers to the period after an AP during 
  which a cell is unable to generate a new AP, or requires a stornger stimulus to do so. It consists of two phases:
  <ol>
    <li>the <strong>absolute</strong> refractory period, wherein a neuron cannot generate a new AP REGARDLESS of the stimulus
    strength. It happens when voltage-gated sodium channels are inactived and cannot reopen immediately after being activated
  and are closed during depolarisation. It occurs from the initial depolarisation phase through the early stages of repolarisation.</li>
    <li>the <strong>relative</strong> refractory period, in which a second action potential can be triggered $iff$ the stimulus is 
    stronger than usual. It requires that stronger stimulus since the membrane is still hyperpolarised (i.e., more negative than $V_m$)
  and some sodium channels are still inactive while others have recovered. This comes at the later states of repolarisation after the 
absolute refractory period. </li>
  </ol></p>
  <p>We see that sodium channels will inactivate briefly after opening. So, only segments of the axon that have not recently been 
    depolarised can generate an action potential. Hence, unidirectional movement is induced.
  </p>
  <h3>Properties of the AP</h3>
        <p>APs are an all-or-none phenomenon—it either fires at all, uniform strength or it does not fire at all. The intensity
          of the stimulus does not change the amplitude nor speed nor magnitude nor duration of the AP within a given 
          neuron, but it can increase the frequency at which the 
          neuron fires. They are also regenerated along the axon, where each adjacent section is depolarised and a new action 
          potential occurs. APs travel unidirectionally (see above).
        </p>
<h3>What are the Molecular Mechanisms
Underlying the Action Potential?</h3>

    <p>Normally, the neuron's resting potential is negative. This is on account of the plasma membrane being primarily permeable to 
      $K^+$ at rest (i.e., at rest, $K^+$ can leave the cell). During an AP, the membrane potential briefly becomes positive due to the 
      membrane briefly become very permeable to $Na^+$ (i.e., $Na^+$ can enter the cell). 
    </p>

      <h3>Action Potential Summary I</h3>
      <p><ol>
        <li>The cell (axon hillock) is depolarised to threshold (becomes more positive).</li>
        <li>The voltage-gated sodium channels open, permitting $Na^+$ into the cell and depolarising it.</li>
        <li>The voltage-gated potassium channels open, letting $K^+$ in and repolarises-hyperpolarises the cell</li>
        <li>The voltage-gated $Na^+$ channels inactivate, thus they no longer pass a current even though the cell is still 
          depolarised
        </li>
        <li>The voltage-gated $K^+$ stay open until the membrane potential returns to the resting potential, or even 
          a bit below, before closing.
        </li>
      </ol></p>
      <h3>The Role Myelination in APs</h3>
      <p>
        Mylenation makes the AP faster! <br><br>
        <strong><u>Definition. </u></strong> The conduction velocity is the speed of propagation of APs. 
        <ul>
          <li>$\leq 150 \frac{m}{sec}$</li> in myelinated axons
          <li>$~0.1 - 10 \frac{m}{sec}$</li> in unmyelinated axons
        </ul>
      </p>
      <p><strong><u>Definition.</u></strong> Saltatory conduction is the "jumping" of the AP from each node to Ranvier to another.
</p>
      <h3>Electrical Transmission</h3>
      <center><p>        <i>What happens when the AP
arrives at the synapse?</i></p></center>
      <p>
        To answer this question, we must define the two types of synapses. 
      </p>
      <p><strong><u>Definition.</u></strong> An electrical synapse is a gap junction which connects two cells physically (which 
      can also be called as "directly"). It enables fast communication between neurons, but is in the minority of synapses in
    the nervous system. Since it establishes a direct link, depolarisation of the presynaptic neuron always 
    results in the depolarisation of the postsynaptic neuron.
  <ul>
    <strong><u>Sub-Definition.</u></strong> A gap junction is an ion channel made by two  halves, each half in a participating cell. 
  </ul></p>

<h3>The Discovery of Chemical Transmission</h3>
<p>
  Otto Loewi discovered chemical neurotransmission in 1921. He did so in the following steps: 
  <ol>
    <li>Use two frog hearts, one with the vagus nerve still attached and another without it (both bathed in the same 
      physiological solution). A fluid pathway is to be drawn from the former heart's bath to the latter heart's bath. 
    </li>
    <li>Electrically stimulate the vagus nerve of the first heart to slow it's heart rate.</li>
    <li>Now that heart No. 1 has slowed, transfer its solution to heart No. 2. One of two outcomes will arise given 
      that heart No,. 2 has no vagus nerve (recall: vagus nerve is in the PNS):
        <ul>
          <li>Nothing, since neurotransmission is electrical (needs direct connection)</li>
          <li>Something, since neurotransmission is chemical</li>
        </ul>
    </li>
  </ol>
</p>
<p> Loewi found at step No. 3 that something happened: the second heart slowed down, showing that something dissolved in the fluid, 
  a chemical messenger later found to be acetylcholine.
</p>
<h3>Chemical Transmission</h3>
<p>The majority of the synapses of the nervous system are chemical: an electrical signal, AP, is converted to 
  a chemical, the release of a neurotransmitter. These chemical synapses can either be excitatory (depolarising) or inhibitory 
(hyperpolarisiing). </p>

<h3>Steps to Synaptic Transmission</h3>
<p>Synaptic transmission can be seen as a series of steps:
  <ol>
    <li>the AP arrives at the presynaptic terminal</li>
    <li>voltage gated $Ca^{2+}$ channels open</li>
    <li>vesicles containing the neurotransmitter release their contents into the synaptic cleft through a 
      process said to be called <i>exocytosis</i>
    </li>
    <li>the neurotransmitter diffuses across the cleft and bind to receptors</li>
    <li>the receptors produce changes in the postsynaptic cell</li>
    <li>the neurotransmitter is removed from the synaptic cleft, either by reuptake by neurons/astrocyroes or degradation by enzymes</li>
  </ol>
</p>
<h3>Properties of Synaptic Potentials</h3>

<p>Synaptic potentials are a type of graded potential that varies in amplitude and duration, as opposed to APs which do NOT. </p>
<p>The sum of potentials at the cell body determines influence on whether the action potential will be fired. </p>
    <p>When neurotransmitters bind to receptors on a postsynaptic neuron, they produce small voltage changes in the membrane called 
      postsynaptic potentials (PSPs). Thse can be: 
      <ul>
        <li>Excitatory Postsynaptic Potentials (EPSPs) that depolarise and bring the cell closer to firing</li>
        <li>Inhibitory Postsynaptic Potentials (IPSPs) that hyperpolarises and makes the cell less likely to fire.</li>
      </ul>
<p>Whether a postsynaptic potential is excitatory (EPSP) or inhibitory (IPSP) depends on the type of neurotransmitter and, crucially, 
  the specific postsynaptic receptor it binds to. This binding process causes ion channels to open or close—the type of ion that can
  pass through the channel determines if the resulting potential change depolarises (EPSP) or hyperpolarises (IPSP) the cell. 
</p>
<p>A single PSP is oftentimes too small to trigger an action potential firing. So, we must take a summation of many PSPs over
  space and time. There are many factors which affect that summation: 
  <ol>
    <li>The size, amplitude of each (E/I)PSP (the bigger, the more powerful)</li>
    <li>The space, location on the neuron (the closer to the axon hillock, the more powerful) </li>
    <li>The time—
      <ul>
        <li>if multiple of the same PSPs occur close together in time, the effects compound and build up</li>
        <li>if multiple PSPs which are different occure close together in time, then overlapping EPSPs and IPSPs cancel</li>
      </ul>
    </li>
  </ol>
</p><p>Essentially, the goal is this: if the net depolarisation at the axon hillock reaches threshold (which is approximately $-55$ mV), then 
  then an action potential fires. 
</p>
<table style="width:100%; border-collapse:collapse; font-size:0.95rem;">
  <thead>
    <tr>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Property</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Action Potential</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Synaptic Potential</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="padding:6px;"><strong>Amplitude & Duration</strong></td>
      <td style="padding:6px;">All-or-none; always the same amplitude and duration</td>
      <td style="padding:6px;">Graded; vary in amplitude and duration</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Location</strong></td>
      <td style="padding:6px;">Axons</td>
      <td style="padding:6px;">Dendrites and soma</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Polarity</strong></td>
      <td style="padding:6px;">Always depolarizing (briefly)</td>
      <td style="padding:6px;">Can be depolarizing (excitatory) or hyperpolarizing (inhibitory)</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Propagation</strong></td>
      <td style="padding:6px;">Regenerates; self-propagating</td>
      <td style="padding:6px;">Does not regenerate; signal weakens as it spreads</td>
    </tr>
  </tbody>
</table>
    

    </p> <br><h3>Ligand Binding & Postsynaptic Response</h3>

<p>What determines the response of a postsynaptic cell to neurotransmitter release? The answer lies in two factors: 
(1) the neurotransmitter released, and (2) the receptor type present on the postsynaptic membrane. In general, any given synapse 
releases only one neurotransmitter, but the postsynaptic response can differ dramatically depending on which receptor family 
receives that signal. Thus, neurotransmission is not a “one size fits all” system: the same transmitter can cause excitation in one 
cell type and inhibition in another.</p>

<h4>Loewi’s Demonstration of a Chemical Messenger</h4>
<p>Otto Loewi’s classic experiment (1921) revealed that nerve signals can be transmitted chemically. Stimulating the vagus nerve of 
a frog’s heart slowed its contractions. When the surrounding solution was transferred to a second heart, that heart also slowed, 
despite lacking nerve input. This showed that the vagus nerve released a chemical messenger—later identified as acetylcholine (ACh)—into 
the fluid, establishing the principle of chemical neurotransmission.</p>

<h4>The First Synapse Studied: Neuromuscular Junction (NMJ)</h4>
<p>The NMJ was the first synapse to be deeply studied. At the NMJ, motor neurons release acetylcholine (ACh) onto skeletal muscle fibers. 
Here, ACh binding produces depolarization (excitatory) and ultimately muscle contraction. This contrasted with the vagus nerve’s use of ACh 
on cardiac muscle, where the effect is inhibitory. These observations illustrate a critical principle: 
<strong>the effect of a neurotransmitter depends on the receptor subtype it activates.</strong></p>

<h4>Vagus Nerve vs Motor Nerves</h4>
<ul>
  <li><strong>Vagus nerve →</strong> releases ACh → decreases heart rate (inhibits cardiac muscle contraction).</li>
  <li><strong>Motor neurons →</strong> release ACh → skeletal muscles contract (induces skeletal muscle contraction).</li>
</ul>
<p>In both cases the neurotransmitter is ACh, but the postsynaptic receptors differ, producing opposite responses.</p>

<h4>Neurotransmitter Receptors: Two Major Families</h4>
<p>Neurotransmitters act by binding to specialized receptors. These receptors control ion flow across the membrane in two main ways:</p>
<ul>
  <li><strong>Ionotropic receptors</strong> (ligand-gated ion channels): the receptor is itself an ion channel that opens when bound by a 
  transmitter. Response is fast and short-lived.</li>
  <li><strong>Metabotropic receptors</strong> (G protein–coupled receptors, GPCRs): the receptor activates intracellular signaling via G proteins, 
  which can then modulate ion channels or other cellular processes. Response is slower, but longer lasting and more versatile.</li>
</ul>

<h4>Examples of ACh Receptors</h4>
<ul>
  <li><strong>Nicotinic ACh receptor (nAChR, ionotropic):</strong> Found at the NMJ. When ACh binds, the receptor-channel opens, allowing Na<sup>+</sup> 
  to flow into the muscle fiber, depolarizing the cell and triggering contraction.</li>
  <li><strong>Muscarinic ACh receptor (mAChR, metabotropic):</strong> Found in the heart. When ACh binds, the receptor activates a G protein, which 
  then opens K<sup>+</sup> channels. The efflux of K<sup>+</sup> hyperpolarizes the cardiac muscle cell, slowing its rate of contraction.</li>
</ul>

<h4>The Versatility of Neurotransmitters</h4>
<p>The same neurotransmitter can produce very different effects depending on the receptor type it activates. This versatility underlies the 
richness of neural signaling. For instance, ACh can either excite skeletal muscle through ionotropic nAChRs or inhibit cardiac muscle through 
metabotropic mAChRs. The diversity of receptor families allows a limited set of neurotransmitters to generate a wide variety of physiological 
responses.</p>

<h4>Summary: Ionotropic vs Metabotropic Receptors</h4>
<table style="width:100%; border-collapse:collapse; font-size:0.95rem;">
  <thead>
    <tr>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Property</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Ionotropic Receptors</th>
      <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Metabotropic Receptors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="padding:6px;"><strong>Mechanism</strong></td>
      <td style="padding:6px;">Receptor is itself a ligand-gated ion channel</td>
      <td style="padding:6px;">Receptor activates G proteins, which influence channels indirectly</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Speed</strong></td>
      <td style="padding:6px;">Fast (milliseconds)</td>
      <td style="padding:6px;">Slower (hundreds of ms to seconds)</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Duration</strong></td>
      <td style="padding:6px;">Short-lived</td>
      <td style="padding:6px;">Long-lasting</td>
    </tr>
    <tr>
      <td style="padding:6px;"><strong>Example</strong></td>
      <td style="padding:6px;">Nicotinic ACh receptor at NMJ (Na<sup>+</sup> influx, muscle contraction)</td>
      <td style="padding:6px;">Muscarinic ACh receptor in heart (K<sup>+</sup> efflux, slows heart rate)</td>
    </tr>
  </tbody>
</table>

      <section id="chapter5"><h2>Neurotransmitters</h2>
        <p>So far, we have focused on how neurons generate and propagate electrical signals and how those signals cross the synapse. 
          We now turn to the “chemical vocabulary” of the nervous system: <i>neurotransmitters</i>. Different neurons speak in 
          slightly different chemical dialects, releasing particular transmitter molecules that act on specific receptors. These 
          combinations of transmitter and receptor endow each neural circuit with its own characteristic mode of signaling, time-course, 
          and function.
        </p>

        <h3>What Is a Neurotransmitter?</h3>
        <p><strong><u>Definition.</u></strong> A <strong>neurotransmitter</strong> is a chemical messenger released by a presynaptic neuron at the synapse 
          that binds to specific receptors on a postsynaptic cell (neuron, muscle fiber, or gland) and changes that cell’s membrane 
          potential or intracellular signaling state.
        </p>
        <p>Classically, a substance is considered a neurotransmitter if it satisfies several criteria:
          <ul>
            <li>It is synthesized in the neuron (often in the soma or terminal) and present in the presynaptic terminal.</li>
            <li>It is released in response to presynaptic depolarization and <strong>Ca<sup>2+</sup>-dependent</strong> exocytosis.</li>
            <li>It acts on specific receptors in the postsynaptic membrane to produce a physiological effect.</li>
            <li>There is a mechanism for its removal or inactivation (e.g., reuptake, enzymatic breakdown).</li>
            <li>Its effects can be mimicked by exogenous application of the substance or by drugs that activate its receptors.</li>
          </ul>
        </p>
        <p>Not all signaling molecules in the nervous system are classical neurotransmitters. Some, such as hormones and neuromodulators, 
          act at longer distances or over longer time scales. Others, like gaseous transmitters, diffuse freely rather than being packaged 
          into vesicles. Nonetheless, the core idea remains: chemical signals allow neurons to influence one another’s electrical activity 
          and gene expression.
        </p>

        <h3>Families of Neurotransmitters</h3>
        <p>Neurotransmitters can be grouped into several broad families based on their chemistry and synthesis:
          <ol>
            <li><strong>Small-molecule neurotransmitters</strong>
              <ul>
                <li><strong>Amino acid transmitters</strong>: glutamate, GABA, glycine.</li>
                <li><strong>Monoamines</strong>: dopamine (DA), norepinephrine (NE), serotonin (5-HT), and others.</li>
                <li><strong>Acetylcholine (ACh)</strong>: a “one-of-a-kind” transmitter in its own category.</li>
              </ul>
            </li><br>
            <li><strong>Neuropeptides</strong>
              <ul>
                <li>Short chains of amino acids (e.g., substance P, endorphins, enkephalins, neuropeptide Y).</li>
                <li>Often co-released with a small-molecule transmitter and act as modulators with slower, longer-lasting effects.</li>
              </ul>
            </li><br>
            <li><strong>Atypical (non-classical) transmitters</strong>
              <ul>
                <li><strong>Gases</strong> such as nitric oxide (NO) and carbon monoxide (CO), which diffuse freely and act retrogradely.</li>
                <li><strong>Endocannabinoids</strong>, lipid-derived messengers that often travel from postsynaptic to presynaptic cell.</li>
              </ul>
            </li>
          </ol>
        </p>
        <p>Each family has its own style of signaling. Small molecules typically mediate fast, point-to-point synaptic communication; 
          peptides and atypical transmitters tend to modulate activity over wider regions and longer time scales.
        </p>

        <h3>“Workhorse” vs. “Boutique” Transmitters</h3>
        <p>One useful way to think about neurotransmitters is to distinguish between those that are nearly ubiquitous—used everywhere 
          in the brain—and those that are more specialized in specific circuits.
        </p>
        <p><strong>Workhorse transmitters</strong> are used by enormous numbers of synapses and form the basic excitatory–inhibitory 
          backbone of neural signaling:
          <ul>
            <li><strong>Glutamate</strong> – the primary fast <strong>excitatory</strong> transmitter in the CNS.</li>
            <li><strong>GABA</strong> (and glycine in the spinal cord and brainstem) – the primary fast <strong>inhibitory</strong> transmitters.</li>
          </ul>
        </p>
        <p><strong>Boutique transmitters</strong> are associated with particular neural pathways and psychological functions:
          <ul>
            <li><strong>Acetylcholine (ACh)</strong></li>
            <li><strong>Dopamine (DA)</strong></li>
            <li><strong>Norepinephrine (NE, noradrenaline)</strong></li>
            <li><strong>Serotonin (5-HT)</strong></li>
            <li><strong>Various peptide transmitters</strong> (e.g., opioids, oxytocin, vasopressin, CCK, NPY).</li>
          </ul>
        </p>
        <p>The “workhorses” are involved in most synaptic computations in the cortex, hippocampus, and cerebellum, mediating fast EPSPs 
          and IPSPs. The “boutique” transmitters ride on top of this background activity, tuning the overall responsiveness and mode of 
          processing of entire circuits (e.g., “alert and vigilant” vs. “calm and sleepy”).
        </p>

        <h3>Glutamate and GABA: The Core Excitatory–Inhibitory Balance</h3>
        <p><strong>Glutamate</strong> is the principal excitatory neurotransmitter in the CNS. When glutamate binds to its 
          postsynaptic receptors, it typically allows cations (Na<sup>+</sup>, sometimes Ca<sup>2+</sup>) to enter the cell, producing 
          EPSPs and bringing the membrane potential closer to threshold.
        </p>
        <p>Major glutamate receptor types include:
          <ul>
            <li><strong>AMPA receptors</strong> – ionotropic; mediate fast EPSPs.</li>
            <li><strong>NMDA receptors</strong> – ionotropic; voltage- and ligand-gated, permeable to Ca<sup>2+</sup>; crucial for synaptic plasticity.</li>
            <li><strong>Kainate receptors</strong> – ionotropic; also contribute to fast excitation.</li>
            <li><strong>mGluRs</strong> (metabotropic glutamate receptors) – GPCRs that modulate excitability and plasticity.</li>
          </ul>
        </p>
        <p><strong>GABA</strong> (γ-aminobutyric acid) is the primary inhibitory transmitter in the adult brain. Activation of GABA receptors 
          usually leads to Cl<sup>−</sup> influx or K<sup>+</sup> efflux, generating IPSPs and making neurons less likely to fire an action potential.
        </p>
        <p>Major GABA receptor types include:
          <ul>
            <li><strong>GABA<sub>A</sub> receptors</strong> – ionotropic; Cl<sup>−</sup> channels that mediate fast inhibition.</li>
            <li><strong>GABA<sub>B</sub> receptors</strong> – metabotropic; activate G proteins that open K<sup>+</sup> channels and/or close Ca<sup>2+</sup> channels.</li>
          </ul>
        </p>
        <p>Many psychoactive drugs (e.g., benzodiazepines, barbiturates, alcohol) act in part by enhancing GABA<sub>A</sub>-mediated inhibition, 
          tilting the balance of excitation and inhibition toward less overall neural activity.
        </p>

        <h3>Cholinergic Systems (Acetylcholine)</h3>
        <p><strong>Acetylcholine (ACh)</strong> is the first neurotransmitter to have been discovered and remains one of the most important. 
          In the peripheral nervous system, ACh is the transmitter at the <strong>neuromuscular junction</strong> (causing skeletal muscle contraction) 
          and at many autonomic synapses. In the brain, ACh is produced by several key groups of neurons whose axons project widely.
        </p>
        <p>Major cholinergic pathways include:
          <ul>
            <li><strong>Basal forebrain cholinergic system</strong> – neurons in the nucleus basalis, medial septum, and related regions 
              project to cortex and hippocampus and are critical for <strong>attention</strong>, <strong>learning</strong>, and 
              <strong>memory</strong>.</li>
            <li><strong>Brainstem cholinergic nuclei</strong> – neurons in the pedunculopontine and laterodorsal tegmental nuclei project to 
              thalamus and basal ganglia and are involved in <strong>arousal</strong> and <strong>REM sleep</strong>.</li>
          </ul>
        </p>
        <p><strong>Examples of ACh function in the brain.</strong>
          <ul>
            <li><strong>Nicotinic ACh receptors</strong> (ionotropic) contribute to <strong>short-term memory</strong> and 
              <strong>reward</strong> circuitry. Nicotine from tobacco is an agonist at these receptors—this is one reason 
              tobacco products are so strongly <strong>addictive</strong>.</li>
            <li><strong>Muscarinic ACh receptors</strong> (metabotropic) support <strong>cognition</strong> and cortical processing. 
              Drugs that block muscarinic receptors can produce <strong>confusion</strong>, <strong>memory problems</strong>, and even 
              <strong>hallucinations</strong>.</li>
          </ul>
        </p>
        <p>Degeneration of basal forebrain cholinergic neurons is a hallmark of Alzheimer’s disease, and many current treatments for 
          Alzheimer’s attempt to enhance cholinergic signaling (e.g., by inhibiting acetylcholinesterase).
        </p>

        <h3>Dopaminergic Pathways</h3>
        <p>Dopamine (DA) is a monoamine transmitter with several discrete pathways in the brain. These pathways support diverse functions 
          including motor control, motivation, and reinforcement learning.
        </p>

        <h4>The Mesostriatal Dopamine Pathway</h4>
        <p>The <strong>mesostriatal</strong> (or nigrostriatal) DA pathway originates in the <strong>substantia nigra</strong> of the midbrain 
          and projects primarily to the <strong>striatum</strong> (caudate nucleus and putamen).
        </p>
        <p><strong>Functions.</strong>
          <ul>
            <li>Critical for <strong>motor control</strong> and the initiation of voluntary movements.</li>
            <li>Modulates activity in basal ganglia circuits that select and sequence actions.</li>
          </ul>
        </p>
        <p>Loss of dopaminergic neurons in the substantia nigra → striatum pathway leads to <strong>Parkinson’s disease</strong>, a disorder 
          characterized by bradykinesia (slowness of movement), resting tremor, rigidity, and postural instability. Treatments such as 
          L-DOPA attempt to restore dopamine levels in this circuit.
        </p>

        <h4>The Mesolimbocortical Dopamine Pathway</h4>
        <p>The <strong>mesolimbocortical</strong> DA pathway originates in the <strong>ventral tegmental area (VTA)</strong> of the midbrain 
          and projects to:
          <ul>
            <li>the <strong>nucleus accumbens</strong> and other parts of the limbic system (ventral striatum), and</li>
            <li>the <strong>prefrontal cortex</strong>.</li>
          </ul>
        </p>
        <p><strong>Functions.</strong>
          <ul>
            <li>Central to <strong>reward</strong> and <strong>reinforcement</strong> learning (signal for “better than expected” outcomes).</li>
            <li>Involved in <strong>motivation</strong>, <strong>goal-directed behavior</strong>, and aspects of <strong>cognition</strong>.</li>
            <li>Heavily implicated in <strong>addiction</strong>; many drugs of abuse increase dopamine in this pathway.</li>
          </ul>
        </p>
        <p>Abnormalities in dopaminergic signaling in mesolimbocortical circuits have been linked to <strong>schizophrenia</strong> and other 
          psychotic disorders. Many antipsychotic medications work by blocking or partially blocking <strong>D<sub>2</sub></strong>-family DA receptors.
        </p>

        <h3>Noradrenergic Pathways (Norepinephrine)</h3>
        <p><strong>Norepinephrine (NE)</strong>, also known as <strong>noradrenaline</strong>, is a monoamine transmitter used both in the peripheral 
          sympathetic nervous system and in the brain.
        </p>
        <p>Central noradrenergic neurons are concentrated primarily in the <strong>locus coeruleus</strong> (LC) in the pons, as well as in a few 
          other brainstem nuclei. Axons from the LC project broadly throughout the cortex, hippocampus, cerebellum, and spinal cord.
        </p>
        <p><strong>Functions of NE in the brain.</strong>
          <ul>
            <li><strong>Arousal and vigilance</strong> – NE helps maintain wakefulness and alertness.</li>
            <li><strong>Attention</strong> – modulates the ability to focus on salient stimuli.</li>
            <li><strong>Mood</strong> – alterations in NE signaling are linked to depression and anxiety.</li>
            <li><strong>Sexual behavior and stress responses</strong> – coordinates physiological changes in challenging situations.</li>
          </ul>
        </p>
        <p>In the body, NE is a key mediator of the <strong>fight-or-flight</strong> response, increasing heart rate, blood pressure, and 
          redirecting blood flow to muscles.
        </p>

        <h3>Serotonergic Pathways (Serotonin)</h3>
        <p><strong>Serotonin</strong> (5-hydroxytryptamine, <strong>5-HT</strong>) is another monoamine transmitter with cell bodies primarily in the 
          <strong>raphe nuclei</strong> of the brainstem. From there, serotonergic fibers project widely throughout the brain and spinal cord.
        </p>
        <p><strong>Functions of 5-HT.</strong>
          <ul>
            <li>Regulation of <strong>sleep–wake cycles</strong> and <strong>dreaming</strong>.</li>
            <li>Modulation of <strong>mood</strong>, including anxiety and depression.</li>
            <li>Influence on <strong>sexual behavior</strong> and appetite.</li>
            <li>Participation in <strong>cognitive functions</strong> such as learning and decision-making.</li>
          </ul>
        </p>
        <p>Many antidepressant drugs, such as selective serotonin reuptake inhibitors (SSRIs; e.g., Prozac), act by <strong>increasing 5-HT levels 
          in the synaptic cleft</strong>. By blocking the serotonin transporter, they prolong and enhance activation of postsynaptic 5-HT receptors.
        </p>

        <h3>Neuropeptides and Other Boutique Transmitters</h3>
        <p><strong>Neuropeptides</strong> include a large and diverse set of signaling molecules:
          <ul>
            <li><strong>Opioid peptides</strong> (e.g., endorphins, enkephalins, dynorphins) – modulate pain, reward, and stress.</li>
            <li><strong>Oxytocin and vasopressin</strong> – involved in social behavior, bonding, and fluid balance.</li>
            <li><strong>Neuropeptide Y (NPY), CCK, substance P</strong> – implicated in feeding, anxiety, and nociception.</li>
          </ul>
        </p>
        <p>Peptide transmitters are often co-released with a classical transmitter (e.g., glutamate, GABA) and act via <strong>metabotropic</strong> 
          receptors to modulate circuit function rather than to drive fast EPSPs or IPSPs.
        </p>

        <h3>Identifying and Naming Neurotransmitter Receptors</h3>
        <p>Every neurotransmitter must bind to a <strong>receptor</strong> to exert its effects. Receptors are typically named according to:
          <ul>
            <li>The transmitter they bind (e.g., glutamate receptors vs. ACh receptors).</li>
            <li>Whether they are <strong>ionotropic</strong> (ligand-gated ion channels) or <strong>metabotropic</strong> (G protein–coupled receptors).</li>
            <li>Their specific pharmacology—for example, which drugs activate (agonists) or block (antagonists) them.</li>
          </ul>
        </p>
        <p>In many cases, a receptor subtype is named after a synthetic drug that selectively activates it. For instance:
          <ul>
            <li><strong>NMDA receptor</strong> – a glutamate receptor subtype named after the agonist N-methyl-D-aspartate.</li>
            <li><strong>AMPA receptor</strong> – named after the agonist AMPA.</li>
            <li><strong>Nicotinic</strong> and <strong>muscarinic</strong> ACh receptors – named after nicotine and muscarine, respectively.</li>
          </ul>
        </p>

        <h3>Major Transmitter Receptor Families (Selected Examples)</h3>
        <p>The table below summarizes several important transmitter systems, their main receptor families, and broad functional roles.
        </p>

        <table style="width:100%; border-collapse:collapse; font-size:0.9rem;">
          <thead>
            <tr>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Transmitter</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Representative Receptor Subtypes</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Receptor Type</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Selected Functions</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="padding:6px;"><strong>Glutamate</strong></td>
              <td style="padding:6px;">AMPA, NMDA, kainate; mGluR<sub>1–8</sub></td>
              <td style="padding:6px;">AMPA/NMDA/kainate: ionotropic; mGluRs: metabotropic</td>
              <td style="padding:6px;">Main fast excitation; synaptic plasticity (especially via NMDA receptors); learning and memory.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>GABA</strong></td>
              <td style="padding:6px;">GABA<sub>A</sub>, GABA<sub>B</sub>, GABA<sub>C</sub> (also called GABA<sub>A</sub>-ρ)</td>
              <td style="padding:6px;">GABA<sub>A</sub>/GABA<sub>C</sub>: ionotropic; GABA<sub>B</sub>: metabotropic</td>
              <td style="padding:6px;">Main inhibition in the brain; controls excitability; prevents runaway excitation and seizures.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Acetylcholine</strong></td>
              <td style="padding:6px;">Nicotinic (nAChR); muscarinic (M<sub>1–5</sub>)</td>
              <td style="padding:6px;">nAChR: ionotropic; muscarinic: metabotropic</td>
              <td style="padding:6px;">Neuromuscular junction (muscle contraction); cortical arousal; attention and memory; autonomic function.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Dopamine (DA)</strong></td>
              <td style="padding:6px;">D<sub>1</sub>, D<sub>2</sub>, D<sub>3</sub>, D<sub>4</sub>, D<sub>5</sub></td>
              <td style="padding:6px;">All metabotropic</td>
              <td style="padding:6px;">Motor control (basal ganglia); reward and reinforcement; motivation; aspects of cognition and psychosis.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Norepinephrine (NE)</strong></td>
              <td style="padding:6px;">α<sub>1</sub>, α<sub>2</sub>, β<sub>1</sub>, β<sub>2</sub>, β<sub>3</sub></td>
              <td style="padding:6px;">All metabotropic</td>
              <td style="padding:6px;">Sympathetic “fight-or-flight” responses; arousal and vigilance; mood; modulation of attention.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Serotonin (5-HT)</strong></td>
              <td style="padding:6px;">5-HT<sub>1</sub>–5-HT<sub>7</sub> families (multiple subtypes)</td>
              <td style="padding:6px;">Most metabotropic; 5-HT<sub>3</sub> is ionotropic</td>
              <td style="padding:6px;">Regulation of mood, anxiety, sleep, appetite, and many cognitive and autonomic functions.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Peptide transmitters</strong></td>
              <td style="padding:6px;">Opioid receptors (μ, κ, δ); receptors for CCK, NPY, substance P, etc.</td>
              <td style="padding:6px;">All metabotropic</td>
              <td style="padding:6px;">Pain control; stress responses; feeding; social and emotional behaviors, depending on peptide and site.</td>
            </tr>
          </tbody>
        </table>
        <p style="font-size:0.85rem; color:#555; margin-top:6px;">
          Note: Each transmitter family contains multiple receptor subtypes with distinct distributions and functions. This diversity allows 
          a relatively small set of chemical messengers to support a vast repertoire of neural computations and behaviors.
        </p>

        <h3>A Glimpse of Neuropharmacology</h3>
        <p>Finally, because neurotransmitters act through specific receptors and transporters, they provide numerous targets for drugs. 
          <strong>Neuropharmacology</strong> is the study of how drugs affect the nervous system and behavior. At synapses, drugs can:
          <ul>
            <li>Act as <strong>agonists</strong>, activating receptors (e.g., nicotine at nicotinic ACh receptors).</li>
            <li>Act as <strong>antagonists</strong>, blocking receptors (e.g., many antipsychotics at D<sub>2</sub> receptors).</li>
            <li>Alter neurotransmitter synthesis, storage, or release.</li>
            <li>Block reuptake transporters (e.g., SSRIs for 5-HT, cocaine for DA/NE).</li>
            <li>Inhibit enzymatic breakdown (e.g., acetylcholinesterase inhibitors for ACh).</li>
          </ul>
        </p>
        <p>Because the same transmitter can have very different effects in different brain regions and receptor contexts, drug actions are 
          both powerful and complex. Understanding the underlying transmitter systems and their receptor families is therefore essential 
          for making sense of how psychoactive drugs—from therapeutic medications to drugs of abuse—alter brain function and behavior.
        </p>
      </section>
      <section id="chapter6"><h2>Neuropharmacology I: Drugs and Neurotransmitters</h2>
        <p>We have seen that neurons use a rich chemical vocabulary—neurotransmitters—to communicate. These
          transmitters act through specific receptors to excite, inhibit, or modulate their targets. 
          <strong>Neuropharmacology</strong> asks a closely related question:
        </p>
        <center><p><i>How can exogenous chemicals—drugs—alter these transmitter systems, and what can that tell us
        about brain function and dysfunction?</i></p></center>

        <h3>Roles of Neurotransmitters in the Brain (Recap)</h3>
        <p>Recall that each neuron usually releases <strong>one</strong>, or mostly one, primary neurotransmitter
          from all of its axon terminals. This “chemical identity” shapes how it participates in a circuit.
        </p>
        <p>We distinguished between:
          <ul>
            <li><strong>Workhorse transmitters</strong> – nearly ubiquitous.
              <ul>
                <li><strong>Glutamate</strong>: fast excitation / depolarization.</li>
                <li><strong>GABA</strong> (and <strong>glycine</strong> in spinal cord and brainstem): fast inhibition / hyperpolarization.</li>
              </ul>
            </li>
            <li><strong>Boutique transmitters</strong> – associated with specific circuits/functions.
              <ul>
                <li><strong>Acetylcholine</strong> (ACh)</li>
                <li><strong>Dopamine</strong> (DA)</li>
                <li><strong>Norepinephrine</strong> (NE; noradrenaline)</li>
                <li><strong>Serotonin</strong> (5-HT)</li>
                <li><strong>Peptide neurotransmitters</strong> (e.g., opioids, CCK, NPY)</li>
              </ul>
            </li>
          </ul>
        </p>
        <p>Workhorse transmitters carry the bulk of <i>fast synaptic traffic</i>, whereas boutique transmitters
          act more like “settings” or “modes” for large-scale circuits—tuning arousal, mood, reward, and
          motivation.
        </p>

        <h3>Review of Major Boutique Transmitter Systems</h3>

        <h4>Cholinergic Pathways and ACh Functions</h4>
        <p><strong>Acetylcholine (ACh)</strong> neurons form several key pathways in the brain:
          <ul>
            <li><strong>Basal forebrain cholinergic system</strong> (nucleus basalis, medial septum):
              projects to cortex and hippocampus; important for <strong>attention</strong>, 
              <strong>learning</strong>, and <strong>memory</strong>.</li>
            <li><strong>Brainstem cholinergic nuclei</strong> (pedunculopontine and laterodorsal
              tegmental nuclei): project to thalamus and basal ganglia; regulate <strong>arousal</strong> 
              and <strong>sleep–wake states</strong>.</li>
          </ul>
        </p>
        <p><strong>Examples of ACh function in the brain.</strong>
          <ul>
            <li><strong>Nicotinic ACh receptors</strong> (ionotropic): contribute to 
              <strong>reward</strong> circuitry.
              <ul>
                <li>Nicotine binds these receptors and enhances dopaminergic reward signaling.</li>
                <li>Hence, tobacco products are powerfully <strong>addictive</strong>.</li>
              </ul>
            </li>
            <li><strong>Muscarinic ACh receptors</strong> (metabotropic): support 
              <strong>cognition</strong> and cortical processing.
              <ul>
                <li>Muscarinic receptor blockers (e.g., certain plant alkaloids and medications) can
                  produce <strong>confusion</strong>, <strong>memory impairments</strong>, and 
                  even <strong>hallucinations</strong>.</li>
              </ul>
            </li>
          </ul>
        </p>

        <h4>Dopaminergic Pathways and Their Functions</h4>
        <p>Dopamine (DA) neurons are clustered in midbrain nuclei and send their axons to specific targets,
          forming distinct pathways.
        </p>

        <p><strong>Mesostriatal (nigrostriatal) pathway.</strong>
          <ul>
            <li>Cell bodies in the <strong>substantia nigra</strong>.</li>
            <li>Axons project to the <strong>striatum</strong> (caudate + putamen).</li>
            <li>Supports <strong>motor control</strong> and the initiation of voluntary movement.</li>
          </ul>
        </p>
        <p>Loss of dopaminergic neurons in the substantia nigra → striatum pathway leads to
          <strong>Parkinson’s disease</strong>, characterized by:
          <ul>
            <li>Bradykinesia (slowness of movement)</li>
            <li>Resting tremor</li>
            <li>Rigidity and postural instability</li>
          </ul>
        </p>

        <p><strong>Mesolimbocortical pathway.</strong>
          <ul>
            <li>Originates in the <strong>ventral tegmental area (VTA)</strong>.</li>
            <li>Projects to the <strong>limbic system</strong> (especially nucleus accumbens) and 
              <strong>prefrontal cortex</strong>.</li>
          </ul>
        </p>
        <p><strong>Functions of DA in this pathway.</strong>
          <ul>
            <li><strong>Reward and reinforcement</strong> – signals “better than expected” outcomes.</li>
            <li><strong>Learning and motivation</strong> – helps assign value to actions and cues.</li>
            <li><strong>Addiction</strong> – many drugs of abuse increase dopamine in these regions.</li>
          </ul>
        </p>
        <p>Abnormal dopaminergic signaling in this pathway is associated with <strong>schizophrenia</strong>
          and related psychotic disorders. Many <strong>antipsychotics</strong> act as antagonists at 
          dopamine receptors, especially of the D<sub>2</sub> family.
        </p>

        <h4>Noradrenergic Pathways and NE Functions</h4>
        <p><strong>Norepinephrine (NE)</strong>, also called <strong>noradrenaline</strong>, is produced by
          neurons in the <strong>locus coeruleus</strong> and a few other brainstem nuclei. Their fibers
          project broadly throughout the brain.
        </p>
        <p><strong>Functions of NE.</strong>
          <ul>
            <li><strong>Arousal and vigilance</strong> – keeps the cortex “awake” and responsive.</li>
            <li><strong>Attention and alertness</strong> – enhances responses to salient stimuli.</li>
            <li><strong>Mood regulation</strong> – disturbances in NE can contribute to depression and anxiety.</li>
            <li><strong>Sexual behavior</strong> and stress responses – coordinates physiological readiness.</li>
          </ul>
        </p>

        <h4>Serotonergic Pathways and 5-HT Functions</h4>
        <p><strong>Serotonin (5-HT)</strong> cell bodies are mainly found in the <strong>raphe nuclei</strong>
          of the brainstem. Serotonergic fibers project widely to cortex, limbic system, and spinal cord.
        </p>
        <p><strong>Functions of 5-HT.</strong>
          <ul>
            <li>Regulation of <strong>sleep</strong> and <strong>circadian rhythms</strong>.</li>
            <li>Modulation of <strong>mood</strong> and <strong>anxiety</strong>.</li>
            <li>Influence on <strong>sexual behavior</strong> and appetite.</li>
          </ul>
        </p>
        <p>Antidepressants such as <strong>Prozac</strong> are 
          <strong>selective serotonin reuptake inhibitors (SSRIs)</strong>. They increase 5-HT in the synaptic 
          cleft by blocking its reuptake, thereby enhancing postsynaptic 5-HT receptor activity.
        </p>

        <h3>Identifying and Naming Neurotransmitter Receptors (Recap)</h3>
        <p>To understand how drugs act, we must first understand the <strong>receptors</strong> they bind. For any given receptor, we ask:
          <ul>
            <li><strong>Which neurotransmitter does it bind?</strong><br>
              – e.g., glutamate receptor vs. acetylcholine receptor.</li>
            <li><strong>What kind of receptor is it?</strong><br>
              – <strong>Ionotropic</strong> (ligand-gated ion channel) or 
                <strong>metabotropic</strong> (G protein–coupled receptor).</li>
            <li><strong>What is its specific pharmacology?</strong><br>
              – Which drugs (agonists/antagonists) bind to it, and how strongly?</li>
          </ul>
        </p>
        <p>Many receptor subtypes are named after synthetic drugs that selectively activate them:
          <ul>
            <li>NMDA and AMPA receptors (glutamate) – named after the agonists 
              N-methyl-D-aspartate and AMPA, respectively.</li>
            <li><strong>Nicotinic</strong> vs. <strong>muscarinic</strong> ACh receptors – named after nicotine and muscarine.</li>
          </ul>
        </p>

        <h3>Why Is Neuropharmacology So Useful?</h3>
        <p>Neuropharmacology is powerful because it provides <i>tools</i> and <i>treatments</i>:
          <ul>
            <li>There are drugs that target almost any step in neural signaling:
              <ul>
                <li>Receptors (direct agonists/antagonists)</li>
                <li>Transporters (reuptake inhibitors)</li>
                <li>Enzymes (breakdown inhibitors)</li>
                <li>Ion channels, second-messenger pathways, gene transcription, etc.</li>
              </ul>
            </li>
            <li>Many of these drugs are <strong>natural products</strong> discovered long ago
              (e.g., plant alkaloids, toxins, venoms).</li>
            <li>We use drugs as <strong>experimental probes</strong> to selectively manipulate 
              molecules and circuits and infer their functions.</li>
            <li>We use drugs as <strong>therapies</strong> to treat a wide range of neurological
              and psychiatric conditions.</li>
          </ul>
        </p>

        <h3>What Is a Drug?</h3>
        <p><strong><u>Definition.</u></strong> In neuropharmacology, a <strong>drug</strong> is an <strong>exogenous</strong> 
          substance (coming from outside the body) that has biological activity in the nervous system
          and is not a normal food or nutrient.
        </p>
        <p>Drugs are usually <strong>specific chemicals</strong> with definable molecular targets, such as:
          <ul>
            <li>a particular receptor subtype,</li>
            <li>a transporter,</li>
            <li>an ion channel, or</li>
            <li>an enzyme involved in transmitter synthesis or degradation.</li>
          </ul>
        </p>
        <p>Drugs differ in their <strong>modes of activity</strong>:
          <ul>
            <li><strong>Agonist</strong> – a drug that <strong>activates</strong> a receptor (mimics or enhances the effect of the endogenous ligand).</li>
            <li><strong>Antagonist</strong> – a drug that <strong>blocks</strong> or reduces activation of a receptor by other ligands.</li>
          </ul>
        </p>

        <h3>Basic Pharmacology Vocabulary</h3>
        <p><strong><u>Definition.</u></strong> A <strong>ligand</strong> is any substance that binds to a receptor,
          whether endogenous (e.g., a neurotransmitter) or exogenous (e.g., a drug or toxin).
        </p>
        <p>We can classify ligands by how they influence receptor activity:
          <ul>
            <li><strong>Agonist</strong> – initiates or enhances the normal effects of the receptor.</li>
            <li><strong>Antagonist</strong> – reduces receptor activation by <i>other</i> ligands; has 
              little or no effect on its own in the absence of the endogenous ligand.</li>
          </ul>
        </p>
        <p>More refined categories (useful later) include:
          <ul>
            <li><strong>Partial agonist</strong> – activates the receptor, but produces a smaller effect than a full agonist, even at full occupancy.</li>
            <li><strong>Inverse agonist</strong> – reduces the receptor’s baseline activity below its resting level.</li>
            <li><strong>Allosteric modulator</strong> – binds at a site distinct from the ligand-binding site and alters the receptor’s response 
              (positively or negatively) to the endogenous ligand.</li>
          </ul>
        </p>

        <h3>Modes of Binding: Competitive vs. Noncompetitive Antagonists</h3>
        <p>To understand how drugs block receptors, we consider where and how they bind.</p>
        <p><strong>Competitive antagonists.</strong>
          <ul>
            <li>Bind to the <strong>same site</strong> on the receptor as the endogenous ligand.</li>
            <li>“Compete” with the ligand for binding; increasing the concentration of the endogenous ligand can <strong>overcome</strong> blockade.</li>
            <li>Typically shift the dose–response curve to the right (need more agonist for the same effect), without changing the maximal possible effect.</li>
          </ul>
        </p>
        <p><strong>Noncompetitive antagonists.</strong>
          <ul>
            <li>Bind to a <strong>different (allosteric) site</strong> or otherwise prevent receptor activation even when the agonist is bound.</li>
            <li>Block receptor function in a way that <strong>cannot be overcome</strong> simply by adding more agonist.</li>
            <li>Often reduce the <strong>maximum</strong> effect achievable by the agonist.</li>
          </ul>
        </p>
        <p>In all cases, the endogenous ligand is the “reference” that tells us what the receptor is <i>normally</i> supposed to do. Drugs then
          mimic, enhance, or interfere with this natural signaling.
        </p>

        <h3>The Dose–Response Curve (DRC)</h3>
        <p>How do we quantify how strongly a drug acts? A central tool is the <strong>dose–response curve</strong>.</p>
        <p><strong><u>Definition.</u></strong> A <strong>dose–response curve (DRC)</strong> plots the <strong>magnitude</strong> or 
          <strong>percentage</strong> of response as a function of the drug dose.
        </p>
        <p>Typically:
          <ul>
            <li>Dose is plotted on a <strong>logarithmic</strong> (log) scale on the x-axis.</li>
            <li>Response (% of subjects responding, or mean effect size) is on the y-axis.</li>
            <li>The curve has a characteristic sigmoidal (S-shaped) form.</li>
          </ul>
        </p>
        <p><strong>ED<sub>50</sub></strong> (effective dose 50) is the dose at which <strong>50%</strong> of subjects show 
          a defined response (or where the effect reaches 50% of its maximum in a given preparation). It is a standard measure of 
          <strong>potency</strong>: lower ED<sub>50</sub> means greater potency.
        </p>
        <p>Two key features of a DRC:
          <ul>
            <li><strong>Potency</strong> – how much drug is needed for a given effect (linked to ED<sub>50</sub>).</li>
            <li><strong>Efficacy</strong> – the <strong>maximum effect</strong> the drug can produce, regardless of dose.</li>
          </ul>
        </p>

        <h3>Therapeutic Index</h3>
        <p>Every drug has two faces: <strong>benefit</strong> and <strong>risk</strong>. We care about the doses that
          produce the desired therapeutic effects and the doses that cause toxicity or death.
        </p>
        <p><strong>Definitions.</strong>
          <ul>
            <li><strong>ED<sub>50</sub></strong> – dose at which 50% of subjects show a therapeutic effect.</li>
            <li><strong>TD<sub>50</sub></strong> – dose at which 50% of subjects show toxicity.</li>
            <li><strong>LD<sub>50</sub></strong> – dose at which 50% of subjects die.</li>
          </ul>
        </p>
        <p><strong><u>Therapeutic index</u></strong> is a measure of <strong>safety</strong>—it reflects the separation
          between the effective dose range and the toxic/lethal dose range. Intuitively:
        </p>
        <center><p><i>A wide gap is good; a narrow gap is dangerous.</i></p></center>
        <p>Conceptually:
          <ul>
            <li><strong>Wide therapeutic index</strong> – large difference between average therapeutic and lethal/toxic doses.
              <ul>
                <li>Safer; dosing errors are less likely to be catastrophic.</li>
              </ul>
            </li>
            <li><strong>Narrow therapeutic index</strong> – small difference between therapeutic and toxic doses.
              <ul>
                <li>Requires close monitoring; small changes in dose or metabolism can push the patient into toxicity.</li>
              </ul>
            </li>
          </ul>
        </p>

        <h3>Drug Tolerance</h3>
        <p>Over time, the same dose of a drug may produce <strong>less effect</strong>. This phenomenon is called
          <strong>tolerance</strong>.
        </p>
        <p><strong><u>Definition.</u></strong> <strong>Drug tolerance</strong> is a decrease in the effect of a drug
          following repeated administration, such that <i>higher doses</i> are required to achieve the same response.
        </p>
        <p>Types of tolerance:
          <ul>
            <li><strong>Metabolic tolerance</strong>
              <ul>
                <li>Organ systems (especially liver, kidneys) become more efficient at <strong>eliminating</strong> the drug.</li>
                <li>Result: less drug reaches the brain for the same administered dose.</li>
              </ul>
            </li>
            <li><strong>Functional tolerance</strong>
              <ul>
                <li>Target tissues (e.g., neurons) become less responsive to the drug.</li>
                <li>Often involves changes in <strong>receptor number</strong> or <strong>signaling</strong>.</li>
              </ul>
            </li>
          </ul>
        </p>

        <h4>Mechanisms of Tolerance in Neurons</h4>
        <p>Recall that the effect of a neurotransmitter or drug depends on how many receptors are present and
          how strongly they signal. Neurons can adapt by changing receptor expression:
        </p>
        <ul>
          <li><strong>Down-regulation</strong> in response to chronic <strong>agonist</strong> exposure
            <ul>
              <li>If a receptor is persistently activated (e.g., by a drug that acts as an agonist), neurons
                may <strong>reduce</strong> the number of receptors on the cell surface.</li>
              <li>Result: the same drug concentration produces less effect → tolerance.</li>
            </ul>
          </li>
          <li><strong>Up-regulation</strong> in response to chronic <strong>antagonist</strong> exposure
            <ul>
              <li>If receptors are chronically blocked by an antagonist, neurons may 
                <strong>increase</strong> the number of receptors.</li>
              <li>Result: heightened sensitivity; if the antagonist is suddenly removed, normal levels of
                neurotransmitter can produce <strong>exaggerated responses</strong> (rebound phenomena).</li>
            </ul>
          </li>
        </ul>
        <p>These changes shift the dose–response curve over time. A dose that was once effective may become
          subtherapeutic (tolerance), or a dose that was once safe may become toxic if metabolic capacity is lost.
        </p>

        <h3>Summary: Agonistic and Antagonistic Actions of Drugs</h3>
        <p>Putting it all together:
          <ul>
            <li><strong>Endogenous ligands</strong> (neurotransmitters, neuromodulators) normally bind their receptors
              and produce specific effects.</li>
            <li><strong>Agonist drugs</strong> mimic or enhance those effects by activating the same receptors (or
              by increasing the availability of the endogenous ligand).</li>
            <li><strong>Antagonist drugs</strong> block or dampen receptor activation, reducing the effect of the
              endogenous ligand.</li>
            <li>Over repeated exposure, the body adjusts through metabolic and functional tolerance, especially via
              receptor up- and down-regulation.</li>
          </ul>
        </p>
        <p>In the subsequent steps of our journey, we will apply these principles to specific drug classes—how they act on 
          particular neurotransmitter systems, what they reveal about brain function, and how they are used (and misused)
          in clinical and everyday settings.
        </p>
      </section>
      <section id="chapter7"><h2>Neuropharmacology II: Classes of Psychoactive Drugs</h2>
        <p>In the previous section, we built the conceptual toolkit of neuropharmacology: we defined neurotransmitters, 
          receptors, agonists and antagonists, dose–response curves, therapeutic index, and tolerance. We saw that 
          drugs can mimic, enhance, or block the actions of endogenous ligands, and that repeated exposure can drive 
          the nervous system to adapt. 
        </p>
        <p>We now put those concepts to work by examining <strong>specific classes of psychoactive drugs</strong>—substances 
          that alter mood, perception, cognition, and behavior by targeting particular neurotransmitter systems. As we 
          do so, keep asking:
        </p>
        <center><p><i>Which transmitter system is being targeted? Which receptors? Is this drug acting as an agonist, antagonist, or something more subtle?</i></p></center>

        <h3>Major Classes of Psychoactive Drugs</h3>
        <p>Psychoactive drugs can be grouped (roughly) by their <strong>primary psychological effects</strong> and 
          <strong>main targets</strong>:
          <ul>
            <li><strong>Opiates / opioids</strong> – powerful analgesics (painkillers); act on endogenous opioid receptors.</li>
            <li><strong>Stimulants</strong> – increase wakefulness, alertness, and energy; act on monoamine and other systems.</li>
            <li><strong>Hallucinogens / psychedelics</strong> – alter perception and cognition; often act on serotonin (5-HT), but also other systems.</li>
          </ul>
        </p>
        <p>In every case, there is a tension between <strong>therapeutic potential</strong> and <strong>risk</strong> 
          (addiction, toxicity, and long-term harm). Neuropharmacology aims to understand both sides.
        </p>

        <h3>Opiates / Opioids</h3>
        <p><strong>Opiates</strong> are drugs derived from the opium poppy; <strong>opioids</strong> more broadly include 
          natural, semi-synthetic, and fully synthetic drugs that act on the same receptors as endogenous opioid peptides 
          (e.g., endorphins, enkephalins).
        </p>
        <p><strong>Examples.</strong>
          <ul>
            <li>Natural/semi-synthetic: <strong>morphine</strong>, <strong>codeine</strong>, <strong>heroin</strong>.</li>
            <li>Prescription painkillers: <strong>oxycodone</strong>, <strong>hydrocodone</strong>, others.</li>
            <li>Synthetic opioids: <strong>fentanyl</strong> and analogs (very potent).</li>
          </ul>
        </p>

        <h4>Mechanism of Action</h4>
        <p>Opioids are generally <strong>agonists</strong> at <strong>opioid receptors</strong> (μ, κ, δ), which are 
          metabotropic (GPCRs) widely expressed in the brain and spinal cord. Activation of these receptors:
          <ul>
            <li>Reduces neuronal excitability (via opening K<sup>+</sup> channels and/or closing Ca<sup>2+</sup> channels).</li>
            <li>Decreases transmission of pain signals in the spinal cord and brainstem → <strong>analgesia</strong>.</li>
            <li>Engages reward circuits in the mesolimbic system → <strong>euphoria</strong> and high addiction liability.</li>
          </ul>
        </p>

        <h4>Clinical and Adverse Effects</h4>
        <p>Clinically, opioids are used as:
          <ul>
            <li><strong>Analgesics</strong> – for acute severe pain (e.g., post-surgical, cancer-related pain).</li>
            <li><strong>Anesthetics adjuncts</strong> – in surgical settings.</li>
          </ul>
        </p>
        <p>However, they also cause:
          <ul>
            <li><strong>Respiratory depression</strong> – suppression of brainstem respiratory centers; this is the primary 
              cause of death in overdose.</li>
            <li><strong>Constipation</strong>, nausea, sedation, and tolerance.</li>
            <li><strong>Dependence and addiction</strong> – with compulsive use despite harm.</li>
          </ul>
        </p>
        <p>Tolerance to opioids can develop rapidly. A particularly dangerous scenario is when a person stops using 
          (e.g., during treatment), loses tolerance, and then relapses at their previous high dose—greatly increasing 
          the risk of fatal overdose.
        </p>

        <h4>The Opioid Crisis and Harm Reduction</h4>
        <p>In many countries, especially the United States, there has been a major <strong>opioid epidemic</strong>:
          <ul>
            <li><strong>Over-prescription</strong> of opioid painkillers and diversion into the black market fueled widespread use.</li>
            <li><strong>Potent synthetic opioids</strong> such as fentanyl, which is much stronger than morphine, significantly 
              increased overdose risk.</li>
          </ul>
        </p>
        <p>A key life-saving tool is <strong>naloxone</strong> (Narcan), a <strong>competitive opioid receptor antagonist</strong>.
          It rapidly displaces opioids from μ-receptors and can reverse opioid-induced respiratory depression if given in time. 
          Making naloxone widely available (e.g., nasal sprays) is an important harm-reduction strategy.
        </p>

        <h3>Stimulants</h3>
        <p><strong>Stimulant</strong> drugs increase wakefulness, alertness, and often produce a sense of energy and confidence. 
          They act by <strong>increasing activity in excitatory or modulatory systems</strong>, particularly acetylcholine, 
          glutamate, and monoamines (dopamine, norepinephrine).
        </p>
        <p>Common examples:
          <ul>
            <li><strong>Caffeine</strong></li>
            <li><strong>Nicotine</strong></li>
            <li><strong>Cocaine</strong></li>
            <li><strong>Amphetamines</strong> (including methamphetamine and related compounds)</li>
          </ul>
        </p>
        <p>All stimulants can produce <strong>tolerance</strong> and sometimes <strong>dependence</strong>; some (particularly 
          cocaine and amphetamines) have high addiction potential and serious health risks.
        </p>

        <h4>Mechanisms (Brief Overview)</h4>
        <p>Different stimulants act at different targets:
          <ul>
            <li><strong>Caffeine</strong> – blocks adenosine receptors (adenosine normally promotes sleep), indirectly increasing 
              neural activity and catecholamine release.</li>
            <li><strong>Nicotine</strong> – agonist at nicotinic ACh receptors; enhances attention and reinforces mesolimbic 
              dopamine signaling → highly addictive.</li>
            <li><strong>Cocaine</strong> – blocks reuptake transporters for dopamine, norepinephrine, and serotonin, increasing 
              their levels in the synaptic cleft.</li>
            <li><strong>Amphetamines</strong> – increase release of dopamine and norepinephrine and can reverse their transporters, 
              flooding synapses with monoamines.</li>
          </ul>
        </p>

        <h4>Medical Use of Amphetamines</h4>
        <p>Several drugs in the <strong>amphetamine family</strong> (or functionally similar stimulants) are prescribed for 
          <strong>attention-deficit/hyperactivity disorder (ADHD)</strong> and certain sleep disorders (e.g., narcolepsy). 
          Examples include:
          <ul>
            <li>Amphetamine/dextroamphetamine combinations (e.g., formulations similar to Adderall).</li>
            <li>Methylphenidate-based drugs (e.g., formulations similar to Ritalin).</li>
            <li>Dexmethylphenidate and related compounds.</li>
          </ul>
        </p>
        <p>These medications, when used under medical supervision, can improve attention and impulse control by modulating 
          catecholamine signaling in prefrontal and striatal circuits. 
        </p>
        <p>However, they are also frequently used <strong>without prescription</strong> for “academic performance” or 
          recreational purposes, which increases the risk of cardiovascular side effects, dependence, and other harms.
        </p>

        <h4>Recreational Amphetamines: Risks</h4>
        <p>Short-term effects of amphetamines may include:
          <ul>
            <li>Increased alertness and wakefulness</li>
            <li>Euphoria and a sense of confidence</li>
            <li>Increased stamina and reduced fatigue</li>
          </ul>
        </p>
        <p>Long-term or high-dose use, however, can be severely damaging:
          <ul>
            <li><strong>Sleeplessness</strong> and profound sleep disruption</li>
            <li><strong>Weight loss</strong> and poor nutrition</li>
            <li><strong>Cardiovascular strain</strong> (elevated heart rate and blood pressure)</li>
            <li><strong>Psychiatric symptoms</strong> – prolonged use can lead to compulsive, agitated behavior and 
              paranoia that can resemble <strong>paranoid schizophrenia</strong>.</li>
          </ul>
        </p>
        <p>Chronic methamphetamine use is notoriously associated with marked physical and psychological deterioration—a 
          vivid reminder of how powerful and destructive monoamine dysregulation can be.
        </p>

        <h3>Hallucinogens / Psychedelics</h3>
        <p><strong>Hallucinogens</strong>, often called <strong>psychedelics</strong>, are drugs that profoundly alter 
          <strong>perception</strong>, <strong>emotion</strong>, and sometimes the sense of self. They can produce:
          <ul>
            <li>Visual distortions and complex imagery</li>
            <li>Altered auditory and somatosensory experiences</li>
            <li>Changes in the perception of time and space</li>
            <li>Intense emotional or “spiritual” experiences</li>
          </ul>
        </p>
        <p>They act on multiple systems, but a major theme is modulation of <strong>serotonin (5-HT) receptors</strong> 
          (especially 5-HT<sub>2A</sub>) in cortex. Others affect glutamate, acetylcholine, and norepinephrine as well.
        </p>
        <p>Many hallucinogens are <strong>abused</strong> (used non-medically or illicitly), but most are not strongly 
          <strong>addictive</strong> in the sense of causing compulsive daily use with severe withdrawal. Their risks arise 
          more from acute psychological distress, unsafe behavior, and (for some agents) potential neurotoxicity.
        </p>

        <h4>LSD and Classic Psychedelics</h4>
        <p><strong>Lysergic acid diethylamide (LSD)</strong> is a semi-synthetic compound originally derived from 
          <strong>ergot</strong> (a fungus that infects grains). A key figure in its discovery and early exploration is 
          often called the “father of LSD.”
        </p>
        <p>LSD acts primarily as an <strong>agonist</strong> (or partial agonist) at several 
          <strong>serotonin receptors</strong>, especially <strong>5-HT<sub>2A</sub></strong>, which are dense in 
          visual cortex and higher-order association areas. It also has actions at other monoamine receptors.
        </p>
        <p>Subjective effects frequently include:
          <ul>
            <li>Intense and vivid colors, geometric patterns</li>
            <li>Novel visual objects and illusions (and, at higher doses, true hallucinations)</li>
            <li>Altered sense of time (minutes feel longer or shorter)</li>
            <li>Emotional lability, from euphoria to anxiety</li>
          </ul>
        </p>
        <p>These experiences are strongly shaped by <strong>set</strong> (mindset, expectations) and 
          <strong>setting</strong> (environment and social context).
        </p>

        <h4>Psychedelics and Possible Clinical Applications</h4>
        <p>Recent research has revisited classic and “newer” psychedelics as <strong>potential treatments</strong> for 
          certain psychiatric conditions, always in <strong>carefully controlled</strong> clinical settings with 
          psychological support. Some of the leading candidates include:
        </p>

        <table style="width:100%; border-collapse:collapse; font-size:0.9rem;">
          <thead>
            <tr>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Drug</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Primary Action in Brain</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Typical Subjective Effects (Recreational)</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Possible Clinical Applications (Under Study)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="padding:6px;"><strong>Psilocybin / psilocin</strong><br><span style="font-size:0.8rem;">(“magic mushrooms”)</span></td>
              <td style="padding:6px;">Partial agonist at 5-HT receptors, especially 5-HT<sub>2A</sub>; alters activity in frontal and occipital cortex.</td>
              <td style="padding:6px;">Intense visual phenomena, changes in time perception, feelings of transcendence or “mystical” experiences; effects strongly depend on set and setting.</td>
              <td style="padding:6px;">Promising results for treatment-resistant depression, anxiety in serious illness, obsessive–compulsive symptoms, and cluster headache when administered in structured therapeutic contexts.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>LSD</strong> (lysergic acid diethylamide)</td>
              <td style="padding:6px;">Agonist at several monoamine receptors, notably 5-HT and DA; increases activity in frontal, cingulate, and visual cortices.</td>
              <td style="padding:6px;">Pronounced perceptual changes, vivid colors and patterns, novel imagery, altered sense of self and time.</td>
              <td style="padding:6px;">Being explored as an adjunct to psychotherapy for alcohol and other substance use disorders, and for some anxiety conditions.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Ketamine</strong></td>
              <td style="padding:6px;">Blocks NMDA-type glutamate receptors; also interacts with opioid and cholinergic systems; produces dissociation.</td>
              <td style="padding:6px;">“Detached” or dreamlike state; distortions of body perception and environment; at higher doses, full anesthesia.</td>
              <td style="padding:6px;">Low doses can produce rapid antidepressant effects in some patients who do not respond to conventional treatments; used in tightly monitored clinical settings.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>MDMA</strong><br><span style="font-size:0.8rem;">(“Ecstasy”)</span></td>
              <td style="padding:6px;">Increases release of serotonin, dopamine, and norepinephrine; enhances oxytocin signaling; acts as a potent monoamine releaser.</td>
              <td style="padding:6px;">Heightened sensory experiences, empathy, strong prosocial feelings, and euphoria.</td>
              <td style="padding:6px;">Studied as an adjunct to psychotherapy for post-traumatic stress disorder (PTSD); safety concerns (e.g., overheating, neurotoxicity) require careful control.</td>
            </tr>
          </tbody>
        </table>
        <p style="font-size:0.85rem; color:#555; margin-top:6px;">
          Important: these potential clinical uses involve carefully controlled doses, medical screening, and structured psychotherapy. 
          This is very different from unsupervised recreational use, which can be dangerous.
        </p>

        <h3>Bringing It Together</h3>
        <p>Across opioids, stimulants, and hallucinogens, the same core principles reappear:
          <ul>
            <li>Drugs act as <strong>agonists</strong>, <strong>antagonists</strong>, or modulators at specific receptors and transporters.</li>
            <li>Their effects are constrained by <strong>dose–response relationships</strong> and <strong>therapeutic index</strong>.</li>
            <li>Repeated use drives <strong>tolerance</strong>, dependence, and sometimes profound neuroadaptations.</li>
            <li>The same molecular mechanisms that give a drug therapeutic power can also create risk for <strong>addiction</strong> and toxicity.</li>
          </ul>
        </p>
        <p>Neuropharmacology, then, is not just about how drugs change the brain; it is also about how the brain changes in response 
          to drugs—and how we can harness these changes safely and ethically in the service of treating disease.
        </p>
      </section>
      <section id="chapter8"><h2>Neuropharmacology III: Clinical Drugs, Cannabinoids & Addiction</h2>
        <p>In the previous section, we explored major classes of psychoactive drugs—opiates, stimulants, and 
          hallucinogens—and began to connect their subjective effects to their molecular actions on neurotransmitter 
          systems. We also saw that some of these compounds, especially psychedelics, may have carefully controlled 
          clinical uses despite their history as recreational substances.
        </p>
        <p>In this final section on neuropharmacology, we will:
          <ul>
            <li>Revisit hallucinogens with an emphasis on their <strong>clinical applications</strong>.</li>
            <li>Survey key <strong>clinical drug classes</strong> (antipsychotics, antidepressants, anesthetics, depressants).</li>
            <li>Introduce <strong>cannabinoids</strong> and the brain’s endocannabinoid system.</li>
            <li>Develop a framework for understanding <strong>addiction / substance use disorders (SUDs)</strong>,
              their neural basis, and approaches to treatment.</li>
          </ul>
        </p>

        <h3>Psychedelics and Their Clinical Potential (Recap)</h3>
        <p>Hallucinogens, or <strong>psychedelics</strong>, are drugs that create profound <strong>perceptual 
          distortions</strong>—visual, auditory, and somatosensory—and shifts in cognition and emotion. As noted earlier:
          <ul>
            <li>They often act as <strong>agonists or partial agonists</strong> at <strong>5-HT<sub>2A</sub></strong> 
              and other monoamine receptors.</li>
            <li>They do <strong>not</strong> typically produce classic physical dependence, but can still be 
              <strong>abused</strong> (non-medical or illicit use).</li>
          </ul>
        </p>
        <p>Key examples include:
          <ul>
            <li><strong>LSD</strong> – a 5-HT<sub>2A</sub> receptor agonist derived from <strong>ergotamine</strong> 
              (a natural product from the ergot fungus). Produces vivid visual changes, complex patterns, altered sense 
              of time and self.</li>
            <li><strong>Psilocybin</strong> – the active component of certain mushrooms; partial agonist at 5-HT receptors, 
              especially 5-HT<sub>2A</sub>, strongly affecting visual cortex and frontal networks.</li>
            <li><strong>Ketamine</strong> – a dissociative anesthetic; <strong>NMDA receptor antagonist</strong> with 
              additional actions on opioid and cholinergic systems.</li>
            <li><strong>MDMA</strong> – increases release of serotonin, dopamine, norepinephrine, and oxytocin, producing 
              intense prosocial and empathogenic effects.</li>
          </ul>
        </p>
        <p>Recent research suggests that, when used in a <strong>structured therapeutic context</strong> (screened patients, 
          controlled dosing, psychotherapy support), these compounds may:
          <ul>
            <li>Rapidly relieve symptoms of <strong>treatment-resistant depression</strong>, <strong>anxiety</strong>, 
              and certain <strong>obsessive–compulsive</strong> symptoms.</li>
            <li>Reduce the burden of <strong>cluster headaches</strong> in some patients.</li>
            <li>Assist in treating <strong>PTSD</strong> (especially MDMA-assisted psychotherapy).</li>
            <li>Support recovery from <strong>alcohol use disorder</strong> and other addictions (e.g., LSD/psilocybin in trials).</li>
          </ul>
        </p>
        <p>Important: this promising work does <strong>not</strong> mean unsupervised use is safe. The clinical setting 
          is tightly controlled, unlike recreational contexts.
        </p>

        <h3>Major Clinical Neuropsychiatric Drugs</h3>
        <p>Beyond recreational substances, many psychoactive drugs are prescribed daily for psychiatric and neurological 
          conditions. Here we consider four broad categories:
          <ol>
            <li><strong>Antipsychotics</strong></li>
            <li><strong>Antidepressants</strong></li>
            <li><strong>Anesthetics</strong></li>
            <li><strong>Depressants</strong> (anxiolytics, sedatives, hypnotics)</li>
          </ol>
        </p>

        <h4>Antipsychotics</h4>
        <p><strong>Antipsychotic drugs</strong> are among the most frequently prescribed classes of medications in psychiatry. 
          They are primarily used to treat <strong>psychotic disorders</strong> such as schizophrenia and schizoaffective disorder, 
          and sometimes bipolar disorder with psychotic features.
        </p>
        <p>Two broad groups are often distinguished:
          <ul>
            <li><strong>Typical (first-generation) antipsychotics</strong>
              <ul>
                <li>Primarily <strong>D<sub>2</sub> dopamine receptor antagonists</strong>.</li>
                <li>Reduce <strong>positive symptoms</strong> of psychosis: paranoia, delusions, hallucinations (e.g., “voices”).</li>
                <li>Side effects often include motor symptoms (Parkinsonian-like effects, tardive dyskinesia) due to DA blockade 
                  in motor pathways.</li>
              </ul>
            </li>
            <li><strong>Atypical (second-generation) antipsychotics</strong>
              <ul>
                <li>Act on DA receptors <strong>and</strong> other transmitters (often serotonin, e.g., 5-HT<sub>2A</sub> antagonism).</li>
                <li>Better at addressing some <strong>negative symptoms</strong> (social withdrawal, blunted affect) and cognitive deficits.</li>
                <li>Generally less motor side effects, but can cause metabolic problems (weight gain, diabetes risk).</li>
              </ul>
            </li>
          </ul>
        </p>

        <h4>Antidepressants</h4>
        <p><strong>Antidepressants</strong> are widely prescribed for major depressive disorder, anxiety disorders, and 
          related conditions. They primarily modulate <strong>monoamine</strong> neurotransmission (5-HT, NE, DA).
        </p>
        <p>Major classes include:
          <ul>
            <li><strong>SSRIs</strong> (selective serotonin reuptake inhibitors) and 
              <strong>SNRIs</strong> (serotonin–norepinephrine reuptake inhibitors)
              <ul>
                <li>Block reuptake of 5-HT (SSRIs) or both 5-HT and NE (SNRIs).</li>
                <li>Increase monoamine levels in the synaptic cleft, enhancing receptor activation.</li>
              </ul>
            </li>
            <li><strong>Tricyclic antidepressants (TCAs)</strong>
              <ul>
                <li>Older drugs that block reuptake of 5-HT, NE, and often DA.</li>
                <li>Effective but can have significant side effects (anticholinergic, cardiotoxic at high doses).</li>
              </ul>
            </li>
            <li><strong>MAOIs</strong> (monoamine oxidase inhibitors)
              <ul>
                <li>Inhibit monoamine oxidase, the enzyme that degrades monoamine neurotransmitters.</li>
                <li>Increase levels of 5-HT, NE, and DA.</li>
                <li>Less commonly used now due to potential <strong>dangerous interactions</strong> 
                  (e.g., with certain foods and medications) and risk of severe side effects.</li>
              </ul>
            </li>
          </ul>
        </p>

        <h4>Anesthetics</h4>
        <p><strong>Anesthetics</strong> are drugs that produce <strong>unconsciousness</strong> (general anesthesia) or 
          <strong>localized loss of sensation</strong> (local anesthesia).
        </p>
        <p><strong>Local anesthetics</strong>:
          <ul>
            <li>Block <strong>voltage-gated Na<sup>+</sup> channels</strong> (VGNaCs) in peripheral nerves.</li>
            <li>Prevent action potentials from propagating along sensory fibers → loss of sensation in the targeted region.</li>
          </ul>
        </p>
        <p><strong>General anesthetics</strong>:
          <ul>
            <li>Often enhance <strong>GABA<sub>A</sub></strong> receptor function (e.g., many IV and inhaled agents, 
              propofol) → increased inhibition → loss of consciousness.</li>
            <li>Some inhibit specific <strong>glutamate receptors</strong> (e.g., ketamine and xenon as NMDA antagonists), 
              leading to dissociative states or anesthesia.</li>
            <li>Multiple molecular targets are usually involved; the precise mechanisms are complex.</li>
          </ul>
        </p>

        <h4>Depressants (Anxiolytics, Sedatives, Hypnotics)</h4>
        <p><strong>Depressants</strong> are drugs that <strong>depress action potential firing</strong> and neural activity 
          (the term “depressant” refers to neural activity, not necessarily mood). They are often used as:
          <ul>
            <li><strong>Anxiolytics</strong> – reduce anxiety.</li>
            <li><strong>Sedatives</strong> – calm and reduce arousal.</li>
            <li><strong>Hypnotics</strong> – promote sleep.</li>
          </ul>
        </p>
        <p>Most act as <strong>agonists</strong> (or positive allosteric modulators) at inhibitory receptors:
          <ul>
            <li><strong>GABA<sub>A</sub></strong> receptors – primary target of benzodiazepines, barbiturates, and 
              ethanol (alcohol).</li>
            <li><strong>Glycine</strong> receptors – additional inhibitory targets in spinal cord and brainstem.</li>
          </ul>
        </p>
        <p>Examples include:
          <ul>
            <li><strong>Benzodiazepines</strong> – enhance GABA<sub>A</sub> receptor activity; used for anxiety, insomnia, seizures.</li>
            <li><strong>Barbiturates</strong> – older sedative–hypnotics; powerful but with high overdose risk.</li>
            <li><strong>Alcohol (ethanol)</strong> – complex actions; prominently increases GABAergic inhibition and alters glutamate signaling.</li>
          </ul>
        </p>

        <h3>Cannabinoids and the Endocannabinoid System</h3>
        <p><strong>Marijuana</strong> is derived from <strong>Cannabis sativa</strong>. Its best-known psychoactive component is 
          <strong>Δ<sup>9</sup>-tetrahydrocannabinol (THC)</strong>, but the plant contains many other biologically active 
          compounds, including cannabinol (CBN), cannabidiol (CBD), and tetrahydrocannabivarin.
        </p>

        <h4>Physiological Effects of Cannabis</h4>
        <p>Cannabis produces a mixture of effects:
          <ul>
            <li>Some <strong>excitatory</strong> or stimulating effects (e.g., mild euphoria, altered perception).</li>
            <li>Sometimes <strong>sedative</strong>, calming effects (but typically without the risk of respiratory failure seen with opioids).</li>
            <li><strong>Mild analgesia</strong> – relief of certain types of pain.</li>
            <li><strong>Antiemetic</strong> effects and <strong>appetite stimulation</strong> (“the munchies”).</li>
            <li>At high doses, can produce <strong>perceptual changes</strong> or hallucinations in some users.</li>
          </ul>
        </p>

        <h4>Endocannabinoids: Natural Cannabinoid-like Transmitters</h4>
        <p>The brain produces its own cannabis-like molecules, called <strong>endocannabinoids</strong>.
          <ul>
            <li>The first identified was <strong>anandamide</strong> (from Sanskrit for “bliss”).</li>
            <li>Another abundant endocannabinoid is <strong>2-arachidonoylglycerol (2-AG)</strong>.</li>
          </ul>
        </p>
        <p>Endocannabinoids are:
          <ul>
            <li><strong>Lipid-like</strong> (fatty) molecules, synthesized on demand in the postsynaptic neuron.</li>
            <li>Often released <strong>retrogradely</strong> (from postsynaptic cell back to presynaptic terminal), where they 
              modulate neurotransmitter release.</li>
          </ul>
        </p>

        <h4>Cannabinoid Receptors</h4>
        <p>There are two major cannabinoid receptor types, both <strong>G protein–coupled (metabotropic)</strong>:
          <ul>
            <li><strong>CB1 receptors</strong>
              <ul>
                <li>Abundant in the <strong>CNS</strong> (cortex, hippocampus, basal ganglia, cerebellum).</li>
                <li>Mediate many of the psychoactive and rewarding properties of cannabinoids, including THC.</li>
              </ul>
            </li>
            <li><strong>CB2 receptors</strong>
              <ul>
                <li>Prominent in the <strong>immune system</strong> and peripheral tissues.</li>
                <li>Involved in inflammation and immune responses; may play a role in pain and immune modulation.</li>
              </ul>
            </li>
          </ul>
        </p>

        <h4>Medical Uses of Cannabis and Cannabinoids</h4>
        <p>Clinically, cannabinoids (plant-derived or synthetic) may be used for:
          <ul>
            <li><strong>Anxiolysis</strong> – reduction of anxiety in some patients.</li>
            <li><strong>Analgesia</strong> – relief of certain chronic pain conditions.</li>
            <li><strong>Anti-emetic and appetite stimulation</strong> – THC-based medications are approved for 
              chemotherapy-induced nausea and appetite loss.</li>
            <li><strong>Anticonvulsant</strong> – CBD-based medications are approved for specific seizure disorders.</li>
            <li><strong>Lowering intraocular pressure</strong> – historically, for glaucoma (now less commonly first-line).</li>
            <li><strong>Cardiovascular effects</strong> – can lower blood pressure in some contexts, though this may not always be desirable.</li>
          </ul>
        </p>
        <p>As with all psychoactive drugs, benefits must be weighed against risks (e.g., cognitive effects, dependence in some individuals, 
          and possible interactions with other conditions or medications).
        </p>

        <h3>Addiction and Substance Use Disorders (SUDs)</h3>
        <p>Not all psychoactive drugs are equally <strong>addictive</strong>. A critical organizing idea is:
        </p>
        <center><p><i>Drugs that strongly activate the brain’s reward circuits have the highest potential for addiction.</i></p></center>
        <p>Examples with high addiction liability:
          <ul>
            <li><strong>Alcohol</strong></li>
            <li><strong>Benzodiazepines</strong> and other depressants</li>
            <li><strong>Nicotine</strong></li>
            <li><strong>Opiates/opioids</strong></li>
            <li><strong>Cocaine</strong>
          </ul></p>

      <h2>Neural Development</h2>
        <p>We have focused till this point on the <strong>adult nervous system</strong>—how neurons are built, how they 
          communicate, and how drugs modulate their activity. But those mature circuits do not simply appear fully formed. 
          They are the end result of a long, tightly orchestrated sequence of developmental events that begin with a single cell.
        </p>
        <p>Neural development asks:
        </p>
        <center><p><i>How do we get from a fertilized egg to a complex brain with billions of neurons and trillions of synapses?</i></p></center>

        <h3>From Fertilized Egg to Germ Layers</h3>
        <p>Development begins at the moment of fertilization:
          <ul>
            <li><strong>Fertilized egg (zygote)</strong> – a single <strong>totipotent</strong> cell.
              <ul>
                <li><strong><u>Definition.</u></strong> A totipotent cell can divide and give rise to <strong>all</strong> 
                  cell types in the body, including extra-embryonic tissues (e.g., placenta).</li>
              </ul>
            </li>
            <li>As the zygote divides, it gives rise to <strong>pluripotent</strong> cells.
              <ul>
                <li><strong><u>Definition.</u></strong> Pluripotent cells have begun to specialize, but can still generate 
                  many different tissues of the embryo proper.</li>
              </ul>
            </li>
          </ul>
        </p>
        <p>Early in development, a key process called <strong>gastrulation</strong> reorganizes the embryo and establishes 
          three primary lineages known as the <strong>germ layers</strong>:
          <ul>
            <li><strong>Endoderm</strong> – gives rise to the lining of the gut and associated organs (e.g., liver, lungs).</li>
            <li><strong>Mesoderm</strong> – forms muscle, bone, blood, and connective tissue.</li>
            <li><strong>Ectoderm</strong> – forms skin and the entire nervous system.</li>
          </ul>
        </p>

        <h3>Neural Tissue from Ectoderm</h3>
        <p>It may feel surprising that the brain—buried inside the skull—is derived from the <strong>outermost</strong> germ 
          layer, the ectoderm. Most ectodermal cells become “outside” structures such as skin. Neural tissue arises because 
          part of this ectodermal sheet <strong>folds inward</strong> into the interior of the embryo.
        </p>
        <p>The sequence looks like this (simplified):
          <ol>
            <li>The dorsal ectoderm thickens to form the <strong>neural plate</strong>.</li>
            <li>The neural plate invaginates (folds in) to form the <strong>neural groove</strong>.</li>
            <li>The sides of the groove elevate and fold toward each other.</li>
            <li>When the folds meet and fuse, they form the <strong>neural tube</strong>.</li>
          </ol>
        </p>
        <p>The neural tube ultimately gives rise to the <strong>central nervous system</strong> (CNS)— brain and spinal cord. 
          The cells at the crest of the folding ectoderm, the <strong>neural crest cells</strong>, migrate out and form much of 
          the <strong>peripheral nervous system</strong> (PNS), including:
          <ul>
            <li>sensory ganglia,</li>
            <li>autonomic ganglia,</li>
            <li>and some non-neural structures (e.g., parts of the face and skull).</li>
          </ul>
        </p>

        <h3>Early Patterning: Spinal Cord to Forebrain</h3>
        <p>Development is <strong>polar</strong>: as the neural tube forms, it becomes spatially organized along its length. 
          Different regions along the rostrocaudal (head-to-tail) axis will form major divisions of the CNS:
          <ul>
            <li><strong>Spinal cord</strong> – caudal (tail) end of the tube.</li>
            <li><strong>Rhombencephalon</strong> (hindbrain) – will give rise to medulla, pons, cerebellum.</li>
            <li><strong>Mesencephalon</strong> (midbrain).</li>
            <li><strong>Diencephalon</strong> and <strong>telencephalon</strong> (forebrain):
              <ul>
                <li><strong>Diencephalon</strong> – thalamus, hypothalamus.</li>
                <li><strong>Telencephalon</strong> – cerebral hemispheres (cortex, basal ganglia, etc.).</li>
              </ul>
            </li>
          </ul>
        </p>
        <p>Signals along the neural tube (from adjacent tissues and internal patterning molecules) help establish where 
          <strong>spinal cord</strong>, <strong>hindbrain</strong>, <strong>midbrain</strong>, and 
          <strong>forebrain</strong> territories will form. This “rough map” is in place very early; the rest of development 
          refines, populates, and connects these regions.
        </p>

        <h3>The Six Stages of Neural Development</h3>
        <p>We can conceptually break neural development into six major stages. In reality, many of these overlap in time, 
          but it is useful to treat them separately:
        </p>
        <ol>
          <li><strong>Neurogenesis</strong> – birth of neurons and glia from precursor cells.</li>
          <li><strong>Cell migration</strong> – movement of cells to their appropriate locations.</li>
          <li><strong>Cell differentiation</strong> – cells become specific neuron or glial types.</li>
          <li><strong>Synaptogenesis</strong> – growth of axons/dendrites and formation of synapses.</li>
          <li><strong>Neuronal cell death</strong> – selective elimination of many neurons.</li>
          <li><strong>Synapse rearrangement</strong> – pruning and refinement of synaptic connections.</li>
        </ol>

        <h4>Stage 1 – Neurogenesis</h4>
        <p><strong><u>Definition.</u></strong> <strong>Neurogenesis</strong> is the production of new nerve cells 
          (neurons) from dividing precursor cells.
        </p>
        <p>Inside the neural tube is a region called the <strong>ventricular zone</strong> (VZ). Here:
          <ul>
            <li><strong>Non-neural precursor cells</strong> undergo <strong>mitosis</strong>.</li>
            <li>These dividing precursors give rise to <strong>neural progenitor cells</strong>.</li>
            <li>Progenitors can then become either <strong>neurons</strong> or <strong>glial cells</strong> 
              (astrocytes, oligodendrocytes).</li>
          </ul>
        </p>
        <p>Early in development, neurogenesis is extremely active; later, much of it slows or stops, and the brain relies more 
          on refining existing circuits than adding entirely new neurons (with some regional exceptions).
        </p>

        <h4>Stage 2 – Cell Migration</h4>
        <p>Once neurons are born, they rarely stay where they were generated. In <strong>cell migration</strong>, neurons move 
          away from the ventricular zone to form distinct layers and nuclei.
        </p>
        <p>Key features:
          <ul>
            <li>Cells closest to the ventricles are established <strong>first</strong>.</li>
            <li>Later-born neurons must often <strong>crawl past older neurons</strong> to form more superficial layers.</li>
            <li><strong>Radial glial cells</strong> act as scaffolding or “glial spokes” along which neurons migrate outward.</li>
            <li><strong>Cell adhesion molecules (CAMs)</strong> help cells stick to appropriate pathways and neighbors.</li>
          </ul>
        </p>
        <p>In the cerebral cortex, this results in an “<strong>inside-out</strong>” layering: older neurons form deeper layers; 
          younger neurons migrate further to form more superficial layers.
        </p>

        <h4>Stage 3 – Cell Differentiation</h4>
        <p>After migration, neurons must acquire their <strong>mature identity</strong>.
          <ul>
            <li>Cells differentiate into specific <strong>neuronal types</strong> (e.g., pyramidal cells, interneurons) or 
              <strong>glial types</strong> (astrocytes, oligodendrocytes).</li>
            <li>Differentiation depends on:
              <ul>
                <li><strong>Intrinsic factors</strong> – gene expression programs already active in the cell.</li>
                <li><strong>Extrinsic cues</strong> – signals from neighboring cells, local environment, and afferent inputs.</li>
              </ul>
            </li>
          </ul>
        </p>
        <p>Location matters: the <strong>physical position</strong> of a cell within the nervous system exposes it to specific 
          cues, which help determine what that cell will become. Once differentiated, neurons must then form functional 
          connections—enter <strong>synaptogenesis</strong>.
        </p>

        <h4>Stage 4 – Synaptogenesis</h4>
        <p><strong>Synaptogenesis</strong> is the process by which neurons extend processes and form synapses with their 
          appropriate targets.
        </p>
        <p>Two related processes occur:
          <ul>
            <li><strong>Process outgrowth</strong> – growth of axons and dendrites.</li>
            <li><strong>Synapse formation</strong> – making specific, functional contacts with target cells.</li>
          </ul>
        </p>
        <p>At the tips of growing axons and dendrites are specialized structures called <strong>growth cones</strong>.
          <ul>
            <li>Growth cones have thin, finger-like protrusions called <strong>filopodia</strong>.</li>
            <li>Filopodia “sample” the environment—probing for chemical and physical cues.</li>
            <li>Growth cones steer toward attractive cues and away from repulsive ones.</li>
          </ul>
        </p>
        <p>Target cells and intermediate guideposts release:
          <ul>
            <li><strong>Chemoattractants</strong> – diffusible or surface-bound chemical cues that attract certain growth cones.</li>
            <li><strong>Chemorepellents</strong> – cues that repel certain growth cones.</li>
          </ul>
        </p>
        <p>The general strategy is:
        </p>
        <center><p><i>Use simple local rules (follow attractants, avoid repellents) to construct complex, large-scale wiring diagrams.</i></p></center>

        <h4>Stage 5 – Neuronal Cell Death (Apoptosis)</h4>
        <p>One of the striking features of neural development is that <strong>many more neurons are produced than will survive</strong>. 
          A significant fraction of neurons undergo programmed cell death.
        </p>
        <p><strong><u>Definition.</u></strong> <strong>Apoptosis</strong> is an active, regulated form of cell death—sometimes 
          called “cellular suicide.” It is not an accident; it is part of the normal developmental program.
        </p>
        <p>Why kill off neurons? Because the nervous system adopts a “<strong>make more than you need, then keep the best</strong>” strategy:
          <ul>
            <li>Neurons compete for <strong>trophic factors</strong> (“nourishing” factors) produced by their target cells.</li>
            <li><strong>Correct synaptic connections</strong> allow neurons to receive the right amount of trophic support.</li>
            <li>Neurons that fail to make appropriate, functional connections receive inadequate trophic support and activate 
              apoptotic pathways.</li>
          </ul>
        </p>
        <p>A simplified model:
          <ul>
            <li>Target cells secrete specific <strong>neurotrophic factors</strong> (e.g., NGF, BDNF).</li>
            <li>Neurons that successfully innervate those targets take up the “right” trophic factor.</li>
            <li>Trophic factor uptake triggers <strong>pro-survival gene expression</strong>.</li>
            <li>Neurons that fail to receive sufficient trophic support undergo apoptosis.</li>
          </ul>
        </p>
        <p>Apoptosis proceeds through characteristic stages:
          <ul>
            <li><strong>Chromatin condensation</strong> – DNA condenses and becomes fragmented.</li>
            <li><strong>Nuclear fragmentation</strong>.</li>
            <li><strong>Blebbing</strong> – cell membrane forms bulges.</li>
            <li><strong>Cell fragmentation</strong> into small vesicles.</li>
            <li>Cell remnants are cleared by <strong>phagocytic cells</strong> (e.g., microglia).</li>
          </ul>
        </p>
        <p>Far from being purely destructive, this “sculpting by cell death” helps match the number of neurons to the size and 
          needs of their target tissues.
        </p>

        <h4>Stage 6 – Synapse Rearrangement (Pruning and Refinement)</h4>
        <p>Even after neuronal cell death, the nervous system is still <strong>over-connected</strong>. Many synapses are present 
          that will not be maintained into adulthood. In <strong>synapse rearrangement</strong>, connections are refined:
          <ul>
            <li>Some synapses are <strong>strengthened</strong> and stabilized.</li>
            <li>Others are <strong>weakened</strong> and eventually eliminated (pruned).</li>
          </ul>
        </p>
        <p>This process is heavily influenced by <strong>neural activity</strong> and <strong>experience</strong>:
          <ul>
            <li>“Active” synapses that contribute to useful circuits tend to be preserved and strengthened.</li>
            <li>“Inactive” or mismatched synapses are more likely to be pruned away.</li>
          </ul>
        </p>
        <p>Pruning helps:
          <ul>
            <li>Sharpen topographic maps (e.g., in sensory cortices).</li>
            <li>Refine motor coordination.</li>
            <li>Optimize efficiency and reduce redundancy in neural circuits.</li>
          </ul>
        </p>
        <p>Thus, development follows a general blueprint:
          <ol>
            <li>Generate lots of cells and processes.</li>
            <li>Let them explore and form many candidate connections.</li>
            <li>Use trophic factors and activity-dependent rules to keep the best matches.</li>
            <li>Eliminate the rest through apoptosis and synaptic pruning.</li>
          </ol>
        </p>

        <h3>Putting It All Together</h3>
        <p>Neural development is not a rigid assembly line but a dynamic conversation between genes, cells, and environment:
          <ul>
            <li><strong>Spatial cues</strong> and <strong>timing</strong> help define who becomes spinal cord, hindbrain, 
              midbrain, or forebrain.</li>
            <li><strong>Migration</strong> and <strong>differentiation</strong> generate the right cell types in the right places.</li>
            <li><strong>Synaptogenesis</strong>, <strong>cell death</strong>, and <strong>synapse rearrangement</strong> refine 
              those early circuits based on trophic support and activity patterns.</li>
          </ul>
        </p>
        <p>The end result is a brain whose structure reflects both a <strong>genetic plan</strong> and a history of 
          <strong>experience</strong>. This developmental framework sets the stage for all of the physiology and 
          neuropharmacology we have discussed—and for the remarkable capacity of the nervous system to adapt, learn, and change 
          across the lifespan.
        </p>
      </section>
      <section id="chapter10"><h2>Circadian Rhythms</h2>
        <p>Just as neural development shapes <strong>where</strong and <strong>how</strong> circuits are wired, 
          circadian systems shape <strong>when</strong> those circuits are most active. The Earth rotates once 
          every 24 hours, producing a regular light–dark cycle. Life evolved in this rhythmic environment, and many 
          organisms—from bacteria to humans—have internal timing systems that anticipate these daily changes rather 
          than merely reacting to them.
        </p>
        <p>The field that studies these daily timing processes is <strong>chronobiology</strong>, and its core concept is the 
          <strong>circadian rhythm</strong>.
        </p>

        <h3>What Is a Circadian Rhythm?</h3>
        <p>The term <strong>circadian</strong> comes from Latin:
        </p>
        <ul>
          <li><strong>circa</strong> – “about” or “approximately”</li>
          <li><strong>dia</strong> – “day”</li>
        </ul>
        <p><strong><u>Definition.</u></strong> A <strong>circadian rhythm</strong> is any biological process that shows a 
          roughly 24-hour cycle in the absence of external timing cues. These rhythms can be:
        </p>
        <ul>
          <li><strong>Behavioral</strong> – sleep–wake cycles, activity vs. rest, feeding patterns.</li>
          <li><strong>Physiological</strong> – body temperature, hormone secretion (e.g., cortisol, melatonin), heart rate.</li>
          <li><strong>Biochemical</strong> – gene expression, enzyme activity, receptor sensitivity.</li>
        </ul>
        <p>Humans show clear circadian rhythms: we tend to sleep at night, have peak alertness during the day, and daily oscillations 
          in temperature and hormone levels—even when external cues are reduced.
        </p>

        <h3>Measuring Circadian Rhythms: Actograms</h3>
        <p>In the lab, circadian rhythms are often visualized using an <strong>actogram</strong>.
        </p>
        <p><strong><u>Definition.</u></strong> An <strong>actogram</strong> is a plot of activity (e.g., wheel running) over time, 
          typically:
        </p>
        <ul>
          <li>Each horizontal line = one day of recording.</li>
          <li>Activity (e.g., wheel revolutions) is marked as dark bars.</li>
          <li>Days are stacked vertically so patterns across days can be seen.</li>
        </ul>
        <p>When animals are kept on a normal 12 h light–12 h dark schedule (LD 12:12), actograms show activity aligned to the 
          light–dark cycle (e.g., nocturnal rodents run mostly during the dark phase). When these external cues are removed 
          (constant darkness, DD), rhythms often “drift,” revealing the properties of the internal clock.
        </p>

        <h3>Endogenous Clocks, Free-Running Rhythms, and Entrainment</h3>
        <p>Circadian rhythms are not simply driven by the environment—they are generated by an internal 
          <strong>endogenous clock</strong>.
        </p>
        <p><strong><u>Definition.</u></strong> A <strong>free-running rhythm</strong> is the rhythm expressed by an organism 
          when it is isolated from time cues (e.g., kept in constant darkness). Under these conditions:
        </p>
        <ul>
          <li>Animals still show regular activity cycles.</li>
          <li>However, the period is often <strong>not exactly 24 h</strong> (e.g., 23.5 h or 24.5 h).</li>
        </ul>
        <p>This shows that the internal clock runs “about” a day—<i>circa dia</i>—but needs the environment to stay perfectly aligned.
        </p>
        <p>External cues that synchronize the internal clock to the outside world are called <strong>zeitgebers</strong>
          (“time-givers”). Common zeitgebers include:
        </p>
        <ul>
          <li><strong>Light–dark cycles</strong> (the most powerful for many species).</li>
          <li><strong>Feeding schedules</strong>.</li>
          <li><strong>Social cues</strong> or temperature cycles.</li>
        </ul>
        <p><strong><u>Definition.</u></strong> <strong>Entrainment</strong> is the process by which the internal circadian clock 
          is <strong>reset</strong> each day to match environmental zeitgebers. When the timing of the zeitgeber changes, the 
          rhythm gradually shifts to realign.
        </p>
        <p>A <strong>phase shift</strong> is the change in the timing of a circadian rhythm in response to a synchronizing cue 
          (for example, when the onset of darkness is moved earlier or later).
        </p>

        <h4>Effect of Changing Zeitgebers</h4>
        <p>When the light–dark schedule is abruptly shifted:
        </p>
        <ul>
          <li>The animal’s activity rhythm gradually shifts to match the new cycle—this is a <strong>phase shift</strong>.</li>
          <li>In constant darkness, with no zeitgebers, the animal shows its intrinsic free-running period (~24 h but not exactly).</li>
        </ul>
        <p>This is analogous to human experiences of jet lag or shift work: our internal clock must gradually re-entrain to a new 
          light–dark schedule.
        </p>

        <h3>The Suprachiasmatic Nucleus: The Master Clock</h3>
        <p>In mammals, the central circadian clock resides in the <strong>suprachiasmatic nucleus (SCN)</strong>, a small 
          bilateral structure in the hypothalamus, located just above the optic chiasm.
        </p>
        <p>Key evidence:
        </p>
        <ul>
          <li><strong>Lesions of the SCN</strong> disrupt circadian rhythms.
            <ul>
              <li>Animals first entrained to a light–dark cycle show clear rhythms.</li>
              <li>After SCN lesions, rhythms become disorganized, especially in constant darkness.</li>
            </ul>
          </li>
          <li><strong>Isolated SCN neurons in culture</strong> maintain rhythmic electrical activity that reflects the previous 
            light–dark cycle—indicating that rhythm generation is intrinsic to SCN cells.</li>
        </ul>
        <p>Strikingly, transplant experiments demonstrate that the SCN not only generates rhythms but also determines their 
          <strong>period</strong>.
        </p>

        <h4>SCN Transplant Experiments</h4>
        <p>Classic experiments in hamsters:
          <ol>
            <li>Lesion the SCN → abolish the animal’s circadian rhythm.</li>
            <li>Transplant fetal SCN tissue from a donor with a known circadian mutation—e.g., the 
              <strong>tau mutation</strong>, which produces a ~20 h period.</li>
            <li>The recipient’s circadian rhythm is restored, but now with the <strong>shorter period</strong> of the donor SCN.</li>
          </ol>
        </p>
        <p>This shows that the SCN contains an intrinsic, transplantable <strong>clock</strong> that sets the period of the 
          organism’s circadian rhythms.
        </p>

        <h3>Light as a Zeitgeber: The Retinohypothalamic Pathway</h3>
        <p>How does light reset the clock in mammals? Light does not act only through rods and cones for vision; there is a 
          dedicated pathway:
        </p>
        <p><strong><u>Definition.</u></strong> The <strong>retinohypothalamic pathway</strong> carries light information from 
          the eye directly to the SCN.
        </p>
        <ul>
          <li>It consists of a special set of <strong>retinal ganglion cells</strong> whose axons project to the SCN.</li>
          <li>These ganglion cells:
            <ul>
              <li>Do <strong>not</strong> rely on rods and cones for their light sensitivity.</li>
              <li>Contain <strong>melanopsin</strong>, a unique photopigment.</li>
              <li>Are especially sensitive to <strong>blue light</strong> (short wavelengths).</li>
            </ul>
          </li>
        </ul>
        <p>In other vertebrates:
        </p>
        <ul>
          <li>In amphibians and birds, the <strong>pineal gland</strong> is directly light-sensitive and participates in 
            circadian photoreception.</li>
          <li>In mammals, the pineal gland primarily secretes <strong>melatonin</strong>, but light detection for entrainment 
            is mediated by retina → SCN.</li>
        </ul>

        <h3>Components of a Circadian System</h3>
        <p>We can think of a circadian system as having three major components:
        </p>
        <ul>
          <li><strong>Input</strong> – pathways that convey zeitgeber information (e.g., retinohypothalamic pathway for light).</li>
          <li><strong>Clock</strong> – the core oscillator (SCN in mammals) that generates ~24 h cycles.</li>
          <li><strong>Output</strong> – neural and hormonal routes through which the SCN influences behavior and physiology 
            (e.g., sleep–wake, hormone release, body temperature).</li>
        </ul>

        <h3>Molecular Basis of the Circadian Clock</h3>
        <p>At the cellular level, the circadian clock in SCN neurons is built from a transcription–translation feedback loop 
          involving specific clock genes and proteins.
        </p>
        <p>In mammals, SCN cells produce at least two key proteins:
        </p>
        <ul>
          <li><strong>Clock</strong></li>
          <li><strong>Bmal1</strong> (the mammalian homolog of the Drosophila protein Cycle)</li>
        </ul>
        <p>These proteins bind to each other to form a <strong>Clock/Bmal</strong> dimer. This dimer acts as a transcription 
          factor to promote expression of other clock genes, including:
        </p>
        <ul>
          <li><strong>Period (Per)</strong></li>
          <li><strong>Cryptochrome (Cry)</strong></li>
        </ul>

        <h4>The Negative Feedback Loop</h4>
        <p>The Per and Cry proteins, once synthesized:
        </p>
        <ul>
          <li>Bind to each other in the cytoplasm to form a <strong>Per/Cry complex</strong>.</li>
          <li>The Per/Cry complex translocates back into the <strong>nucleus</strong>.</li>
          <li>Inside the nucleus, it <strong>inhibits</strong> the activity of the Clock/Bmal dimer, reducing transcription of 
            the Per and Cry genes.</li>
        </ul>
        <p>As a result:
        </p>
        <ul>
          <li>Per and Cry protein levels gradually decline as existing proteins degrade.</li>
          <li>Once they drop sufficiently, inhibition is lifted, Clock/Bmal activity resumes, and a new cycle of Per/Cry 
            production begins.</li>
        </ul>
        <p>This feedback loop takes about <strong>24 hours</strong> to complete, generating a molecular oscillation that 
          underlies the circadian rhythm.
        </p>

        <h4>How Light Resets the Molecular Clock</h4>
        <p>Light can reset the phase of this molecular clock:
        </p>
        <ul>
          <li>In <strong>flies</strong>, light reaches the brain directly and can <strong>degrade Cry protein</strong>, 
            resetting the feedback loop.</li>
          <li>In <strong>mammals</strong>:
            <ul>
              <li>Light is detected by melanopsin-containing retinal ganglion cells.</li>
              <li>These cells send signals via the <strong>retinohypothalamic pathway</strong> to the SCN.</li>
              <li>At the SCN, they release <strong>glutamate</strong> onto clock neurons.</li>
              <li>Glutamate-triggered signaling leads to increased <strong>Per</strong> expression, shifting the phase of 
                the Per/Cry cycle and, consequently, the animal’s behavior.</li>
            </ul>
          </li>
        </ul>

        <h3>Sleeping and Waking: A Behavioral Output of the Clock</h3>
        <p>One of the most obvious circadian outputs in humans is the <strong>sleep–wake cycle</strong>.
        </p>
        <ul>
          <li>Sleep tends to be synchronized to outside events, especially light–dark cycles.</li>
          <li>Additional cues—jobs, mealtimes, alarm clocks—act as zeitgebers that shape when we are awake or asleep.</li>
        </ul>
        <p>When external cues are removed, humans show a free-running period of about <strong>25 hours</strong> on average 
          (with some individual variation and age dependence). This highlights the importance of daily entrainment by light 
          and social schedules.
        </p>

        <h3>Sleep Across the Life Span</h3>
        <p>Human sleep patterns change dramatically with age.
        </p>
        <p><strong>Infancy.</strong> Newborns and infants:
        </p>
        <ul>
          <li>Sleep much more overall than adults.</li>
          <li>Have <strong>shorter sleep cycles</strong> (e.g., 50–60 minutes rather than 90 minutes).</li>
          <li>Spend a larger fraction of sleep in <strong>REM sleep</strong> (rapid eye movement sleep)—around 50% in early life.</li>
        </ul>
        <p>REM sleep is characterized by:
        </p>
        <ul>
          <li>Rapid eye movements.</li>
          <li>Low muscle tone (near paralysis).</li>
          <li>Vivid dreaming.</li>
        </ul>
        <p>The high amount of REM sleep in infancy may provide essential internal stimulation for the developing nervous system 
          (when external sensory experience is limited).
        </p>
        <p>Some infants are slow to <strong>entrain</strong> their sleep to the day–night cycle, leading to highly irregular 
          sleep for the baby—and for the caregiver. Classic case studies highlight just how variable early circadian development 
          can be.
        </p>

        <p><strong>Adulthood and aging.</strong> As we age:
        </p>
        <ul>
          <li>Total sleep time generally decreases.</li>
          <li>Proportion of REM sleep declines compared to infancy.</li>
          <li>Sleep may become more fragmented in older adulthood.</li>
        </ul>

        <h3>Developmental Changes in Circadian Rhythms</h3>
        <p>During <strong>puberty</strong>, many individuals experience a noticeable shift in their circadian rhythms:
        </p>
        <ul>
          <li>They naturally prefer to fall asleep later and wake up later.</li>
          <li>This is not just “laziness”—it reflects a biologically driven phase delay in the circadian system.</li>
        </ul>
        <p>Unfortunately, many high schools require very early start times, forcing adolescents to wake up long before their 
          internal clock says “morning.” This mismatch:
        </p>
        <ul>
          <li>Reduces total sleep time.</li>
          <li>Increases daytime sleepiness and in-class sleeping.</li>
          <li>Is associated with worse mood and greater risk of depression.</li>
        </ul>
        <p>Studies of districts that have delayed school start times show:
        </p>
        <ul>
          <li>Improved attendance and enrollment.</li>
          <li>Less daytime sleepiness.</li>
          <li>Better mood and academic outcomes.</li>
        </ul>

        <h3>Extreme Variants: Sleep Phase Syndromes</h3>
        <p>Some individuals show extreme deviations from typical sleep timing that have a <strong>genetic basis</strong>.
        </p>
        <ul>
          <li><strong>Familial advanced sleep phase syndrome (FASPS)</strong>
            <ul>
              <li>People become sleepy very early in the evening and wake up very early in the morning.</li>
              <li>Often linked to mutations in core clock genes (e.g., Per genes).</li>
            </ul>
          </li>
          <li><strong>Delayed sleep phase syndrome (DSPS)</strong>
            <ul>
              <li>Sleep onset is greatly delayed; individuals naturally fall asleep and wake much later than typical.</li>
              <li>Can cause significant social and occupational impairment when schedules conflict with the internal clock.</li>
            </ul>
          </li>
        </ul>
        <p>These syndromes illustrate that our preferred sleep–wake timing is not purely a matter of “willpower”—underlying 
          clock mechanisms and genetics play a major role.
        </p>

        <h3>Summary</h3>
        <p>Circadian rhythms demonstrate how deeply time is embedded in neurobiology:
          <ul>
            <li>Endogenous clocks generate ~24 h rhythms.</li>
            <li>External zeitgebers, especially light, <strong>entrain</strong> these clocks to the environment.</li>
            <li>The SCN and its molecular clockwork coordinate timing across the brain and body.</li>
            <li>Sleep–wake cycles, hormone secretion, and even cognitive performance all bear the imprint of circadian control.</li>
          </ul>
        </p>
        <p>Understanding circadian rhythms is therefore essential not only for basic neuroscience, but also for practical issues 
          like shift work, jet lag, school schedules, and the treatment of sleep and mood disorders.
        </p>
      </section>
      <section id="chapter11"><h2>Sensory Processing I</h2>
        <p>We have covered how neurons are built, how they communicate, and how their activity is timed across the day. 
          The next question is: <strong>how does all of this circuitry allow us to sense the world?</strong> Sensory systems are 
          the brain’s interfaces with the external (and internal) environment—they convert physical events into neural signals 
          that the CNS can interpret and act upon.
        </p>
        <p>In this section we will:
        </p>
        <ul>
          <li>Introduce general principles of sensory processing.</li>
          <li>Explain the idea of <strong>labeled lines</strong> and <strong>range fractionation</strong>.</li>
          <li>Use the <strong>skin</strong> as a concrete example of a complex sensory organ.</li>
        </ul>

        <h3>What Is Sensation?</h3>
        <p>The body has specialized organs and receptor cells that detect particular kinds of stimuli. These stimuli can be:
        </p>
        <ul>
          <li><strong>Substances</strong> – e.g., molecules that carry the scent of vanilla, or chemicals that activate taste receptors.</li>
          <li><strong>Forms of energy</strong> – e.g., a photon of light, mechanical pressure on the skin, heat, or sound waves.</li>
        </ul>
        <p><strong><u>Definition.</u></strong> <strong>Sensation</strong> is the detection of a stimulus by specialized receptor 
          cells and its conversion into an electrical signal that the nervous system can use.
        </p>
        <p>These receptor cells carry out <strong>sensory transduction</strong>—they translate physical events into graded 
          electrical changes, and ultimately into <strong>action potentials</strong> in sensory neurons. The brain then 
          <strong>integrates information across multiple sensory modalities</strong> (vision, touch, hearing, etc.) to construct 
          a coherent representation of the world.
        </p>

        <h3>What Kinds of Stimuli Can We Detect?</h3>
        <p>Sensory systems can be organized by the type of stimulus energy they detect. Examples include:
        </p>
        <ul>
          <li><strong>Mechanical</strong> – touch, pressure, stretch, vibration, sound (mechanical movement of air), proprioception.</li>
          <li><strong>Visual</strong> – photons of light in a particular wavelength range.</li>
          <li><strong>Thermal</strong> – warmth and cold, via temperature-sensitive receptors.</li>
          <li><strong>Chemical</strong> – taste, smell, internal chemical composition (e.g., CO₂, pH, hormones).</li>
          <li><strong>Electrical and magnetic</strong> – important in many non-human species (e.g., electroreception in fish, 
            magnetoreception in migratory animals).</li>
        </ul>
        <p>Regardless of the stimulus category, the brain faces the same problem:
        </p>
        <center><p><i>How can a single “language” of action potentials represent so many different kinds of signals?</i></p></center>

        <h3>Themes of Sensory Processing</h3>
        <p>There are several recurring principles across sensory systems:
        </p>
        <ul>
          <li><strong>Specialization of receptor cells.</strong> Different sensory neurons are specialized to translate specific 
            kinds of stimuli into electrical signals (e.g., photoreceptors for light, mechanoreceptors for touch).</li>
          <li><strong>Preservation of spatial information.</strong> The anatomical organization of the CNS often mirrors the 
            spatial layout of receptors (e.g., maps of the body surface, visual space, or auditory space).</li>
          <li><strong>Difference detection.</strong> The nervous system emphasizes changes and contrasts:
            <ul>
              <li>New or changing stimuli are highlighted.</li>
              <li>Edges and boundaries are exaggerated (e.g., where light or touch changes abruptly).</li>
            </ul>
          </li>
          <li><strong>Bottom-up and top-down influences.</strong> Sensory signals are shaped both by incoming information 
            (“bottom-up”) and by expectations, goals, and attention from higher brain centers (“top-down”).</li>
        </ul>

        <h3>Labeled Lines: How Does the Brain Know What Type of Stimulus It Was?</h3>
        <p>All sensory systems ultimately use the same basic currency—<strong>action potentials</strong>. An AP on a given axon 
          looks essentially like an AP on any other axon. So how does the brain distinguish heat from a pinprick, or sound from light?
        </p>
        <p>The answer lies in <strong>specialization of receptor neurons</strong> and their wiring.
        </p>
        <ul>
          <li>Individual sensory neurons are tuned to <strong>one particular modality</strong> (or a narrow range of modalities):
            <ul>
              <li>Some respond only to mechanical stretch.</li>
              <li>Others respond only to temperature changes.</li>
              <li>Others respond only to photons in a certain wavelength range, etc.</li>
            </ul>
          </li>
          <li>The axons of these neurons project along <strong>specific pathways</strong> to defined regions of the CNS.</li>
        </ul>
        <p>This leads to a <strong>“labeled lines”</strong> organization:
        </p>
        <p><strong><u>Definition.</u></strong> In <strong>labeled line coding</strong>, each sensory neuron and its pathway 
          carry information about <strong>one type</strong> of stimulus. The brain can infer the stimulus type simply from 
          <strong>which line is active</strong>, even though the action potentials themselves look the same.
        </p>
        <p>For example, if a particular set of touch receptors is active, the brain interprets the signal as “vibration on the 
          fingertip,” not “flash of light,” because those axons originate in skin receptors and terminate in somatosensory pathways.
        </p>

        <h3>Skin as a Sensory Organ: Sensory Transduction and Receptor Potentials</h3>
        <p>The skin is a rich example of a complex sensory organ. It contains multiple receptor types, each tuned to a particular 
          form of mechanical or thermal stimulus (light touch, deep pressure, stretch, vibration, pain, temperature).
        </p>
        <p><strong>Sensory transduction</strong> begins when a stimulus causes a change in membrane potential in the receptor cell.
          In many somatosensory neurons, the receptor is a specialized ending of the neuron itself.
        </p>
        <p>When a stimulus is applied:
        </p>
        <ul>
          <li>Ion channels in the receptor ending open or close.</li>
          <li>This produces a <strong>receptor potential</strong> (also called a <strong>generator potential</strong>)—a 
            local, graded change in membrane potential.</li>
          <li>If the receptor potential is large enough to reach threshold at the trigger zone (often near the first node of Ranvier), 
            the sensory neuron generates action potentials.</li>
        </ul>
        <p>Compare this to <strong>synaptic potentials</strong>:
        </p>
        <ul>
          <li>Previously, we discussed: <em>neurotransmitter</em> → postsynaptic potential → threshold → action potential.</li>
          <li>For sensory neurons, the sequence is: <em>sensory stimulus</em> → receptor potential → threshold → action potential.</li>
        </ul>
        <p>The logic is similar—small, graded potentials are integrated, and if they are large enough, an “all-or-none” action potential 
          is produced. The difference lies in the <strong>source</strong> of the graded potential: synaptic input vs. sensory receptor activation.
        </p>

        <h4>Example: Detecting Vibration with the Pacinian Corpuscle</h4>
        <p>The <strong>Pacinian corpuscle</strong> (or lamellated corpuscle) is a mechanoreceptor in the skin specialized for detecting 
          <strong>vibration</strong> and rapid changes in pressure.
        </p>
        <ul>
          <li>It consists of a nerve ending wrapped in concentric layers of connective tissue (like an onion).</li>
          <li>When the skin is vibrated or rapidly deformed, these layers are distorted, and the nerve ending is mechanically 
            stretched.</li>
        </ul>
        <p>At the molecular level:
        </p>
        <ul>
          <li>The nerve ending contains <strong>stretch-sensitive cation channels</strong>.</li>
          <li>Deformation of the membrane opens these channels.</li>
          <li>Positive ions (e.g., Na⁺, Ca²⁺) enter, depolarizing the membrane—this is the receptor potential.</li>
        </ul>
        <p>If the receptor potential is large enough, it triggers action potentials in the associated sensory axon. Stronger vibration 
          produces larger receptor potentials and thus higher frequencies of action potentials.
        </p>

        <h3>Encoding Stimulus Intensity</h3>
        <p>Action potentials are binary events—each one either occurs or it does not. So how does the nervous system encode the 
          <strong>intensity</strong> of a stimulus (e.g., light brush vs. firm pressure)?
        </p>
        <p>There are two main strategies:
        </p>
        <ol>
          <li><strong>Frequency coding (within a single neuron).</strong>
            <ul>
              <li>As stimulus intensity increases, the <strong>frequency</strong> of action potentials increases.</li>
              <li>A stronger stimulus → larger receptor potential → more rapid AP firing (up to a physiological limit).</li>
            </ul>
          </li>
          <li><strong>Population coding and range fractionation (across multiple neurons).</strong>
            <ul>
              <li>Different sensory neurons of the <strong>same modality</strong> (e.g., stretch-sensitive neurons) can have 
                <strong>different thresholds</strong> for firing.</li>
              <li>“High-sensitivity” neurons respond to weak stimuli; “low-sensitivity” neurons fire only when the stimulus is strong.</li>
            </ul>
          </li>
        </ol>
        <p><strong><u>Definition.</u></strong> <strong>Range fractionation</strong> is the strategy in which different cells 
          in a sensory system have different thresholds, allowing the system as a whole to encode a wide range of stimulus 
          intensities.
        </p>
        <p>By reading out:
        </p>
        <ul>
          <li>Which neurons are active (low-threshold vs. high-threshold), and</li>
          <li>How fast they are firing,</li>
        </ul>
        <p>the CNS can infer both the <strong>quality</strong> and the <strong>intensity</strong> of the stimulus.
        </p>

        <h3>Difference Detection and Sensory Adaptation</h3>
        <p>Sensory systems are particularly good at detecting <strong>changes</strong> rather than steady-state conditions. 
          When a new stimulus appears:
        </p>
        <ul>
          <li>Sensory neurons often fire a <strong>burst</strong> of high-frequency action potentials.</li>
          <li>If the stimulus continues without change, the firing rate typically <strong>declines over time</strong>.</li>
        </ul>
        <p>This decline in responsiveness during a constant stimulus is called <strong>sensory adaptation</strong>.
        </p>
        <p><strong><u>Definition.</u></strong> <strong>Sensory adaptation</strong> is the progressive decrease in receptor 
          response (and thus firing rate) during a sustained stimulus.
        </p>
        <p>Adaptation helps the nervous system:
        </p>
        <ul>
          <li>Filter out unchanging background stimulation.</li>
          <li>Direct attention to <strong>novel</strong> or changing stimuli—things that may be more behaviorally relevant.</li>
        </ul>

        <h4>Phasic vs. Tonic Receptors</h4>
        <p>Not all sensory neurons adapt to the same degree.
        </p>
        <ul>
          <li><strong>Phasic receptors</strong> show strong adaptation:
            <ul>
              <li>They respond vigorously when a stimulus is first applied.</li>
              <li>Their firing rate drops quickly if the stimulus is maintained.</li>
              <li>They are excellent at signaling changes or stimulus onset/offset.</li>
            </ul>
          </li>
          <li><strong>Tonic receptors</strong> show little or no adaptation:
            <ul>
              <li>They continue to fire as long as the stimulus is present.</li>
              <li>They encode the <strong>ongoing level</strong> of a stimulus (e.g., sustained pain, steady pressure).</li>
            </ul>
          </li>
        </ul>
        <p>Adaptation is one mechanism by which the nervous system implicitly says, 
          “this stimulus is no longer new—shift attention elsewhere.”
        </p>

        <h4>Other Ways to Control Sensory Input</h4>
        <p>In addition to adaptation, the nervous system can regulate sensory input by:
        </p>
        <ul>
          <li><strong>Accessory structures</strong> – physical structures that limit or modulate stimulation:
            <ul>
              <li>Eyelids that close or narrow the opening,</li>
              <li>Pupil constriction or dilation,</li>
              <li>Middle-ear muscles that dampen loud sounds.</li>
            </ul>
          </li>
          <li><strong>Top-down processing</strong> – higher brain centers can:
            <ul>
              <li>Suppress some sensory inputs (e.g., ignoring background noise), or</li>
              <li>Amplify others (e.g., focusing attention on a faint sound).</li>
            </ul>
          </li>
        </ul>

        <h3>Somatosensory Receptive Fields</h3>
        <p>To know <strong>where</strong> a stimulus came from, the brain relies on the concept of 
          <strong>receptive fields</strong>.
        </p>
        <p><strong><u>Definition.</u></strong> The <strong>receptive field</strong> of a somatosensory neuron is the specific 
          region of the body surface in which a stimulus will alter the firing of that neuron.
        </p>
        <p>Important consequences:
        </p>
        <ul>
          <li>The <strong>location</strong> of an active neuron tells the brain which body region is stimulated.</li>
          <li>The <strong>size</strong> of the receptive field limits spatial resolution.</li>
        </ul>

        <h4>The Two-Point Discrimination Test</h4>
        <p>A simple demonstration of receptive fields is the <strong>two-point discrimination test</strong>.
        </p>
        <ul>
          <li>Two points (e.g., toothpicks) are pressed simultaneously against the skin.</li>
          <li>The distance between the points is varied.</li>
          <li>The subject reports whether they feel one point or two.</li>
        </ul>
        <p>If the two points fall within the same neuron’s receptive field, they are perceived as <strong>one</strong> stimulus. 
          If they fall in separate receptive fields, they are perceived as <strong>two</strong>.
        </p>
        <p>Results:
        </p>
        <ul>
          <li>On the fingertip, two points as close as <strong>2–3 mm</strong> can be distinguished.</li>
          <li>On the back, the threshold distance is around <strong>40 mm</strong>.</li>
        </ul>
        <p>This difference reflects:
        </p>
        <ul>
          <li>Much <strong>smaller receptive fields</strong> on the fingertips, and</li>
          <li><strong>Higher density</strong> of sensory neurons in regions where fine touch discrimination is behaviorally important.</li>
        </ul>

        <h3>Somatosensory Maps in Cortex</h3>
        <p>The <strong>somatosensory system</strong> detects body sensations, including touch, temperature, proprioception, and pain. 
          Information from the body surface ultimately reaches the <strong>primary somatosensory cortex (S1)</strong>.
        </p>
        <ul>
          <li>The body surface is mapped onto S1 in an orderly, <strong>somatotopic</strong> fashion.</li>
          <li>Each part of the body corresponds to a specific cortical region.</li>
          <li>Sensory information is organized largely in a <strong>contralateral</strong> manner (left body → right cortex, and vice versa).</li>
          <li>The amount of cortical area devoted to a body part is proportional to its <strong>sensory importance</strong> and 
            <strong>receptor density</strong> (e.g., large areas for hands and face, smaller for trunk and legs).</li>
        </ul>
        <p>This cortical “map” (often illustrated as a <strong>sensory homunculus</strong>) reflects how central the skin and body 
          senses are for guiding our behavior and interaction with the world.
        </p>

        <p>Together, concepts like labeled lines, receptor potentials, adaptation, range fractionation, and receptive fields form the 
          foundation for understanding sensory processing. In subsequent sections we will delve more deeply into specific sensory 
          modalities and how their detailed circuitry supports perception.
        </p>
      </section>

      <section id="chapter12"><h2>Sensory Processing II &amp; Pain</h2>
        <p>In the previous section we focused on how sensory receptors in the skin translate physical stimuli into 
          receptor potentials and action potentials, and how concepts like labeled lines, range fractionation, and 
          receptive fields allow the nervous system to encode <strong>what</strong> and <strong>how strong</strong> a stimulus is. 
          We now follow these signals into the central nervous system and examine one of the most complex and important 
          sensory experiences: <strong>pain</strong>.
        </p>

        <h3>Organization of the Somatosensory System</h3>
        <p>The <strong>somatosensory system</strong> detects body sensations, including touch, proprioception, temperature, and pain. 
          Several organizing principles carry over from the periphery into the brain:
        </p>
        <ul>
          <li><strong>Stimulus type and location.</strong>
            <ul>
              <li>Stimulus <strong>type</strong> is encoded by which receptor class is activated (mechanoreceptors, thermoreceptors, 
                nociceptors, etc.).</li>
              <li>Stimulus <strong>location</strong> is inferred from the position of the activated receptors on the body surface.</li>
            </ul>
          </li>
          <li><strong>Contralateral processing.</strong> Information from one side of the body is largely processed in the 
            <strong>opposite</strong> (contralateral) hemisphere.</li>
          <li><strong>Somatotopic mapping.</strong> The body surface is systematically mapped onto the 
            <strong>primary somatosensory cortex (S1)</strong>. Neighboring points on the skin project to neighboring regions in S1.</li>
          <li><strong>Cortical magnification.</strong> The amount of cortex devoted to a body part is proportional to its 
            <strong>sensory acuity</strong>, not to its physical size (large representation of hands and lips; small of back and trunk).</li>
          <li><strong>Thalamic relay.</strong> Somatosensory information typically passes through the <strong>thalamus</strong> 
            before reaching S1. The thalamus acts as a relay and processing hub for sensory signals.</li>
        </ul>

        <h4>Primary vs. Secondary Somatosensory Areas</h4>
        <p>Within cortex, we can distinguish between:
        </p>
        <ul>
          <li><strong>Primary somatosensory cortex (S1).</strong>
            <ul>
              <li>The first cortical area to receive somatosensory input from the thalamus.</li>
              <li>Contains a detailed somatotopic map.</li>
              <li>Encodes basic features such as location, intensity, and type of somatic stimulus.</li>
            </ul>
          </li>
          <li><strong>Secondary somatosensory cortex (SII) and higher areas.</strong>
            <ul>
              <li>Receive input from S1 and other regions.</li>
              <li>Integrate somatosensory signals with information from other modalities and with memory.</li>
              <li>Contribute to learning, recognition of objects by touch (stereognosis), and more abstract representations of the body.</li>
            </ul>
          </li>
        </ul>
        <p>Thus, somatosensory processing progresses from <strong>basic detection</strong> in S1 to 
          <strong>higher-order interpretation and integration</strong> in SII and beyond.
        </p>

        <h3>Pain: An Unpleasant but Adaptive Experience</h3>
        <p><strong>Pain</strong> is defined as an unpleasant sensory and emotional experience associated with actual or potential 
          tissue damage. Despite its negative quality, pain is profoundly <strong>adaptive</strong>:
        </p>
        <ul>
          <li>It motivates us to <strong>withdraw</strong> from harmful stimuli.</li>
          <li>It encourages <strong>rest and recuperation</strong> when tissue is damaged.</li>
          <li>It serves as a <strong>social signal</strong> to others, recruiting help and modifying social behavior.</li>
        </ul>
        <p>There are large individual differences in sensitivity to pain. At one extreme, complete inability to sense pain is 
          possible—but dangerously so.
        </p>

        <h4>Congenital Insensitivity to Pain (CIP)</h4>
        <p><strong>Congenital insensitivity to pain</strong> is a rare inherited disorder in which individuals cannot feel pain.
        </p>
        <ul>
          <li>Often caused by mutations in specific <strong>voltage-gated sodium channels</strong> expressed in nociceptive neurons.</li>
          <li>Because these channels do not function normally, affected sensory neurons cannot generate action potentials in response 
            to painful stimuli.</li>
          <li>Children with CIP frequently present with:
            <ul>
              <li>Severe oral injuries from biting tongue or lips.</li>
              <li>Untreated fractures or burns.</li>
              <li>Advanced infections due to unnoticed injuries.</li>
            </ul>
          </li>
        </ul>
        <p>Paradoxically, the absence of pain is <strong>not</strong> a blessing—it removes a critical protective system.
        </p>

        <h4>Paroxysmal Extreme Pain Disorder (PEPD)</h4>
        <p>Another rare inherited condition involving the same sodium channel gene produces the opposite problem:
          <strong>paroxysmal extreme pain disorder</strong>.
        </p>
        <ul>
          <li>Characterized by sudden, intense bouts of pain, often in specific body regions (e.g., jaw, rectal area, eyes).</li>
          <li>Here the sodium channel is <strong>over-active</strong>, making nociceptive neurons hyperexcitable.</li>
        </ul>
        <p>Together, CIP and PEPD illustrate how small genetic changes in ion channels can drastically alter pain perception.
        </p>

        <h4>Phantom Limb Pain</h4>
        <p><strong>Phantom limb pain</strong> is a form of <strong>neuropathic pain</strong> that occurs after amputation.
        </p>
        <ul>
          <li>Individuals feel pain seemingly coming from a limb that is no longer present.</li>
          <li>The phantom limb is often perceived as “clenched” or “twisted,” and attempts to “move” it may change the pain.</li>
          <li>Neurons in the CNS that formerly received input from the missing limb can develop <strong>aberrant activity patterns</strong> 
            in the absence of normal input.</li>
          <li>Cortical maps can reorganize (plasticity), and inputs from neighboring body regions may invade territory formerly 
            devoted to the missing limb.</li>
        </ul>
        <p>Treatments such as <strong>mirror therapy</strong> (creating the visual appearance of a controllable limb) can sometimes 
          reduce phantom pain by re-establishing a more coherent link between intended movement and sensory feedback.
        </p>

        <h3>Measuring Human Pain: The McGill Pain Questionnaire</h3>
        <p>Pain is not simply a single sensation; it has multiple components. The <strong>McGill Pain Questionnaire</strong> 
          distinguishes three major dimensions:
        </p>
        <ul>
          <li><strong>Sensory–discriminative</strong> – the quality and intensity of the pain:
            <ul>
              <li>e.g., throbbing, stabbing, burning, aching; mild vs. intense.</li>
            </ul>
          </li>
          <li><strong>Motivational–affective</strong> – the emotional quality:
            <ul>
              <li>e.g., tiring, sickening, fearful, punishing.</li>
            </ul>
          </li>
          <li><strong>Cognitive–evaluative</strong> – how the pain is interpreted and appraised:
            <ul>
              <li>e.g., “no pain,” “annoying,” “unbearable,” “excruciating.”</li>
            </ul>
          </li>
        </ul>
        <p>These dimensions help explain why two people with similar injuries can report very different pain experiences, and why 
          psychological factors (attention, expectation, mood) strongly shape pain perception.
        </p>

        <h3>Nociceptors: Peripheral Pain Receptors</h3>
        <p><strong>Nociception</strong> is the neural process of encoding and processing noxious (potentially tissue-damaging) stimuli. 
          The receptors that initiate nociception are called <strong>nociceptors</strong>.
        </p>
        <ul>
          <li>Nociceptors are specialized <strong>free nerve endings</strong> in the dermis and deeper tissues.</li>
          <li>They express receptor proteins that can be activated by:
            <ul>
              <li>Extreme temperatures (hot or cold).</li>
              <li>Mechanical damage (pinch, cut, strong pressure).</li>
              <li>Chemicals released during tissue injury or inflammation (e.g., prostaglandins, bradykinin, H⁺, ATP).</li>
            </ul>
          </li>
        </ul>

        <h4>Examples: Heat, Cold, and Chemical Activation</h4>
        <p>Some nociceptors express <strong>transient receptor potential (TRP)</strong> channels that act as molecular 
          thermometers and chemoreceptors.
        </p>
        <ul>
          <li><strong>TRPV1 (transient receptor potential vanilloid type 1)</strong>
            <ul>
              <li>Activated by <strong>painful heat</strong> (around &gt; 43 °C).</li>
              <li>Also activated by the chemical <strong>capsaicin</strong>—the compound that makes chili peppers feel “hot.”</li>
              <li>Expressed on <strong>C fibers</strong>: thin, unmyelinated axons that conduct action potentials slowly.</li>
              <li>Responsible for <strong>slow, dull, burning pain</strong> that lingers.</li>
            </ul>
          </li>
          <li><strong>TRP2</strong>
            <ul>
              <li>Activated by <strong>even higher temperatures</strong> (more intense heat).</li>
              <li>Does <strong>not</strong> respond to capsaicin.</li>
              <li>Expressed on <strong>Aδ fibers</strong> (A-delta): larger, myelinated axons that conduct more rapidly.</li>
              <li>Associated with fast, sharp, well-localized pain.</li>
            </ul>
          </li>
          <li><strong>CMR1 (cool–menthol receptor 1)</strong>
            <ul>
              <li>Activated by <strong>cool temperatures</strong>.</li>
              <li>Also activated by <strong>menthol</strong>, which is why menthol feels cool.</li>
              <li>Typically found on C fibers, contributing to slow, cool sensations.</li>
            </ul>
          </li>
        </ul>
        <p>By combining information from different fiber types (Aδ vs. C) and different receptors (TRPV1, TRP2, CMR1, etc.), the CNS 
          can distinguish sharp vs. dull pain and hot vs. cold stimuli.
        </p>

        <h4>C Fibers vs. Aδ Fibers</h4>
        <p>Two major classes of nociceptive fibers carry pain information:
        </p>
        <ul>
          <li><strong>Aδ fibers</strong>
            <ul>
              <li>Lightly myelinated, relatively fast conduction.</li>
              <li>Convey the initial, sharp, pricking pain (“first pain”).</li>
            </ul>
          </li>
          <li><strong>C fibers</strong>
            <ul>
              <li>Unmyelinated, slow conduction.</li>
              <li>Convey delayed, diffuse, dull, or burning pain (“second pain”).</li>
            </ul>
          </li>
        </ul>

        <h3>The Spinothalamic (Anterolateral) Pathway: Pain to the Brain</h3>
        <p>Pain and temperature information ascends to the brain via the <strong>anterolateral</strong> (or 
          <strong>spinothalamic</strong>) system.
        </p>
        <ol>
          <li><strong>Peripheral transduction.</strong> Nociceptors in the skin or deeper tissues transduce noxious stimuli and 
            generate action potentials.</li>
          <li><strong>Entry into spinal cord.</strong> Nociceptive fibers enter the spinal cord through the dorsal root and 
            synapse on neurons in the <strong>dorsal horn</strong>.</li>
          <li><strong>Crossing the midline.</strong> Second-order neurons in the dorsal horn send axons that cross to the 
            <strong>contralateral side</strong> of the spinal cord.</li>
          <li><strong>Ascending to thalamus.</strong> These axons ascend in the anterolateral white matter to reach the 
            <strong>thalamus</strong>.</li>
          <li><strong>Cortical targets.</strong> From the thalamus, projections go to:
            <ul>
              <li>Primary and secondary somatosensory cortices (encoding location and intensity).</li>
              <li>Limbic regions (e.g., anterior cingulate cortex, insula) that contribute to the emotional aspects of pain.</li>
            </ul>
          </li>
        </ol>
        <p>This dual projection pattern—toward both motor/sensory regions and limbic structures—helps explain why pain 
          simultaneously triggers <strong>reflexive movement</strong> away from the stimulus and a strong 
          <strong>emotional reaction</strong>.
        </p>

        <h4>Two Responses, Two Brain Regions</h4>
        <ul>
          <li><strong>Motor response.</strong> Pain-related projections to motor areas and spinal circuits produce withdrawal 
            reflexes and more complex avoidance behaviors.</li>
          <li><strong>Affective response.</strong> Projections to the <strong>limbic system</strong>, especially the 
            <strong>anterior cingulate cortex (ACC)</strong>, help generate the unpleasant, aversive component of pain.</li>
        </ul>

        <h3>Analgesia: Reducing Pain</h3>
        <p><strong>Analgesia</strong> is relief from pain, whereas <strong>anesthesia</strong> refers to a broader loss of 
          sensation or consciousness. Pain can be modulated at multiple levels:
        </p>
        <ul>
          <li><strong>Peripheral mechanisms.</strong></li>
          <li><strong>Spinal cord mechanisms.</strong></li>
          <li><strong>Central (brain) mechanisms, including top-down control.</strong></li>
        </ul>

        <h4>Peripheral Sites of Analgesic Action</h4>
        <p>Some analgesics act at or near the site of injury:
        </p>
        <ul>
          <li><strong>Non-steroidal anti-inflammatory drugs (NSAIDs)</strong> such as ibuprofen:
            <ul>
              <li>Block enzymes (cyclooxygenases) involved in synthesis of <strong>prostaglandins</strong>.</li>
              <li>Prostaglandins sensitize nociceptors; blocking them reduces pain and inflammation.</li>
            </ul>
          </li>
          <li><strong>Acetaminophen</strong> (paracetamol):
            <ul>
              <li>Also reduces pain and fever, though its exact mechanism is somewhat distinct and centrally acting.</li>
            </ul>
          </li>
          <li><strong>Local anesthetics</strong> (e.g., lidocaine):
            <ul>
              <li>Block voltage-gated sodium channels in peripheral nerves.</li>
              <li>Prevent action potentials, temporarily eliminating sensation (including pain) from a region.</li>
            </ul>
          </li>
        </ul>

        <h4>Spinal Cord as a Site of Analgesic Action</h4>
        <p>Analgesic or anesthetic agents can be delivered near the spinal cord:
        </p>
        <ul>
          <li><strong>Epidural anesthesia</strong>:
            <ul>
              <li>Injection of drug into the epidural space (outside the dura mater) surrounding the spinal cord.</li>
              <li>Blocks action potential conduction in spinal nerves, reducing or eliminating sensation from lower body regions.</li>
            </ul>
          </li>
        </ul>

        <h4>Top-Down Analgesia: Pain Control from the Brain</h4>
        <p>The brain can actively modulate pain signals descending to the spinal cord. This involves <strong>endogenous opioids</strong> 
          and a set of descending control pathways.
        </p>
        <ul>
          <li><strong>Endogenous opioid peptides</strong> (e.g., endorphins, enkephalins, dynorphins) are neurotransmitters that 
            bind to opioid receptors in the brain and spinal cord.</li>
          <li><strong>Opiate drugs</strong> (e.g., morphine) are effective analgesics because they mimic these endogenous opioids.</li>
        </ul>

        <h5>Descending Pain Pathways</h5>
        <p>A key structure in descending pain modulation is the <strong>periaqueductal gray (PAG)</strong> in the midbrain:
        </p>
        <ul>
          <li>Activation of the PAG produces potent analgesia.</li>
          <li>The PAG is rich in opioid receptors and receives input from higher brain areas.</li>
          <li>From the PAG, signals descend to the <strong>raphe nuclei</strong> in the brainstem.</li>
        </ul>
        <p>Raphe neurons release <strong>serotonin (5-HT)</strong> onto neurons in the spinal dorsal horn:
        </p>
        <ul>
          <li>5-HT release activates opioid-containing interneurons in the spinal cord.</li>
          <li>These interneurons release endogenous opioids, which inhibit ascending nociceptive pathways at the level of the 
            spinal cord.</li>
        </ul>
        <p>Thus, top-down signals can “turn down the volume” on pain before it reaches higher centers.
        </p>

        <h4>Types of Pain Relief</h4>
        <p>There are multiple classes of pain-relieving strategies, which can be loosely grouped as:
        </p>
        <ul>
          <li><strong>Psychogenic mechanisms</strong> – psychological and cognitive factors:
            <ul>
              <li><strong>Placebo</strong> – expectation of relief can activate endogenous opioid systems.</li>
              <li><strong>Hypnosis</strong> – alters perception of pain.</li>
              <li><strong>Stress-induced analgesia</strong> – intense stress can trigger endorphin release.</li>
              <li><strong>Cognitive and coping strategies</strong> – reappraisal, distraction, and learning can modify pain.</li>
            </ul>
          </li>
          <li><strong>Pharmacological mechanisms</strong>:
            <ul>
              <li><strong>Opiates</strong> – bind opioid receptors in PAG and spinal cord.</li>
              <li><strong>Local or spinal blocks</strong> – block conduction of pain signals.</li>
              <li><strong>Anti-inflammatory drugs</strong> – block inflammatory mediators.</li>
              <li><strong>Cannabinoids</strong> – act on CB receptors in nociceptors, spinal cord, and brain.</li>
            </ul>
          </li>
          <li><strong>Stimulation-based mechanisms</strong>:
            <ul>
              <li><strong>TENS (transcutaneous electrical nerve stimulation)</strong> or mechanical stimulation – activation of 
                large non-nociceptive fibers can reduce pain signals (gate control theory).</li>
              <li><strong>Acupuncture</strong> – may activate endogenous opioids and modulate peripheral pathways.</li>
              <li><strong>Electrical stimulation of PAG or related structures</strong> – engages endorphin-mediated pain control systems.</li>
            </ul>
          </li>
        </ul>

        <p>Overall, pain is not a simple “input” but a complex, multidimensional experience shaped by peripheral receptors, 
          spinal processing, ascending pathways, cortical and limbic networks, and powerful descending control systems. Understanding 
          these layers is essential both for basic neuroscience and for developing effective strategies to treat pain.
        </p>
      </section>

      <section id="chapter13"><h2>Visual Processing I</h2>
        <p>As of late, we have focused on how sensory receptors convert physical stimuli into electrical signals and how 
          the somatosensory system, including pain pathways, carries that information into the brain. Vision follows the same 
          basic logic—receptors detect a stimulus, convert it into action potentials, and send those signals centrally—but with 
          its own elaborate anatomy and specializations.
        </p>
        <p>In this section we will:
        </p>
        <ul>
          <li>Describe the <strong>overall organization</strong> of the visual system.</li>
          <li>Explain how light is <strong>focused onto the retina</strong>.</li>
          <li>Examine the <strong>cellular organization of the retina</strong>.</li>
          <li>Contrast <strong>rod-based (scotopic)</strong> and <strong>cone-based (photopic)</strong> vision, especially at the fovea.</li>
          <li>Introduce <strong>phototransduction</strong> in rods and cones and mechanisms for handling an enormous range of light intensities.</li>
          <li>Show how the retina begins to compute edges and contrast via <strong>center–surround receptive fields</strong> and 
            <strong>lateral inhibition</strong>.</li>
        </ul>

        <h3>Overall Organization of the Visual System</h3>
        <p>The visual system is organized as a series of stages, each transforming the representation of the visual world:
        </p>
        <ul>
          <li>Light enters the eye and is focused onto the <strong>retina</strong>.</li>
          <li>Photoreceptors (rods and cones) in the retina transduce light into electrical signals.</li>
          <li>These signals are processed by local retinal circuits and converge onto <strong>retinal ganglion cells</strong>.</li>
          <li>Ganglion cell axons form the <strong>optic nerve</strong>, which exits the eye and partially crosses at the <strong>optic chiasm</strong>.</li>
          <li>Beyond the chiasm, axons form the <strong>optic tracts</strong>, projecting mainly to the <strong>lateral geniculate nucleus (LGN)</strong> of the thalamus.</li>
          <li>From the LGN, visual information is relayed to <strong>primary visual cortex (V1)</strong> and then to higher-order visual areas.</li>
        </ul>
        <center><p><i>At every stage, the system preserves critical information about where in space light originated and what features it carries.</i></p></center>

        <h4>Binocular Vision and Visual Fields</h4>
        <p>Each eye sees part of the world, and their views overlap in the middle. The system is organized by 
          <strong>visual field</strong>, not by individual eye:
        </p>
        <ul>
          <li>Light from the <strong>right visual field</strong> strikes the nasal (inner) retina of the right eye and the temporal (outer) retina of the left eye.</li>
          <li>At the optic chiasm:
            <ul>
              <li>Axons from nasal retinae cross to the opposite side.</li>
              <li>Axons from temporal retinae remain on the same side.</li>
            </ul>
          </li>
          <li>As a result:
            <ul>
              <li>Information from the <strong>right visual field</strong> travels in the <strong>left optic tract</strong> and is processed by the left hemisphere.</li>
              <li>Information from the <strong>left visual field</strong> travels in the <strong>right optic tract</strong> and is processed by the right hemisphere.</li>
            </ul>
          </li>
        </ul>
        <p>This arrangement supports <strong>binocular vision</strong>, allowing the brain to combine slightly different views from both eyes 
          to compute depth and spatial relationships.
        </p>

        <h3>Focusing Light onto the Retina</h3>
        <p>For vision to be sharp, light rays from a point in the world must be brought to a <strong>focus</strong> on the retina.
        </p>
        <p>Several structures contribute:
        </p>
        <ul>
          <li><strong>Cornea</strong> – provides most of the eye’s refractive power; its curvature bends incoming light.</li>
          <li><strong>Lens</strong> – fine-tunes focus; its shape can be adjusted to bring near or far objects into sharp focus.</li>
          <li><strong>Iris</strong> – the colored ring of muscle that controls the size of the pupil.</li>
          <li><strong>Pupil</strong> – the opening in the iris that regulates how much light enters the eye.</li>
        </ul>
        <p><strong><u>Definition.</u></strong> <strong>Accommodation</strong> is the process by which the lens changes shape to focus light from 
          objects at different distances onto the retina.
        </p>
        <ul>
          <li>For <strong>near objects</strong>, the ciliary muscles contract, allowing the lens to become rounder and more powerful.</li>
          <li>For <strong>distant objects</strong>, the ciliary muscles relax, making the lens thinner and less powerful.</li>
        </ul>
        <p>Simultaneously, the <strong>pupil</strong> adjusts its size:
        </p>
        <ul>
          <li>In bright light, the pupil constricts, reducing light entry and improving depth of field.</li>
          <li>In dim light, the pupil dilates, allowing more photons to reach the retina.</li>
        </ul>

        <h3>Organization of the Retina</h3>
        <p>The retina is a thin, layered sheet of neural tissue lining the back of the eye. Interestingly, its organization is 
          <strong>inverted</strong>:
        </p>
        <ul>
          <li>Light passes through several layers of neurons and glial cells <strong>before</strong> reaching the photoreceptors at the back.</li>
          <li>Processed signals then move from photoreceptors <strong>forward</strong> through the retinal circuitry to the ganglion cells.</li>
        </ul>
        <p>The retina contains several major cell types arranged in distinct layers:
        </p>
        <ul>
          <li><strong>Photoreceptor cells</strong> – <strong>rods</strong> and <strong>cones</strong>; transduce light into receptor potentials.</li>
          <li><strong>Bipolar cells</strong> – receive input from photoreceptors and relay it to ganglion cells.</li>
          <li><strong>Retinal ganglion cells</strong> – receive input from bipolar cells; their axons form the optic nerve.</li>
          <li><strong>Horizontal cells</strong> – interneurons that make lateral connections among photoreceptors and bipolar cells.</li>
          <li><strong>Amacrine cells</strong> – interneurons that make lateral connections among bipolar and ganglion cells.</li>
        </ul>
        <p>Horizontal and amacrine cells are particularly important for <strong>lateral inhibition</strong> and other computations that shape 
          receptive fields and emphasize contrast.
        </p>

        <h3>Rods and Cones: Scotopic vs Photopic Vision</h3>
        <p>Rods and cones serve overlapping but distinct roles in vision.
        </p>
        <ul>
          <li><strong>Rods</strong> – the basis of the <strong>scotopic system</strong>:
            <ul>
              <li>Extremely sensitive to light; operate well in <strong>dim</strong> conditions.</li>
              <li>Do not support color vision; essentially <strong>black-and-white</strong> detectors.</li>
              <li>Provide poor spatial resolution compared to cones.</li>
              <li>Numerous in the <strong>periphery</strong> of the retina; completely absent from the fovea.</li>
            </ul>
          </li>
          <li><strong>Cones</strong> – the basis of the <strong>photopic system</strong>:
            <ul>
              <li>Require more light; best in <strong>daylight</strong> or bright conditions.</li>
              <li>Support <strong>color vision</strong> and high acuity.</li>
              <li>Densest at the <strong>fovea</strong>—the central region of the retina where visual acuity is highest.</li>
            </ul>
          </li>
        </ul>

        <h4>The Fovea: High-Acuity, Cone-Only Vision</h4>
        <p>The <strong>fovea</strong> is the point on the retina where light from the center of gaze is focused. It has several specializations:
        </p>
        <ul>
          <li>Contains <strong>only cones</strong>; no rods.</li>
          <li>Outer layers of cells are displaced to the side, allowing light more direct access to photoreceptors.</li>
          <li>Photoreceptors are <strong>densely packed</strong>, providing high spatial resolution.</li>
        </ul>
        <p>Because of this, the fovea supports:
        </p>
        <ul>
          <li>Fine detail discrimination (e.g., reading small print).</li>
          <li>Color vision (due to the presence of multiple cone types).</li>
        </ul>
        <p>Furthermore, a disproportionately large portion of <strong>visual cortex</strong> is devoted to processing input from the 
          fovea:
        </p>
        <p><strong><u>Note.</u></strong> This <strong>cortical magnification</strong> means that the central visual field has far more 
          “brain real estate” than the periphery, reflecting its importance for fine visual tasks.
        </p>

        <h4>Rod-Dominated Periphery</h4>
        <p>Rods are almost absent from the fovea but become increasingly dense toward the peripheral retina. This arrangement:
        </p>
        <ul>
          <li>Makes peripheral vision especially sensitive to <strong>dim light</strong>.</li>
          <li>Explains why faint stars are often easier to see when you look slightly to the side rather than directly at them.</li>
        </ul>

        <h3>Phototransduction: Rhodopsin and Signal Amplification</h3>
        <p>Photoreceptors are extraordinarily sensitive to light. One reason for this is the <strong>amplification</strong> built into 
          the phototransduction cascade.
        </p>
        <p>In rods, the key photopigment is <strong>rhodopsin</strong>.
        </p>
        <ul>
          <li>Rhodopsin consists of:
            <ul>
              <li><strong>RETINAL</strong> (a form of vitamin A derivative, retinaldehyde), the light-sensitive chromophore.</li>
              <li><strong>OPSIN</strong>, a seven-transmembrane <strong>G protein–coupled receptor (GPCR)</strong>.</li>
            </ul>
          </li>
        </ul>
        <p>When a photon is absorbed:
        </p>
        <ul>
          <li>RETINAL changes shape (isomerizes) from <strong>11-cis</strong> to <strong>all-trans</strong>.</li>
          <li>This conformational change activates opsin.</li>
          <li>Activated opsin triggers a G protein cascade in the photoreceptor, leading to closure of cGMP-gated ion channels.</li>
        </ul>
        <p>The cascade allows <strong>one photon</strong> to influence many ion channels, producing a detectable change in membrane potential. 
          This GPCR-based amplification is a crucial reason why the visual system can operate over extremely low light levels.
        </p>

        <h3>Range of Sensitivity and Adaptation</h3>
        <p>The visual system must cope with an enormous range of light intensities—from starlight to bright sunlight. It uses several 
          strategies:
        </p>
        <ul>
          <li><strong>GPCR amplification</strong> – increases sensitivity at low light levels.</li>
          <li><strong>Pupil adjustments</strong> – the pupil constricts in bright light and dilates in dim light, regulating how many photons enter the eye.</li>
          <li><strong>Range fractionation across receptors</strong> – different receptors (e.g., rods vs cones, and cone subtypes) have different 
            operating ranges and thresholds.</li>
          <li><strong>Photoreceptor adaptation</strong> – photoreceptors themselves reduce their response during sustained, strong stimulation.</li>
        </ul>
        <p>As a result, the visual system maintains useful responsiveness across many orders of magnitude of illumination, while still 
          preserving contrast information.
        </p>

        <h3>The Visual System as a Difference Detector</h3>
        <p>Like other sensory systems, the visual system is especially tuned to <strong>differences</strong> and <strong>edges</strong> rather than absolute illumination levels.
        </p>
        <center><p><i>We “see” edges, borders, and changes more vividly than uniform surfaces.</i></p></center>
        <p>This emphasis begins in the retina itself, where circuits create <strong>center–surround receptive fields</strong> and employ 
          <strong>lateral inhibition</strong> to enhance contrast.
        </p>

        <h3>Retinal Processing and Center–Surround Receptive Fields</h3>
        <p>The output neurons of the retina are the <strong>ganglion cells</strong>. Each ganglion cell receives input from a specific 
          set of photoreceptors via bipolar and horizontal cells. The part of visual space that influences a ganglion cell’s firing is 
          its <strong>receptive field</strong>.
        </p>
        <p>Retinal ganglion cell receptive fields typically have a <strong>center–surround organization</strong>:
        </p>
        <ul>
          <li>A central region (the <strong>center</strong>) where light has one effect on firing.</li>
          <li>A surrounding region (the <strong>surround</strong>) where light has the <strong>opposite</strong> effect.</li>
        </ul>

        <h4>On-Center vs Off-Center Ganglion Cells</h4>
        <p>There are two main types:
        </p>
        <ul>
          <li><strong>On-center, off-surround cells</strong>
            <ul>
              <li>Light in the <strong>center</strong> of the receptive field <strong>increases</strong> firing (excitation).</li>
              <li>Light in the <strong>surround</strong> <strong>decreases</strong> firing below baseline (inhibition).</li>
            </ul>
          </li>
          <li><strong>Off-center, on-surround cells</strong>
            <ul>
              <li>Light in the <strong>center</strong> <strong>decreases</strong> firing.</li>
              <li>Light in the <strong>surround</strong> <strong>increases</strong> firing.</li>
            </ul>
          </li>
        </ul>
        <p>These receptive fields are created by the pattern of connections from photoreceptors to bipolar cells and the modulatory 
          influences of horizontal cells in the outer retina.
        </p>
        <p>On-center and off-center ganglion cells are not simply “light detectors”; they are tuned to 
          <strong>contrast</strong>—they respond most strongly when there is a difference between the illumination in center and surround.
        </p>

        <h4>Lateral Inhibition and Edge Enhancement</h4>
        <p><strong>Lateral inhibition</strong> is a circuit motif in which active cells inhibit their neighbors, sharpening boundaries and 
          enhancing differences.
        </p>
        <ul>
          <li>In the retina, <strong>horizontal cells</strong> receive input from arrays of photoreceptors and feed back inhibitory signals 
            onto those photoreceptors and bipolar cells.</li>
          <li>When a region of the retina is strongly illuminated, the photoreceptors there inhibit neighboring regions via horizontal cells.</li>
        </ul>
        <p>The result is that at edges, where illumination changes abruptly, ganglion cell responses are enhanced. This leads to perceptual phenomena such as the <strong>Mach band illusion</strong>, where uniform gradients appear to have 
            exaggerated brightness differences at edges.</li>
          </p>
        <p>Center–surround receptive fields and lateral inhibition thus help the visual system act as a <strong>difference detector</strong>, 
          prioritizing edges and changes over uniform areas.
        </p>

                <h3>Color Vision and Color-Opponent Processing</h3>
        <p>Color vision arises because different classes of cones are tuned to different portions of the visible spectrum. 
          The visual system compares activity across these cone types rather than reading any single cone in isolation. 
          This comparison, together with center–surround receptive fields, allows us to detect both <strong>hue</strong> and 
          <strong>color contrast</strong>.
        </p>

        <p><strong><u>Recall.</u></strong> Cones form the basis of the <strong>photopic system</strong>—they operate in bright light, 
          support high acuity, and allow color vision. Rods dominate scotopic (dim-light) vision and do not provide color information.
        </p>

        <p>In humans there are three main functional cone types:</p>
        <ul>
          <li><strong>S-cones</strong> (“short” wavelength) – most sensitive to <strong>blue</strong> light.</li>
          <li><strong>M-cones</strong> (“medium” wavelength) – most sensitive to <strong>green</strong> light.</li>
          <li><strong>L-cones</strong> (“long” wavelength) – most sensitive to <strong>red</strong> light.</li>
        </ul>

        <p>Any given wavelength of light will stimulate all three cone types to different degrees. The brain interprets the 
          <strong>pattern of activity</strong> across S, M, and L cones as a particular color. This “trichromatic” coding is only 
          the first step. Retinal circuits then reorganize this information into <strong>color-opponent channels</strong>.</p>

        <p><strong><u>Definition.</u></strong> <strong>Color-opponent ganglion cells</strong> are retinal ganglion cells whose 
          receptive fields are built from cones of different spectral sensitivities, arranged in a center–surround organization. 
          Typical examples include:
        </p>
        <ul>
          <li><strong>Red–green opponent cells</strong>
            <ul>
              <li>Center might receive input primarily from L-cones (red) and surround from M-cones (green), or vice versa.</li>
              <li>Excited when “red” part of the receptive field is more active than “green,” inhibited when the opposite is true.</li>
            </ul>
          </li>
          <li><strong>Blue–yellow opponent cells</strong>
            <ul>
              <li>Center might be driven by S-cones (blue) and surround by a combination of M+L cones (yellowish), or the reverse.</li>
              <li>Enhance contrast between “blue-ish” and “yellow-ish” regions in the image.</li>
            </ul>
          </li>
        </ul>

        <p>Just as luminance-sensitive ganglion cells emphasize edges in brightness, color-opponent cells emphasize 
          <strong>edges in chromatic content</strong>. This organization:
        </p>
        <ul>
          <li>Improves our ability to discriminate fine differences in color.</li>
          <li>Contributes to color constancy across changes in lighting.</li>
        </ul>

        <p><strong><u>Note.</u></strong> Genetic defects that eliminate or alter one cone type disrupt these comparisons, 
          resulting in <strong>color blindness</strong> (e.g., red–green dichromacy). The brain’s color circuitry is intact, but it 
          has insufficiently distinct cone signals to compute certain color differences.
        </p>

        <h3>From Retina to Cortex: LGN and Orientation Selectivity</h3>
        <p>Signals from retinal ganglion cells travel along the <strong>optic nerve</strong>, pass through the 
          <strong>optic chiasm</strong>, and continue as the <strong>optic tracts</strong> to the 
          <strong>lateral geniculate nucleus (LGN)</strong> of the thalamus. The LGN is the main relay station from eye to cortex.
        </p>

        <p>Several key principles are preserved in the LGN:</p>
        <ul>
          <li><strong>Retinotopic mapping.</strong> Neighboring points on the retina project to neighboring neurons in the LGN, 
            preserving the spatial layout of the visual scene.</li>
          <li><strong>Eye-specific layers.</strong> Inputs from each eye are kept largely separate in distinct LGN layers, 
            setting up the substrate for later binocular processing.</li>
          <li><strong>Center–surround receptive fields.</strong> LGN neurons maintain a similar center–surround organization 
            to retinal ganglion cells (ON-center/OFF-surround and OFF-center/ON-surround).</li>
        </ul>

        <p>From the LGN, axons project via the <strong>optic radiations</strong> to <strong>primary visual cortex (V1)</strong> 
          in the occipital lobe. In V1, receptive fields become more complex.</p>

        <h4>Simple and Complex Cells in V1</h4>
        <p>In V1, neurons can be categorized (classically) as <strong>simple</strong> or <strong>complex</strong> cells, 
          based on their receptive field properties:
        </p>
        <ul>
          <li><strong>Simple cells</strong>
            <ul>
              <li>Respond best to <strong>bars or edges</strong> of a particular <strong>orientation</strong> (e.g., vertical, horizontal).</li>
              <li>Have fairly well-defined excitatory and inhibitory subregions within their receptive field.</li>
              <li>Can be constructed conceptually by summing inputs from multiple LGN cells with aligned center–surround fields.</li>
            </ul>
          </li>
          <li><strong>Complex cells</strong>
            <ul>
              <li>Also selective for <strong>orientation</strong>, but receptive fields are larger and less clearly divided into 
                excitatory/inhibitory zones.</li>
              <li>Often respond best to oriented bars that are <strong>moving</strong> in a particular direction.</li>
            </ul>
          </li>
        </ul>

        <p>Thus, the cortex builds <strong>orientation-selective</strong> receptive fields by combining input from many LGN neurons, 
          each with center–surround receptive fields. This is a classic example of <strong>hierarchical processing</strong>:
        </p>
        <ul>
          <li>Retina and LGN encode points and contrast.</li>
          <li>V1 combines these to detect <strong>edges and bars</strong> at specific orientations and positions.</li>
          <li>Higher visual areas then combine oriented elements into <strong>contours, shapes, and objects</strong>.</li>
        </ul>

        <h3>Dorsal (“Where”) and Ventral (“What”) Streams</h3>
        <p>Beyond primary visual cortex, information is sent to multiple higher-order areas that specialize in different aspects 
          of visual perception. A prominent organizational scheme distinguishes two major processing streams:
        </p>
        <ul>
          <li><strong>Ventral stream (“what” pathway)</strong>
            <ul>
              <li>Projects from occipital cortex into the <strong>inferior temporal lobe</strong>.</li>
              <li>Specialized for <strong>object recognition</strong>, including shapes, categories, and faces.</li>
              <li>Neurons in this stream respond to increasingly complex and abstract features (e.g., a particular object or face).</li>
            </ul>
          </li>
          <li><strong>Dorsal stream (“where” or “how” pathway)</strong>
            <ul>
              <li>Projects from occipital cortex into the <strong>parietal lobe</strong>.</li>
              <li>Specialized for <strong>spatial processing</strong>, motion, and visually guided action (reaching, grasping).</li>
              <li>Helps answer “Where is it?” and “How do I interact with it?”</li>
            </ul>
          </li>
        </ul>

        <h4>Lesions and Visual Deficits</h4>
        <p>Damage to different parts of these streams leads to characteristic deficits that highlight their functions.</p>

        <p><strong>Ventral stream lesions: agnosias</strong></p>
        <ul>
          <li><strong>Visual agnosia</strong>
            <ul>
              <li>Difficulty recognizing objects despite normal basic vision (intact acuity, normal pupillary responses, etc.).</li>
              <li>A patient may copy a drawing accurately but be unable to say what the object is.</li>
            </ul>
          </li>
          <li><strong>Prosopagnosia (“face blindness”)</strong>
            <ul>
              <li>Specific inability to recognize faces, even of close friends or family members.</li>
              <li>Associated with damage to the <strong>fusiform face area</strong> in the ventral temporal cortex.</li>
              <li>Patients often rely on non-facial cues (voice, clothing, posture) to identify people.</li>
            </ul>
          </li>
        </ul>

        <p><strong>Dorsal stream lesions: spatial and action deficits</strong></p>
        <ul>
          <li><strong>Optic ataxia</strong>
            <ul>
              <li>Difficulty using vision to guide movements (e.g., reaching incorrectly for objects).</li>
              <li>Patients may see and verbally identify an object but cannot accurately reach toward it.</li>
            </ul>
          </li>
          <li><strong>Hemispatial neglect</strong> (often involving parietal damage)
            <ul>
              <li>Failure to attend to or acknowledge stimuli on one side of space (typically the side opposite the lesion).</li>
              <li>Patients may ignore half of drawings, shave only one side of the face, or deny that anything is missing.</li>
            </ul>
          </li>
        </ul>

        <p>Altogether, the ventral and dorsal pathways illustrate how visual processing is divided into specialized streams: 
          one concerned primarily with <strong>what</strong> things are, and the other with <strong>where</strong> they are and 
          <strong>how</strong> to act upon them. Disruptions in these circuits reveal the remarkable complexity underlying what 
          feels like effortless visual perception.
        </p>

      </section>
            <section id="chapter14"><h2>Auditory System and Language</h2>
        <p>Thus far, we have examined how sensory systems such as touch and vision detect physical stimuli and transform them into 
          patterned neural activity. Hearing and language follow the same basic principles—specialized receptors convert <strong>mechanical vibrations</strong> 
          of air into electrical signals, which are then interpreted by higher brain areas as <strong>sound</strong> and, in humans, as 
          <strong>speech and language</strong>.
        </p>
        <center><p><i>How does the nervous system turn tiny air pressure changes into rich experiences like music, speech, and meaning?</i></p></center>

        <h3>Physical Dimensions of Sound</h3>
        <p>Sound is a <strong>mechanical wave</strong>—repeating changes in air pressure over time. Two key physical properties of sound 
          relate directly to how we perceive it:
        </p>
        <ul>
          <li><strong>Amplitude (intensity)</strong> – the size of the pressure changes; we perceive this as <strong>loudness</strong>.
            <ul>
              <li>Larger amplitude → louder sound.</li>
              <li>Measured in decibels (dB) on a logarithmic scale.</li>
            </ul>
          </li>
          <li><strong>Frequency</strong> – the number of cycles of vibration per second, measured in <strong>Hertz (Hz)</strong>; we perceive this as <strong>pitch</strong>.
            <ul>
              <li>Low frequency (e.g., 100 Hz) → low-pitched sounds (bass).</li>
              <li>High frequency (e.g., 4000 Hz) → high-pitched sounds (treble).</li>
            </ul>
          </li>
        </ul>
        <p>Our auditory system can detect an impressive range of both amplitude and frequency, from faint whispers to loud concerts, 
          and from low rumbles to high chirps.</p>

        <h3>From Air to Fluid: The Outer and Middle Ear</h3>
        <p>Before sound can be transduced into neural activity, it must be collected and mechanically transformed by the ear.
        </p>
        <h4>The External (Outer) Ear</h4>
        <ul>
          <li><strong>Pinna</strong> – the visible “ear” on the side of the head. Its complex folds:
            <ul>
              <li>Help collect and funnel sound into the ear canal.</li>
              <li>Shape the spectrum of incoming sounds, providing cues about the <strong>vertical</strong> location of sound sources.</li>
            </ul>
          </li>
          <li><strong>Ear canal</strong> – guides sound waves toward the <strong>tympanic membrane (eardrum)</strong>.</li>
        </ul>

        <h4>The Middle Ear: Impedance Matching</h4>
        <p>The middle ear converts large, low-pressure vibrations in air into smaller, higher-pressure vibrations in fluid. This is 
          necessary because fluid is harder to move than air.</p>
        <ul>
          <li><strong>Tympanic membrane (eardrum)</strong> – vibrates in response to incoming sound waves.</li>
          <li><strong>Ossicles</strong> – three tiny bones that form a lever system:
            <ul>
              <li><strong>Malleus</strong> (hammer)</li>
              <li><strong>Incus</strong> (anvil)</li>
              <li><strong>Stapes</strong> (stirrup)</li>
            </ul>
            These bones transmit vibrations from the tympanic membrane to the <strong>oval window</strong> of the inner ear.
          </li>
        </ul>
        <p><strong><u>Note.</u></strong> By focusing the force from the large area of the eardrum onto the much smaller oval window, 
          the ossicles <strong>concentrate sound energy</strong> and improve transfer of vibrations into the fluid-filled cochlea.
        </p>

        <h3>The Inner Ear and the Cochlea</h3>
        <p>The <strong>inner ear</strong> houses the machinery that converts mechanical energy into neural signals. The core auditory 
          structure is the <strong>cochlea</strong>.</p>
        <ul>
          <li>The cochlea is a <strong>spiral-shaped, fluid-filled tube</strong> with a <strong>base</strong> (near the oval window) 
            and an <strong>apex</strong> (the tip of the spiral).</li>
          <li>Within the cochlea lies the <strong>organ of Corti</strong>, which contains the sensory receptors for hearing: 
            <strong>hair cells</strong>.</li>
        </ul>

        <h4>The Organ of Corti</h4>
        <p>The organ of Corti sits on the <strong>basilar membrane</strong> and contains three key components:</p>
        <ul>
          <li><strong>Hair cells</strong> – specialized sensory cells that convert movement into neurotransmitter release.
            <ul>
              <li>Their “hairs” are <strong>stereocilia</strong>, small, rigid projections organized in bundles.</li>
            </ul>
          </li>
          <li><strong>Basilar membrane</strong> – vibrates up and down in response to sound-induced pressure waves in the cochlear fluid.</li>
          <li><strong>Supporting cells</strong> and neighboring membranes (including the tectorial membrane) that help translate 
            basilar membrane motion into stereocilia deflection.</li>
        </ul>

        <h4>Tonotopic Mapping in the Cochlea</h4>
        <p>Different sound frequencies cause different regions of the basilar membrane to vibrate most strongly:
        </p>
        <ul>
          <li><strong>High-frequency sounds</strong> (e.g., 8–20 kHz) maximally displace the <strong>narrow, stiff base</strong> of the basilar membrane.</li>
          <li><strong>Low-frequency sounds</strong> (e.g., 100–500 Hz) maximally displace the <strong>wider, more flexible apex</strong>.</li>
        </ul>
        <p>This systematic mapping of frequency onto position along the basilar membrane is called <strong>tonotopy</strong>. 
          It is the auditory analog of retinotopy in vision and is preserved all the way up into the auditory cortex.
        </p>

        <h3>Hair Cell Transduction: From Motion to Current</h3>
        <p>When the basilar membrane vibrates, it causes the hair cell stereocilia to bend. This bending is the key to turning 
          mechanical energy into a receptor potential.</p>
        <ul>
          <li><strong>Tip links</strong> – fine protein filaments that connect the tips of shorter stereocilia to mechanically gated ion channels on their taller neighbors.</li>
          <li>When stereocilia are deflected in the <strong>preferred direction</strong>:
            <ul>
              <li>Tip links stretch and mechanically open ion channels.</li>
              <li>Positively charged ions (especially K<sup>+</sup> from the high-potassium endolymph) flow into the hair cell.</li>
              <li>The hair cell <strong>depolarizes</strong>, opening voltage-gated Ca<sup>2+</sup> channels at its base.</li>
              <li>Ca<sup>2+</sup> entry triggers <strong>neurotransmitter release</strong> (primarily glutamate) onto auditory nerve fibers.</li>
            </ul>
          </li>
        </ul>
        <p>Deflection in the opposite direction slackens the tip links, closes ion channels, and <strong>hyperpolarizes</strong> the cell, 
          reducing transmitter release. In this way, hair cells encode sound vibrations as graded changes in membrane potential and transmitter output.</p>

        <p><strong><u>Note.</u></strong> <strong>Inner hair cells</strong> provide most of the auditory information to the brain, while 
          <strong>outer hair cells</strong> act as a <em>cochlear amplifier</em>, actively fine-tuning and amplifying basilar membrane motion.</p>

        <h3>Auditory Pathways: From Cochlea to Cortex</h3>
        <p>The electrical signals generated by hair cells are carried into the brain along the <strong>auditory nerve</strong>, part of 
          cranial nerve VIII, the <strong>vestibulocochlear nerve</strong>.</p>
        <ul>
          <li><strong>Auditory nerve fibers</strong> – receive glutamatergic input from inner hair cells and encode sound frequency (via tonotopy) and intensity (via firing rate).</li>
          <li>These fibers project to the <strong>cochlear nuclei</strong> in the brainstem.</li>
          <li>From the cochlear nuclei, information is relayed to the <strong>superior olivary nuclei</strong>, where <strong>binaural</strong> (two-ear) comparisons are first made.</li>
          <li>Signals then ascend to the <strong>inferior colliculi</strong> in the midbrain.</li>
          <li>From there, they project to the <strong>medial geniculate nucleus (MGN)</strong> of the thalamus.</li>
          <li>Finally, MGN neurons send projections to <strong>primary auditory cortex (A1)</strong> in the temporal lobe.</li>
        </ul>
        <p>At each stage, tonotopic organization is preserved: neighboring neurons respond to neighboring sound frequencies.</p>

        <h3>Binaural Cues and Sound Localization</h3>
        <p>How do we determine where a sound is coming from? The brain uses <strong>binaural cues</strong>, based on information from 
          both ears. The key computations occur in the <strong>superior olivary nucleus</strong>.</p>
        <ul>
          <li><strong>Intensity differences</strong> (interaural level differences):
            <ul>
              <li>For high-frequency sounds, the head casts an “acoustic shadow.”</li>
              <li>The ear closer to the sound receives a slightly <strong>louder</strong> signal.</li>
            </ul>
          </li>
          <li><strong>Latency (time) differences</strong> (interaural time differences):
            <ul>
              <li>A sound reaching the right ear slightly before the left indicates a source to the right, and vice versa.</li>
              <li>Especially important for <strong>low-frequency</strong> sounds, where intensity differences are smaller.</li>
            </ul>
          </li>
        </ul>
        <p>By comparing inputs from both ears, neurons in the superior olive can compute the <strong>horizontal location</strong> of 
          a sound source.</p>

        <h3>Tonotopic Maps in the Auditory Cortex</h3>
        <p><strong>Primary auditory cortex (A1)</strong> in the temporal lobe maintains a <strong>tonotopic map</strong> of sound 
          frequency, similar to how the primary visual cortex maintains a retinotopic map.</p>
        <ul>
          <li>Neighboring cortical neurons prefer similar sound frequencies.</li>
          <li>Frequency preferences shift systematically across the cortical surface.</li>
        </ul>
        <p>Beyond A1, <strong>secondary auditory areas</strong> process more complex features such as combinations of frequencies, 
          temporal patterns, and, in humans, the acoustic structure of speech and music.</p>

        <h3>Higher-Order Auditory Processing Streams</h3>
        <p>The brain organizes auditory information into partially distinct processing streams, analogous to the dorsal (“where”) 
          and ventral (“what”) streams in vision.</p>
        <ul>
          <li><strong>Dorsal auditory stream</strong> – projects into parietal regions.
            <ul>
              <li>Specialized for <strong>spatial location</strong> of sounds (“where”).</li>
              <li>Helps orient toward or away from sound sources.</li>
            </ul>
          </li>
          <li><strong>Ventral auditory stream</strong> – remains largely within temporal regions.
            <ul>
              <li>Analyzes the <strong>identity</strong> and components of complex sounds (“what”).</li>
              <li>Critical for recognizing <strong>speech, voices, and environmental sounds</strong>.</li>
            </ul>
          </li>
        </ul>
        <p>Human <strong>language processing</strong> relies heavily on these temporal lobe structures, especially in the left hemisphere.</p>

        <h3>Lateralization of Language and Auditory Functions</h3>
        <p>Unlike basic hearing, which is relatively symmetric, <strong>language</strong> is strongly <strong>lateralized</strong>.</p>
        <p><strong><u>Definition.</u></strong> <strong>Lateralization</strong> refers to the specialization of the two cerebral hemispheres 
          for different functions.</p>
        <ul>
          <li>For most people, the <strong>left hemisphere</strong> is dominant for core language functions, including speech production and comprehension.</li>
          <li>The <strong>right hemisphere</strong> contributes more to:
            <ul>
              <li>Perception of <strong>music</strong>.</li>
              <li>Processing of <strong>prosody</strong> (emotional tone, intonation) in speech.</li>
            </ul>
          </li>
        </ul>

        <h4>Evidence from the Wada Test and Split-Brain Patients</h4>
        <p><strong>The Wada test</strong> temporarily anesthetizes one hemisphere at a time (using sodium amytal) to determine which side 
          supports language.</p>
        <ul>
          <li>When the <strong>left hemisphere</strong> is anesthetized in a left-language-dominant person, speech and comprehension are severely disrupted.</li>
          <li>Anesthetizing the <strong>right hemisphere</strong> typically has less dramatic effects on language but can affect spatial and musical abilities.</li>
        </ul>

        <p><strong>Split-brain patients</strong>—individuals whose corpus callosum has been surgically severed or is absent—provide further evidence:
        </p>
        <ul>
          <li>Visual or auditory stimuli presented exclusively to the <strong>right hemisphere</strong> (e.g., via the left visual field) may not be verbally reported, 
            illustrating the left hemisphere’s dominance for speech.</li>
          <li>However, the right hemisphere can still show evidence of understanding via nonverbal responses (e.g., pointing), revealing its partial language capacity.</li>
        </ul>

        <h3>What is Language?</h3>
        <p>Language is a <strong>highly specialized form of communication</strong> uniquely elaborated in humans.</p>
        <p><strong><u>Definition.</u></strong> Language is the system in which <strong>arbitrary symbols</strong> (sounds, signs, written marks) are combined 
          according to <strong>rules (grammar)</strong> to convey an essentially unlimited range of meanings—objects, actions, abstractions, and relationships.
        </p>
        <p>Key features:</p>
        <ul>
          <li><strong>Phonology</strong> – basic sound units.</li>
          <li><strong>Syntax and grammar</strong> – rules for combining words into meaningful sentences.</li>
          <li><strong>Semantics</strong> – meaning associated with words and sentences.</li>
        </ul>

        <h3>Overview of the Language Network</h3>
        <p>Language is processed primarily in the <strong>left hemisphere</strong>, but involves a distributed network of regions in temporal, 
          frontal, and parietal lobes.</p>
        <ul>
          <li><strong>Posterior temporal cortex</strong> – important for <strong>speech perception</strong> and comprehension.</li>
          <li><strong>Inferior frontal cortex</strong> – important for <strong>speech production</strong> and planning of articulation.</li>
          <li><strong>Parietal regions</strong> – contribute to reading, writing, and integration of auditory and visual language information.</li>
        </ul>
        <p>Damage to these regions results in characteristic language deficits known as <strong>aphasias</strong>.</p>

        <h3>Aphasia: When Language Breaks Down</h3>
        <p><strong><u>Definition.</u></strong> <strong>Aphasia</strong> is an acquired impairment of language production and/or comprehension, typically 
          following brain injury such as stroke.</p>
        <p>Common signs include:</p>
        <ul>
          <li><strong>Paraphasia</strong> – substituting an incorrect sound or word (e.g., “tephelone” for “telephone”).</li>
          <li><strong>Neologism</strong> – producing a novel, meaningless word.</li>
          <li><strong>Nonfluent speech</strong> – effortful, halting speech with short phrases and reduced melodic intonation.</li>
        </ul>

        <h4>Broca’s (Nonfluent) Aphasia</h4>
        <ul>
          <li>Associated with damage to the <strong>inferior frontal gyrus</strong> in the left hemisphere (<strong>Broca’s area</strong>).</li>
          <li>Patients have:
            <ul>
              <li>Great difficulty producing fluent speech.</li>
              <li>Relatively preserved comprehension (especially for simple sentences).</li>
              <li>Telegraphic speech—mostly content words, few function words.</li>
            </ul>
          </li>
          <li>Classic case: patient “Tan,” who could say little more than that single syllable despite understanding much of what was said to him.</li>
        </ul>

        <h4>Wernicke’s (Fluent) Aphasia</h4>
        <ul>
          <li>Associated with damage to the <strong>posterior superior temporal gyrus</strong> and adjacent parietal cortex (<strong>Wernicke’s area</strong>).</li>
          <li>Patients:
            <ul>
              <li>Produce fluent, well-articulated speech that is often <strong>semantically empty</strong> and filled with paraphasias and neologisms.</li>
              <li>Have marked difficulty understanding spoken and written language.</li>
            </ul>
          </li>
          <li>Speech may sound “normal” in rhythm and prosody but is often unintelligible in content.</li>
        </ul>

        <h4>Global Aphasia</h4>
        <ul>
          <li>Results from large left-hemisphere lesions involving multiple language areas.</li>
          <li>Patients show severe impairments in both <strong>production</strong> and <strong>comprehension</strong> of language.</li>
          <li>Spontaneous speech is limited or absent; comprehension is also severely reduced.</li>
        </ul>

        <h3>Dyslexia: Difficulties with Reading</h3>
        <p><strong>Dyslexia</strong> refers to difficulty in learning to read or in processing written language, despite adequate intelligence 
          and educational opportunity.</p>
        <h4>Acquired Dyslexias</h4>
        <ul>
          <li><strong>Deep dyslexia</strong> – acquired after brain injury; written words may be read as semantically related but incorrect words 
            (e.g., “cow” read as “horse”).</li>
          <li><strong>Surface dyslexia</strong> – difficulty reading words with irregular spelling-to-sound rules (e.g., “though,” “cough”), 
            relying heavily on letter-by-letter pronunciation.</li>
        </ul>

        <h4>Developmental Dyslexia</h4>
        <ul>
          <li>Begins in childhood and can persist into adulthood.</li>
          <li>Occurs across languages, although specific reading challenges depend on the writing system (orthography).</li>
          <li>Genetic factors contribute; variants in genes such as <strong>DYX1C1</strong>, <strong>ROBO1</strong>, and <strong>DCDC2</strong> 
            are associated with increased risk.</li>
          <li>Neuroanatomical studies reveal:
            <ul>
              <li><strong>Ectopic cell clusters</strong> (neurons in abnormal locations).</li>
              <li><strong>Micropolygyria</strong> (excessively folded small regions) in language-related cortical areas.</li>
            </ul>
          </li>
        </ul>

        <h3>Animal Models of Vocal Learning and “Language-Like” Behavior</h3>
        <p>Although true human language is unique, animal models help us study components of language such as vocal learning and symbolic communication.</p>

        <h4>Songbirds</h4>
        <ul>
          <li>Male songbirds learn a species-typical song by listening to adult tutors and their own vocal output.</li>
          <li>There is a <strong>critical period</strong> during which song must be learned; after this period, the song becomes 
            <strong>“crystallized”</strong> and relatively fixed.</li>
          <li>Song learning is guided by auditory feedback: birds compare what they produce to a stored template and adjust via trial-and-error.</li>
          <li>This provides a powerful experimental model for studying the neural basis of vocal learning.</li>
        </ul>

        <h4>Nonhuman Primates and Other Animals</h4>
        <ul>
          <li><strong>Nonhuman primates</strong> (e.g., chimpanzees, gorillas):
            <ul>
              <li>Have been taught vocabulary using sign language or symbol systems.</li>
              <li>Show some ability to combine signs and use them communicatively.</li>
              <li>Debate remains about whether this constitutes true language, as grammar and generativity are limited.</li>
            </ul>
          </li>
          <li><strong>Alex the parrot</strong> (African Grey parrot):
            <ul>
              <li>Learned over 100 words and could use them appropriately in many contexts.</li>
              <li>Demonstrated impressive cognitive abilities (e.g., labeling colors, shapes, counting small numbers).</li>
              <li>His training illustrates how limited “language-like” systems can be used to probe animal cognition, without claiming full human-like language.</li>
            </ul>
          </li>
        </ul>

        <p>All together, studies of auditory processing, language networks, and animal models highlight how the brain transforms 
          simple vibrations into rich perceptual experiences and complex symbolic communication.
        </p>
      </section>
      <section id="chapter14"><h2>The Auditory System and Language</h2>
        <p>Up to now, we have examined how sensory systems such as touch and vision detect physical stimuli and transform them into 
          patterned neural activity. Hearing and language follow the same basic principles—specialized receptors convert <strong>mechanical vibrations</strong> 
          of air into electrical signals, which are then interpreted by higher brain areas as <strong>sound</strong> and, in humans, as 
          <strong>speech and language</strong>.
        </p>
        <center><p><i>How does the nervous system turn tiny air pressure changes into rich experiences like music, speech, and meaning?</i></p></center>

        <h3>Physical Dimensions of Sound</h3>
        <p>Sound is a <strong>mechanical wave</strong>—repeating changes in air pressure over time. Two key physical properties of sound 
          relate directly to how we perceive it:
        </p>
        <ul>
          <li><strong>Amplitude (intensity)</strong> – the size of the pressure changes; we perceive this as <strong>loudness</strong>.
            <ul>
              <li>Larger amplitude → louder sound.</li>
              <li>Measured in decibels (dB) on a logarithmic scale.</li>
            </ul>
          </li>
          <li><strong>Frequency</strong> – the number of cycles of vibration per second, measured in <strong>Hertz (Hz)</strong>; we perceive this as <strong>pitch</strong>.
            <ul>
              <li>Low frequency (e.g., 100 Hz) → low-pitched sounds (bass).</li>
              <li>High frequency (e.g., 4000 Hz) → high-pitched sounds (treble).</li>
            </ul>
          </li>
        </ul>
        <p>Our auditory system can detect an impressive range of both amplitude and frequency, from faint whispers to loud concerts, 
          and from low rumbles to high chirps.</p>

        <h3>From Air to Fluid: The Outer and Middle Ear</h3>
        <p>Before sound can be transduced into neural activity, it must be collected and mechanically transformed by the ear.
        </p>
        <h4>The External (Outer) Ear</h4>
        <ul>
          <li><strong>Pinna</strong> – the visible “ear” on the side of the head. Its complex folds:
            <ul>
              <li>Help collect and funnel sound into the ear canal.</li>
              <li>Shape the spectrum of incoming sounds, providing cues about the <strong>vertical</strong> location of sound sources.</li>
            </ul>
          </li>
          <li><strong>Ear canal</strong> – guides sound waves toward the <strong>tympanic membrane (eardrum)</strong>.</li>
        </ul>

        <h4>The Middle Ear: Impedance Matching</h4>
        <p>The middle ear converts large, low-pressure vibrations in air into smaller, higher-pressure vibrations in fluid. This is 
          necessary because fluid is harder to move than air.</p>
        <ul>
          <li><strong>Tympanic membrane (eardrum)</strong> – vibrates in response to incoming sound waves.</li>
          <li><strong>Ossicles</strong> – three tiny bones that form a lever system:
            <ul>
              <li><strong>Malleus</strong> (hammer)</li>
              <li><strong>Incus</strong> (anvil)</li>
              <li><strong>Stapes</strong> (stirrup)</li>
            </ul>
            These bones transmit vibrations from the tympanic membrane to the <strong>oval window</strong> of the inner ear.
          </li>
        </ul>
        <p><strong><u>Note.</u></strong> By focusing the force from the large area of the eardrum onto the much smaller oval window, 
          the ossicles <strong>concentrate sound energy</strong> and improve transfer of vibrations into the fluid-filled cochlea.
        </p>

        <h3>The Inner Ear and the Cochlea</h3>
        <p>The <strong>inner ear</strong> houses the machinery that converts mechanical energy into neural signals. The core auditory 
          structure is the <strong>cochlea</strong>.</p>
        <ul>
          <li>The cochlea is a <strong>spiral-shaped, fluid-filled tube</strong> with a <strong>base</strong> (near the oval window) 
            and an <strong>apex</strong> (the tip of the spiral).</li>
          <li>Within the cochlea lies the <strong>organ of Corti</strong>, which contains the sensory receptors for hearing: 
            <strong>hair cells</strong>.</li>
        </ul>

        <h4>The Organ of Corti</h4>
        <p>The organ of Corti sits on the <strong>basilar membrane</strong> and contains three key components:</p>
        <ul>
          <li><strong>Hair cells</strong> – specialized sensory cells that convert movement into neurotransmitter release.
            <ul>
              <li>Their “hairs” are <strong>stereocilia</strong>, small, rigid projections organized in bundles.</li>
            </ul>
          </li>
          <li><strong>Basilar membrane</strong> – vibrates up and down in response to sound-induced pressure waves in the cochlear fluid.</li>
          <li><strong>Supporting cells</strong> and neighboring membranes (including the tectorial membrane) that help translate 
            basilar membrane motion into stereocilia deflection.</li>
        </ul>

        <h4>Tonotopic Mapping in the Cochlea</h4>
        <p>Different sound frequencies cause different regions of the basilar membrane to vibrate most strongly:
        </p>
        <ul>
          <li><strong>High-frequency sounds</strong> (e.g., 8–20 kHz) maximally displace the <strong>narrow, stiff base</strong> of the basilar membrane.</li>
          <li><strong>Low-frequency sounds</strong> (e.g., 100–500 Hz) maximally displace the <strong>wider, more flexible apex</strong>.</li>
        </ul>
        <p>This systematic mapping of frequency onto position along the basilar membrane is called <strong>tonotopy</strong>. 
          It is the auditory analog of retinotopy in vision and is preserved all the way up into the auditory cortex.
        </p>

        <h3>Hair Cell Transduction: From Motion to Current</h3>
        <p>When the basilar membrane vibrates, it causes the hair cell stereocilia to bend. This bending is the key to turning 
          mechanical energy into a receptor potential.</p>
        <ul>
          <li><strong>Tip links</strong> – fine protein filaments that connect the tips of shorter stereocilia to mechanically gated ion channels on their taller neighbors.</li>
          <li>When stereocilia are deflected in the <strong>preferred direction</strong>:
            <ul>
              <li>Tip links stretch and mechanically open ion channels.</li>
              <li>Positively charged ions (especially K<sup>+</sup> from the high-potassium endolymph) flow into the hair cell.</li>
              <li>The hair cell <strong>depolarizes</strong>, opening voltage-gated Ca<sup>2+</sup> channels at its base.</li>
              <li>Ca<sup>2+</sup> entry triggers <strong>neurotransmitter release</strong> (primarily glutamate) onto auditory nerve fibers.</li>
            </ul>
          </li>
        </ul>
        <p>Deflection in the opposite direction slackens the tip links, closes ion channels, and <strong>hyperpolarizes</strong> the cell, 
          reducing transmitter release. In this way, hair cells encode sound vibrations as graded changes in membrane potential and transmitter output.</p>

        <p><strong><u>Note.</u></strong> <strong>Inner hair cells</strong> provide most of the auditory information to the brain, while 
          <strong>outer hair cells</strong> act as a <em>cochlear amplifier</em>, actively fine-tuning and amplifying basilar membrane motion.</p>

        <h3>Auditory Pathways: From Cochlea to Cortex</h3>
        <p>The electrical signals generated by hair cells are carried into the brain along the <strong>auditory nerve</strong>, part of 
          cranial nerve VIII, the <strong>vestibulocochlear nerve</strong>.</p>
        <ul>
          <li><strong>Auditory nerve fibers</strong> – receive glutamatergic input from inner hair cells and encode sound frequency (via tonotopy) and intensity (via firing rate).</li>
          <li>These fibers project to the <strong>cochlear nuclei</strong> in the brainstem.</li>
          <li>From the cochlear nuclei, information is relayed to the <strong>superior olivary nuclei</strong>, where <strong>binaural</strong> (two-ear) comparisons are first made.</li>
          <li>Signals then ascend to the <strong>inferior colliculi</strong> in the midbrain.</li>
          <li>From there, they project to the <strong>medial geniculate nucleus (MGN)</strong> of the thalamus.</li>
          <li>Finally, MGN neurons send projections to <strong>primary auditory cortex (A1)</strong> in the temporal lobe.</li>
        </ul>
        <p>At each stage, tonotopic organization is preserved: neighboring neurons respond to neighboring sound frequencies.</p>

        <h3>Binaural Cues and Sound Localization</h3>
        <p>How do we determine where a sound is coming from? The brain uses <strong>binaural cues</strong>, based on information from 
          both ears. The key computations occur in the <strong>superior olivary nucleus</strong>.</p>
        <ul>
          <li><strong>Intensity differences</strong> (interaural level differences):
            <ul>
              <li>For high-frequency sounds, the head casts an “acoustic shadow.”</li>
              <li>The ear closer to the sound receives a slightly <strong>louder</strong> signal.</li>
            </ul>
          </li>
          <li><strong>Latency (time) differences</strong> (interaural time differences):
            <ul>
              <li>A sound reaching the right ear slightly before the left indicates a source to the right, and vice versa.</li>
              <li>Especially important for <strong>low-frequency</strong> sounds, where intensity differences are smaller.</li>
            </ul>
          </li>
        </ul>
        <p>By comparing inputs from both ears, neurons in the superior olive can compute the <strong>horizontal location</strong> of 
          a sound source.</p>

        <h3>Tonotopic Maps in the Auditory Cortex</h3>
        <p><strong>Primary auditory cortex (A1)</strong> in the temporal lobe maintains a <strong>tonotopic map</strong> of sound 
          frequency, similar to how the primary visual cortex maintains a retinotopic map.</p>
        <ul>
          <li>Neighboring cortical neurons prefer similar sound frequencies.</li>
          <li>Frequency preferences shift systematically across the cortical surface.</li>
        </ul>
        <p>Beyond A1, <strong>secondary auditory areas</strong> process more complex features such as combinations of frequencies, 
          temporal patterns, and, in humans, the acoustic structure of speech and music.</p>

        <h3>Higher-Order Auditory Processing Streams</h3>
        <p>The brain organizes auditory information into partially distinct processing streams, analogous to the dorsal (“where”) 
          and ventral (“what”) streams in vision.</p>
        <ul>
          <li><strong>Dorsal auditory stream</strong> – projects into parietal regions.
            <ul>
              <li>Specialized for <strong>spatial location</strong> of sounds (“where”).</li>
              <li>Helps orient toward or away from sound sources.</li>
            </ul>
          </li>
          <li><strong>Ventral auditory stream</strong> – remains largely within temporal regions.
            <ul>
              <li>Analyzes the <strong>identity</strong> and components of complex sounds (“what”).</li>
              <li>Critical for recognizing <strong>speech, voices, and environmental sounds</strong>.</li>
            </ul>
          </li>
        </ul>
        <p>Human <strong>language processing</strong> relies heavily on these temporal lobe structures, especially in the left hemisphere.</p>

        <h3>Lateralization of Language and Auditory Functions</h3>
        <p>Unlike basic hearing, which is relatively symmetric, <strong>language</strong> is strongly <strong>lateralized</strong>.</p>
        <p><strong><u>Definition.</u></strong> <strong>Lateralization</strong> refers to the specialization of the two cerebral hemispheres 
          for different functions.</p>
        <ul>
          <li>For most people, the <strong>left hemisphere</strong> is dominant for core language functions, including speech production and comprehension.</li>
          <li>The <strong>right hemisphere</strong> contributes more to:
            <ul>
              <li>Perception of <strong>music</strong>.</li>
              <li>Processing of <strong>prosody</strong> (emotional tone, intonation) in speech.</li>
            </ul>
          </li>
        </ul>

        <h4>Evidence from the Wada Test and Split-Brain Patients</h4>
        <p><strong>The Wada test</strong> temporarily anesthetizes one hemisphere at a time (using sodium amytal) to determine which side 
          supports language.</p>
        <ul>
          <li>When the <strong>left hemisphere</strong> is anesthetized in a left-language-dominant person, speech and comprehension are severely disrupted.</li>
          <li>Anesthetizing the <strong>right hemisphere</strong> typically has less dramatic effects on language but can affect spatial and musical abilities.</li>
        </ul>

        <p><strong>Split-brain patients</strong>—individuals whose corpus callosum has been surgically severed or is absent—provide further evidence:
        </p>
        <ul>
          <li>Visual or auditory stimuli presented exclusively to the <strong>right hemisphere</strong> (e.g., via the left visual field) may not be verbally reported, 
            illustrating the left hemisphere’s dominance for speech.</li>
          <li>However, the right hemisphere can still show evidence of understanding via nonverbal responses (e.g., pointing), revealing its partial language capacity.</li>
        </ul>

        <h3>What is Language?</h3>
        <p>Language is a <strong>highly specialized form of communication</strong> uniquely elaborated in humans.</p>
        <p><strong><u>Definition.</u></strong> Language is the system in which <strong>arbitrary symbols</strong> (sounds, signs, written marks) are combined 
          according to <strong>rules (grammar)</strong> to convey an essentially unlimited range of meanings—objects, actions, abstractions, and relationships.
        </p>
        <p><strong>Remark.</strong> This is different to the definition of a language derivable mathematically. </p>
        <p>Key features:</p>
        <ul>
          <li><strong>Phonology</strong> – basic sound units.</li>
          <li><strong>Syntax and grammar</strong> – rules for combining words into meaningful sentences.</li>
          <li><strong>Semantics</strong> – meaning associated with words and sentences.</li>
        </ul>

        <h3>Overview of the Language Network</h3>
        <p>Language is processed primarily in the <strong>left hemisphere</strong>, but involves a distributed network of regions in temporal, 
          frontal, and parietal lobes.</p>
        <ul>
          <li><strong>Posterior temporal cortex</strong> – important for <strong>speech perception</strong> and comprehension.</li>
          <li><strong>Inferior frontal cortex</strong> – important for <strong>speech production</strong> and planning of articulation.</li>
          <li><strong>Parietal regions</strong> – contribute to reading, writing, and integration of auditory and visual language information.</li>
        </ul>
        <p>Damage to these regions results in characteristic language deficits known as <strong>aphasias</strong>.</p>

        <h3>Aphasia: When Language Breaks Down</h3>
        <p><strong><u>Definition.</u></strong> <strong>Aphasia</strong> is an acquired impairment of language production and/or comprehension, typically 
          following brain injury such as stroke.</p>
        <p>Common signs include:</p>
        <ul>
          <li><strong>Paraphasia</strong> – substituting an incorrect sound or word (e.g., “tephelone” for “telephone”).</li>
          <li><strong>Neologism</strong> – producing a novel, meaningless word.</li>
          <li><strong>Nonfluent speech</strong> – effortful, halting speech with short phrases and reduced melodic intonation.</li>
        </ul>

        <h4>Broca’s (Nonfluent) Aphasia</h4>
        <ul>
          <li>Associated with damage to the <strong>inferior frontal gyrus</strong> in the left hemisphere (<strong>Broca’s area</strong>).</li>
          <li>Patients have:
            <ul>
              <li>Great difficulty producing fluent speech.</li>
              <li>Relatively preserved comprehension (especially for simple sentences).</li>
              <li>Telegraphic speech—mostly content words, few function words.</li>
            </ul>
          </li>
          <li>Classic case: patient “Tan,” who could say little more than that single syllable despite understanding much of what was said to him.</li>
        </ul>

        <h4>Wernicke’s (Fluent) Aphasia</h4>
        <ul>
          <li>Associated with damage to the <strong>posterior superior temporal gyrus</strong> and adjacent parietal cortex (<strong>Wernicke’s area</strong>).</li>
          <li>Patients:
            <ul>
              <li>Produce fluent, well-articulated speech that is often <strong>semantically empty</strong> and filled with paraphasias and neologisms.</li>
              <li>Have marked difficulty understanding spoken and written language.</li>
            </ul>
          </li>
          <li>Speech may sound “normal” in rhythm and prosody but is often unintelligible in content.</li>
        </ul>

        <h4>Global Aphasia</h4>
        <ul>
          <li>Results from large left-hemisphere lesions involving multiple language areas.</li>
          <li>Patients show severe impairments in both <strong>production</strong> and <strong>comprehension</strong> of language.</li>
          <li>Spontaneous speech is limited or absent; comprehension is also severely reduced.</li>
        </ul>

        <h3>Dyslexia: Difficulties with Reading</h3>
        <p><strong>Dyslexia</strong> refers to difficulty in learning to read or in processing written language, despite adequate intelligence 
          and educational opportunity.</p>
        <h4>Acquired Dyslexias</h4>
        <ul>
          <li><strong>Deep dyslexia</strong> – acquired after brain injury; written words may be read as semantically related but incorrect words 
            (e.g., “cow” read as “horse”).</li>
          <li><strong>Surface dyslexia</strong> – difficulty reading words with irregular spelling-to-sound rules (e.g., “though,” “cough”), 
            relying heavily on letter-by-letter pronunciation.</li>
        </ul>

        <h4>Developmental Dyslexia</h4>
        <ul>
          <li>Begins in childhood and can persist into adulthood.</li>
          <li>Occurs across languages, although specific reading challenges depend on the writing system (orthography).</li>
          <li>Genetic factors contribute; variants in genes such as <strong>DYX1C1</strong>, <strong>ROBO1</strong>, and <strong>DCDC2</strong> 
            are associated with increased risk.</li>
          <li>Neuroanatomical studies reveal:
            <ul>
              <li><strong>Ectopic cell clusters</strong> (neurons in abnormal locations).</li>
              <li><strong>Micropolygyria</strong> (excessively folded small regions) in language-related cortical areas.</li>
            </ul>
          </li>
        </ul>

        <h3>Animal Models of Vocal Learning and “Language-Like” Behavior</h3>
        <p>Although true human language is unique, animal models help us study components of language such as vocal learning and symbolic communication.</p>

        <h4>Songbirds</h4>
        <ul>
          <li>Male songbirds learn a species-typical song by listening to adult tutors and their own vocal output.</li>
          <li>There is a <strong>critical period</strong> during which song must be learned; after this period, the song becomes 
            <strong>“crystallized”</strong> and relatively fixed.</li>
          <li>Song learning is guided by auditory feedback: birds compare what they produce to a stored template and adjust via trial-and-error.</li>
          <li>This provides a powerful experimental model for studying the neural basis of vocal learning.</li>
        </ul>

        <h4>Nonhuman Primates and Other Animals</h4>
        <ul>
          <li><strong>Nonhuman primates</strong> (e.g., chimpanzees, gorillas):
            <ul>
              <li>Have been taught vocabulary using sign language or symbol systems.</li>
              <li>Show some ability to combine signs and use them communicatively.</li>
              <li>Debate remains about whether this constitutes true language, as grammar and generativity are limited.</li>
            </ul>
          </li>
          <li><strong>Alex the parrot</strong> (African Grey parrot):
            <ul>
              <li>Learned over 100 words and could use them appropriately in many contexts.</li>
              <li>Demonstrated impressive cognitive abilities (e.g., labeling colors, shapes, counting small numbers).</li>
              <li>His training illustrates how limited “language-like” systems can be used to probe animal cognition, without claiming full human-like language.</li>
            </ul>
          </li>
        </ul>

        <p>In short, studies of auditory processing, language networks, and animal models highlight how the brain transforms 
          simple vibrations into rich perceptual experiences and complex symbolic communication.
        </p>
      </section>
      <section id="chapter15"><h2>Motor Control</h2>
        <p>So far, we have treated the nervous system primarily as a <strong>sensing</strong> and <strong>signaling</strong> device:
          detecting stimuli, processing them, and transmitting information across synapses. But much of the brain’s purpose is
          ultimately to <strong>act</strong> on the world—to move the eyes, shift posture, speak, grasp, walk, or play an instrument.
        </p>
        <center><p><i>How does the nervous system convert patterns of neural activity into coordinated, purposeful movement?</i></p></center>
        <p>Motor control links <strong>motoneurons</strong>, <strong>muscles</strong>, <strong>spinal circuits</strong>, and 
          <strong>multiple brain regions</strong> in a hierarchical system. At the periphery, the neuromuscular junction produces
          reliable contractions; centrally, the spinal cord, cortex, cerebellum, and basal ganglia work together to initiate, refine, 
          and adapt movement.
        </p>

        <h3>The Neuromuscular Junction (NMJ)</h3>
        <p>The final common pathway from the nervous system to skeletal muscle is the <strong>neuromuscular junction</strong>.</p>
        <p><strong><u>Definition.</u></strong> The <strong>neuromuscular junction (NMJ)</strong> is the chemical synapse where the 
          terminal of a <strong>motor neuron</strong> contacts a <strong>skeletal muscle fiber</strong> and controls its contraction.
        </p>
        <ul>
          <li>The NMJ is an extremely <strong>effective</strong> synapse: a single action potential in the motor neuron almost always
            produces a <strong>muscle action potential</strong> and a contraction.</li>
          <li>A single spinal motor neuron can branch extensively and form NMJs on many muscle fibers.</li>
        </ul>
        <p><strong><u>Definition.</u></strong> A <strong>motor unit</strong> is a single motor neuron and <strong>all</strong> of the 
          muscle fibers it innervates. Motor units are the fundamental units of control in the skeletal muscle system.</p>
        <ul>
          <li>Small motor units (few fibers) → allow <strong>fine control</strong> (e.g., fingers, extraocular muscles).</li>
          <li>Large motor units (many fibers) → generate <strong>large forces</strong> but coarse control (e.g., postural muscles).</li>
        </ul>

        <h4>Acetylcholine at the NMJ</h4>
        <p>The neurotransmitter at the skeletal NMJ is <strong>acetylcholine (ACh)</strong>.</p>
        <ul>
          <li>An action potential in the motor neuron arrives at the NMJ and opens voltage-gated Ca<sup>2+</sup> channels.</li>
          <li>Ca<sup>2+</sup> influx triggers vesicle fusion and <strong>ACh release</strong> into the synaptic cleft.</li>
          <li>ACh binds to <strong>nicotinic ACh receptors</strong> on the muscle fiber membrane (the motor endplate).</li>
          <li>These ionotropic receptors open and allow cations (mainly Na<sup>+</sup>) to enter the muscle, <strong>depolarizing</strong> it.</li>
          <li>If the endplate potential reaches threshold, a <strong>muscle action potential</strong> is generated and triggers contraction.</li>
        </ul>

        <h4>Disorder Spotlight: Myasthenia Gravis</h4>
        <p><strong>Myasthenia gravis</strong> is a classic example of how altering ACh signaling at the NMJ disrupts movement.</p>
        <ul>
          <li>It is an <strong>autoimmune disease</strong> in which antibodies target and destroy <strong>nicotinic ACh receptors</strong> 
            at the NMJ.</li>
          <li>Fewer functional receptors → less effective neuromuscular transmission.</li>
          <li>Clinically, it presents as <strong>muscle weakness that worsens with use</strong> (e.g., drooping eyelids, difficulty chewing or speaking as the day goes on).</li>
          <li>Treatment often includes drugs that <strong>inhibit acetylcholinesterase (AChE)</strong>, the enzyme that breaks down ACh, thereby increasing ACh levels at the NMJ and partially compensating for receptor loss.</li>
        </ul>

        <h3>How Skeletal Muscle Produces Movement</h3>
        <p>Skeletal muscles attach to bones via tendons and can only <strong>pull</strong> (contract) or relax—they cannot push.</p>
        <ul>
          <li>Movements are produced by <strong>coordinated activation</strong> of different muscle groups.</li>
          <li><strong>Antagonistic muscle pairs</strong> (e.g., biceps and triceps) act around joints to allow flexion and extension.</li>
          <li>The <strong>shape of the joint</strong> (hinge, ball-and-socket, etc.) constrains the possible range of motion.</li>
        </ul>
        <p>By selectively activating different sets of motor units in multiple muscles, the nervous system can generate a vast repertoire of movements.</p>

        <h3>Proprioception: Knowing Where We Are</h3>
        <p>To control movement, the brain must continuously monitor the body’s position and tension.</p>
        <p><strong><u>Definition.</u></strong> <strong>Proprioception</strong> is the sense of the body’s own movements and positions, mediated by 
          specialized <strong>sensory receptors</strong> in muscles and tendons.
        </p>
        <ul>
          <li><strong>Muscle spindles</strong> – stretch-sensitive receptors embedded within the muscle:
            <ul>
              <li>Detect <strong>muscle length</strong> and rate of change of length.</li>
              <li>Provide feedback about how much and how quickly a muscle is being stretched.</li>
            </ul>
          </li>
          <li><strong>Golgi tendon organs</strong> – located in tendons:
            <ul>
              <li>Monitor <strong>muscle tension</strong> (force of contraction).</li>
              <li>Help prevent damage by signaling when tension is dangerously high.</li>
            </ul>
          </li>
        </ul>
        <p>Together, these proprioceptors give the nervous system a continuous “internal map” of limb position and muscle load, allowing for 
          smooth, coordinated adjustments during movement.</p>

        <h3>Spinal Reflexes: Fast, Stereotyped Movements</h3>
        <p>Not all movements require deliberation or cortical involvement. Some are mediated by <strong>spinal circuits</strong> alone.</p>
        <p><strong><u>Definition.</u></strong> A <strong>reflex</strong> is a simple, unvarying, and unlearned response to a specific sensory stimulus.
          Reflexes are mediated by small neural circuits within the spinal cord and brainstem.
        </p>
        <ul>
          <li>Spinal connections between <strong>dorsal roots</strong> (sensory input) and <strong>ventral roots</strong> (motor output) form the basis of reflex arcs.</li>
          <li>Reflexes provide <strong>rapid protective responses</strong> (e.g., withdrawal from pain, maintaining posture).</li>
        </ul>

        <h4>The Knee-Jerk (Stretch) Reflex</h4>
        <p>The classic <strong>knee-jerk response</strong> illustrates a simple monosynaptic reflex arc:</p>
        <ol>
          <li>Tap the patellar tendon → stretches the quadriceps muscle.</li>
          <li>Muscle spindles detect this rapid stretch and fire action potentials.</li>
          <li>These sensory afferents enter the spinal cord via the <strong>dorsal root</strong> and synapse directly on the motor neurons to the same muscle.</li>
          <li>Motor neurons fire and cause the quadriceps to contract, producing leg extension.</li>
        </ol>
        <p>This circuit provides an automatic, very rapid response that helps maintain posture and muscle tone.</p>

        <h3>A Hierarchy of Motor Control Systems</h3>
        <p>Voluntary movement arises from a <strong>hierarchical organization</strong> of control systems.</p>
        <ul>
          <li><strong>Spinal cord</strong> – contains circuits for reflexes and central pattern generators (basic rhythmic movements).</li>
          <li><strong>Primary motor cortex (M1)</strong> – initiates voluntary commands for action.</li>
          <li><strong>Nonprimary motor cortex</strong> – helps plan and sequence movements.</li>
          <li><strong>Cerebellum and basal ganglia</strong> – modulate and refine motor commands via loops through the thalamus and back to cortex.</li>
        </ul>

        <h4>Brain vs. Spinal Control</h4>
        <ul>
          <li>Most skeletal muscles are innervated by <strong>spinal motor neurons</strong>; commands descend from the brain to the spinal cord and then out to muscles.</li>
          <li>Some muscles—especially those of the <strong>head and neck</strong> (e.g., facial expression, tongue, jaw)—are controlled directly by:
            <ul>
              <li><strong>Cranial motor nuclei</strong> in the brainstem, whose axons form various <strong>cranial nerves</strong>.</li>
            </ul>
          </li>
        </ul>

        <h3>Descending Motor Pathways: Pyramidal and Extrapyramidal Systems</h3>
        <p>Commands from the brain reach spinal motor neurons via two major pathways.</p>
        <h4>The Pyramidal (Corticospinal) System</h4>
        <p><strong><u>Definition.</u></strong> The <strong>pyramidal system</strong> consists of axons that originate primarily in the 
          <strong>primary motor cortex (M1)</strong> and descend through the brainstem to the spinal cord, forming the <strong>pyramidal tract</strong>.
        </p>
        <ul>
          <li>Many of these fibers originate from neurons in the <strong>precentral gyrus</strong> (M1).</li>
          <li>They pass through the internal capsule and form visible “pyramids” on the ventral surface of the medulla.</li>
          <li>Most fibers <strong>decussate</strong> (cross) in the medulla, so the left hemisphere controls the right side of the body and vice versa.</li>
          <li>The pyramidal system is especially important for <strong>fine, voluntary movements</strong>, such as finger control.</li>
        </ul>

        <h4>The Motor Homunculus</h4>
        <p>As with somatosensory cortex, M1 contains a <strong>somatotopic map</strong> of the body, sometimes depicted as a 
          <strong>motor homunculus</strong>.</p>
        <ul>
          <li>Body parts requiring <strong>fine motor control</strong> (e.g., hands, face, tongue) occupy <strong>disproportionately large</strong> areas of M1.</li>
          <li>Less dexterous regions (e.g., trunk) occupy relatively smaller areas.</li>
        </ul>

        <h4>The Extrapyramidal System</h4>
        <p>The <strong>extrapyramidal system</strong> includes several subcortical structures, chiefly the <strong>basal ganglia</strong> and 
          <strong>cerebellum</strong>, that modulate motor commands.</p>
        <ul>
          <li>These structures do not directly innervate motor neurons; instead, they:
            <ul>
              <li>Form <strong>loops</strong> with cortex via the thalamus.</li>
              <li>Adjust the <strong>timing, scaling, and initiation</strong> of movements.</li>
            </ul>
          </li>
        </ul>

        <h3>Nonprimary Motor Cortex: Planning and Sequencing</h3>
        <p><strong>Nonprimary motor areas</strong> lie anterior to M1 and contribute to the planning and organization of movements.</p>
        <ul>
          <li><strong>Supplementary Motor Area (SMA)</strong>:
            <ul>
              <li>Important for <strong>internally generated</strong> sequences of movement (e.g., playing a memorized piano piece).</li>
              <li>Activated during <strong>mental rehearsal</strong> of complex movement sequences, even without overt movement.</li>
              <li>Receives strong input from the <strong>basal ganglia</strong>.</li>
            </ul>
          </li>
          <li><strong>Premotor Cortex</strong>:
            <ul>
              <li>Involved in movements that are <strong>guided by external cues</strong> (e.g., visually guided reaching).</li>
              <li>Participates in learning <strong>arbitrary associations</strong> between stimuli and motor responses.</li>
              <li>Includes <strong>Broca’s area</strong> (on the left), a region critical for <strong>motor aspects of speech production</strong>.</li>
            </ul>
          </li>
        </ul>

        <h4>Mirror Neurons</h4>
        <p>Within the <strong>ventral premotor cortex</strong>, some neurons exhibit a remarkable property.</p>
        <p><strong><u>Definition.</u></strong> <strong>Mirror neurons</strong> are neurons that fire both when an individual 
          <strong>executes</strong> a particular movement and when they <strong>observe</strong> someone else performing the same movement.
        </p>
        <ul>
          <li>Thought to contribute to understanding the actions of others.</li>
          <li>May be important for <strong>imitation learning</strong> and possibly for aspects of social cognition.</li>
        </ul>

        <h3>Disorders of the Pyramidal System: ALS</h3>
        <p><strong>Amyotrophic lateral sclerosis (ALS)</strong> is a progressive neurodegenerative disease that affects the pyramidal system.</p>
        <ul>
          <li>Both <strong>upper motor neurons</strong> (in M1) and <strong>lower motor neurons</strong> (in spinal cord and cranial motor nuclei) degenerate.</li>
          <li>As motor neurons die, muscles receive less or no stimulation and <strong>atrophy</strong>.</li>
          <li>Patients gradually lose voluntary control of muscles, including those for speech and breathing.</li>
        </ul>

        <h3>The Basal Ganglia: GO and STOP Circuits</h3>
        <p>The <strong>basal ganglia</strong> are a group of interconnected subcortical nuclei that play a crucial role in the control of movement.</p>
        <ul>
          <li><strong>Striatum</strong> – composed of:
            <ul>
              <li><strong>Caudate nucleus</strong></li>
              <li><strong>Putamen</strong></li>
            </ul>
          </li>
          <li><strong>Globus pallidus</strong></li>
          <li>Associated structures:
            <ul>
              <li><strong>Substantia nigra</strong></li>
              <li><strong>Subthalamic nucleus</strong></li>
            </ul>
          </li>
        </ul>
        <p>The basal ganglia help determine:</p>
        <ul>
          <li>The <strong>amplitude</strong> and <strong>direction</strong> of movement.</li>
          <li>Whether a planned movement is <strong>initiated</strong> or <strong>suppressed</strong>.</li>
        </ul>
        <p>They are especially important for movements that are <strong>influenced by past experience and learning</strong> (habitual or 
          practiced actions). Conceptually, the basal ganglia contain:
        </p>
        <ul>
          <li>A <strong>“GO” pathway</strong> that facilitates voluntary movement.</li>
          <li>A <strong>“STOP” pathway</strong> that inhibits competing or inappropriate movements.</li>
        </ul>

        <h4>Huntington’s Disease: Too Much Movement</h4>
        <p><strong>Huntington’s disease (HD)</strong> is a hereditary neurodegenerative disorder that prominently affects the basal ganglia.</p>
        <ul>
          <li>Characterized by <strong>cell loss in the striatum and cortex</strong>.</li>
          <li>Motor symptoms include <strong>chorea</strong>—involuntary, writhing movements and grimacing, reflecting 
            <strong>inadequate inhibition</strong> of motion.</li>
          <li>Non-motor symptoms:
            <ul>
              <li><strong>Cognitive impairment</strong></li>
              <li><strong>Depression</strong> and other mood changes</li>
              <li><strong>Personality changes</strong></li>
            </ul>
          </li>
        </ul>
        <p>HD is also a classic genetic disease:</p>
        <ul>
          <li>Caused by an expanded <strong>CAG trinucleotide repeat</strong> in the gene <strong>huntingtin</strong>.</li>
          <li>Normal alleles: ~10–34 CAG repeats; HD alleles: <strong>&gt;36 repeats</strong>.</li>
          <li>The more repeats, the <strong>earlier the onset</strong> of symptoms.</li>
          <li>HD and similar disorders are sometimes referred to as <strong>“CAG repeat”</strong> or <strong>“poly-Q”</strong> diseases.</li>
        </ul>

        <h3>The Cerebellum: Coordination and Precision</h3>
        <p>The <strong>cerebellum</strong> (literally “little brain”) is another major component of the extrapyramidal system, essential for 
          smooth, coordinated movement.</p>
        <ul>
          <li>The cerebellar cortex is organized around <strong>Purkinje cells</strong>, which send powerful <strong>inhibitory</strong> outputs to deep cerebellar nuclei.</li>
          <li>Through this inhibitory output, the cerebellum <strong>fine-tunes</strong> motor commands and adjusts ongoing movement.</li>
          <li>Across vertebrates, cerebellar size correlates with the <strong>range and complexity</strong> of movements the animal can perform.</li>
        </ul>

        <h4>Ataxia and Cerebellar Disorders</h4>
        <p><strong>Ataxia</strong> refers to uncoordinated movements resulting from cerebellar damage.</p>
        <ul>
          <li>Symptoms can include stumbling, difficulty with gait, jerky or imprecise limb movements, and tremors.</li>
          <li><strong>Spinocerebellar ataxias (SCAs)</strong> are a family of neurodegenerative disorders in which the cerebellum is primarily affected.</li>
        </ul>

        <h3>Summary: Brain Areas Involved in Movement</h3>
        <p>Many brain regions participate in the selection, planning, execution, and refinement of movement. Their roles can be summarized as follows:</p>

        <table style="width:100%; border-collapse:collapse; font-size:0.9rem;">
          <thead>
            <tr>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Structure</th>
              <th style="text-align:left; border-bottom:1px solid #ccc; padding:6px;">Primary Functions in Motor Control</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="padding:6px;"><strong>Prefrontal cortex</strong></td>
              <td style="padding:6px;">Selects appropriate behaviors and goals using information about the external environment and internal state.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Premotor cortex</strong></td>
              <td style="padding:6px;">Programs movements based on target location, body position, and external cues; important for learned stimulus–response associations.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Supplementary motor area (SMA)</strong></td>
              <td style="padding:6px;">Plans and sequences complex, internally generated movements; coordinates bimanual actions.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Primary motor cortex (M1)</strong></td>
              <td style="padding:6px;">Executes voluntary movements by sending commands via the pyramidal tract; controls force and direction of movement.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Basal ganglia</strong></td>
              <td style="padding:6px;">Integrates cortical and sensory information to facilitate desired movements and inhibit competing ones; crucial for movement initiation and habit learning.</td>
            </tr>
            <tr>
              <td style="padding:6px;"><strong>Cerebellum</strong></td>
              <td style="padding:6px;">Maintains balance, refines ongoing movements, and supports learning of motor skills; contributes to error correction and timing.</td>
            </tr>
          </tbody>
        </table>

        <p>Together, these systems transform neural plans into fluid, adaptive actions—from a simple reflexive knee-jerk to the 
          coordinated motor patterns of speech, music, and skilled movement.
        </p>
      </section>


</body>
<br><p><center>[ <a href="#top"><b>BACK TO TOP</b></a> ]</center></p><br><br>
</html>
